Serum and tissue protein studies in Down's syndrome. by Rundle, A. T.
SERUM AND TISSUE PROTEIN STUDIES IN DOWN'S
SYNDROME
A thesis submitted to the Faculty of Biological and
■ ■ U V;-' -•
Chemical Sciences for the Collaborative degree of 
Doctor of Philosophy in respect of work carried out 
at St* Lawrence's Hospital, Caterham, Surrey, and 
University of Surrey, Guildford, Surrey.
A.T. RUNDLE
MAY 1975 ,cS)?\
&
ProQuest Number: 10804432
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a com p le te  manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
uest
ProQuest 10804432
Published by ProQuest LLC(2018). Copyright of the Dissertation is held by the Author.
All rights reserved.
This work is protected against unauthorized copying under Title 17, United States C ode
Microform Edition © ProQuest LLC.
ProQuest LLC.
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml 48106- 1346
SUMMARY
In the quarter of a century since the first observation that 
patients with Down's syndrome exhibited an extra chromosome 
(24), numerous investigators have suggested the possibility 
of altered protein metabolism* Most of the subsequent 
effects of this additional chromosome were sought in altera­
tions in serum and tissue proteins with particular emphasis 
placed on the electrophoretic separation of serum proteins 
and the estimation of serum and tissue enzymes* Most of the 
claims for significant changes in enzyme levels due to the 
extra chromosome were later to be shown to be due to morpho­
logical changes in the tissues themselves, and apparent 
changes in the serum fractions to be due to the crude tech­
niques applied*
The increasing availability of more refined techniques for 
the separation of serum proteins on more sophisticated 
support media, and the increasing use of immunological 
methods allows for a re-evaluation of the whole subject of 
possible changes in protein metabolism concomitant to the 
extra chromosome, and it is to this end that this thesis is 
directed*
In the first section, the data on sixteen specific serum and
plasma proteins in 150 subjects with Down's syndrome is com­
pared with data on a similar number of mentally retarded 
control subjects. This section also contains data on 
electrophoretic fractionation of serum proteins and glyco­
proteins. The structure of some 30 individual proteins were 
screened using both Immunoelectrophoresis and double 
diffusion techniques, and the IgG fraction after purification 
were subjected to papain hydrolysis and the F^g and F^ frag­
ments of the Down's and control groups are compared.
In the second section, the data on the frequency distribution 
of a number of serum and red cell polymorphisms and isoenzyme 
systems are compared, and the genotype and phenotype 
frequencies are estimated.
In the third section, an investigation into the effects of 
parental age and some of the phenotype frequencies described 
in the second section are described, and a relationship' 
between one system (haptoglobin) and the parental age at 
birth of the Down's subjects is proposed.
In the fourth section, the screening of the Down's subjects 
for the presence of Australia antigen (hepatitis-associated 
antigen) are described, and possible relationships between 
the presence of this antigen, a suggested immunological defect
and changes in proteins is considered
In the fifth section, a comparison of the data from the 
first two sections with a group of 54 subjects with tuberous 
sclerosis is made* Both the affected groups of subjects 
show high mortality rates and similar patterns of infections 
and by comparing similarities and differences between these 
two groups possible changes in the Down's subjects due to 
selection by mortality are proposed*
In the sixth section a mathematical model is derived and 
applied to phenotype frequency distributions in Down's 
syndrome, and by its use an attempt is made to assess the 
value of such phenotype distributions in locating gene loci 
situated on the additional chromosome*
In the final section the data outlined in this thesis is 
summarised and in the light of the present findings sugges­
tions are made for the continuation of this aspect of Down's 
syndrome*
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INTRODUCTION
Furfuraceous idiocy was the description given by Seguin in 
1846 to a specific form of mental retardation (1) which is 
still considered today to be the most accurate description 
of the physical characteristics of growth in Down*s syndrome, 
although he considered the condition to be a sub-group of 
cretinism* In his classic paper of 1866 Langdon Down gave 
the first comprehensive description of the condition and ob­
served that certain classes of the mentally subnormal had 
similar characteristics >hich seemed to place them within 
definite ethnic families (2).
In 1876, Mitchel (3) summarised his findings on 62 cases and 
these notes were accompanied by a perfect description of a 
woman with the condition made by Fraser. The following year 
saw enough information for Ireland to produce his monograph 
on Idiocy and Imbecility (4) in which he recognised Down*s 
syndrome as a special type of mental subnormality, a sugges­
tion not totally accepted, as shown by Shuttleworth (1886) 
who regarded them as unfinished children and the causation to 
be one of arrested development (5) (although it should be 
noted that this author also remarked on the high frequency of 
cases being the last born of a long family). The physical
stigmata now considered as typical of the syndrome were 
rapidly established through a series of publications which 
covered such features as the mouth and jaw (6), eyes (7), 
hands (8) and the relationship between the syndrome and heart 
defect (9)*
‘ :
The present century has seen the accumulation of a vast 
literature on the condition (not to mention its own peculiar 
mythology} establishing it as a clinical entity, and only 
some of the more important reviews can be mentioned*
In 1909, Shuttleworth in England presented a review of the 
condition (10) followed by reviews from America (ll),
Germany (12), Spain (13) and Engler in England in 1949 (14)* 
It is of interesting historical note to point out that the 
last quoted work by Engler a quarter of a century ago was 
carried out in the hospital in which most of this work was 
done, and three of his original subjects are included in this 
investigation, it should also be noted that the second 
largest group of Down's subjects were resident at the Royal 
Earlswood Hospital, Redhill, which was the institution in 
which Langdon Down made his first observations*
The appearance of the work of Benda (15, 16) heralded the
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pathological approach which cars be traced to this day through 
monographs such os those of Donner (17) and Gustavson (18),
It hod long been suspected that the condition could be assoc­
iated with chromosomal abberations {X9 - 22) but at that time 
the cytological techniques were not adequate for the analysis 
of the human karyotype* With' improvements of technique# Thio 
and Levan were able to establish the diploid number of humans 
to be 46 (23) in 1956, m d  in less than three years later 
Lejeune et al (24) reported the underlying chromosomal anomaly 
in Down's syndrome.
Literature on Protein Metcbolosm in Down's Syndrome
The presence of the additional chromosome suggested to many 
the possibility of alterations in protein metabolism (25 - 27) 
and a survey of the literature on serum proteins and the syn­
drome could lead to the conclusion that the information was 
reasonably well-documented and a high degree of agreement 
existed between investigators* The agreement is more illusory 
than real# and the range of investigations is not only super­
ficial but limited to the extreme* In their critical review# 
Woodford and Bearn (28) have pointed out that many investiga­
tions were inadequately controlled# with the data on Down's 
subjects often being compared with normal data from different
3
laboratories often using alternative methods.
Although at least 70 chemical elements of the sera of Down's 
subjects were investigated in the decade following the 
chromosomal observation (29f 30) most activity was in the 
field of serum and tissue enzymes as a result of the first 
demonstration of elevated leukocyte alkaline phosphatase 
activity by Alter et al (26) a finding rapidly confirmed, and 
confirmed, and confirmed by numerous investigators (31 - 33). 
The next enpyme to be the subject of intensive work and ex­
tensive claims was whole blood galactose-l-phosphate-uridyl 
transferase on which Brandt, in no less than three publica­
tions (35 - 37), described elevated levels, subsequently con­
firmed by Hsia et al (36) who found elevated whole blood 
levels but not in erythrocytes, the same authors failing to 
detect any abnormal levels in either leukocytes or erythro­
cytes of a number of other enzymes.
Subsequently a number of serum and tissue enzymes became 
implicated, including erythrocyte galactokinase (39), 
erythrocyte alkaline phosphatase and acetlylcholinesterase 
(40), phosphohexokinase (41) and glutamicoxaloacetic 
transaminase (42) and serum pseudocholinesterase (43). 
Interest in enzyme levels as a method of gene location began 
to wane as reports based on stringent criteria began to
-  4 -
contradict earlier findings and finally doubt was cast even 
on the validity of the theoretical basis for such investiga­
tions (44)*
Before the human karyotype was defined, classical genetical 
methods of determining gene linkage were available, but in 
the case of the autosomal genes if was impossible to assign a 
linkage group to any particular autosome* Recent advances in 
cytogenetics have increased the theoretical methods available 
for the mapping of autosomal genes, particularly where large 
parts of chromosomes have either been duplicated as in the 
case of Down's syndrome and D/D trisomy or hove been deleted 
as in the case of myeloid leukemia (45). The procedure would 
involve the search for deviations in the frequency distribu­
tion of phenotypes, for example in a frisomic population, and 
compare this with the normal disomic population (46)* Prior 
to the start of this investigation there was already an 
extensive literature on the application of the phenotype shift 
to the location of genes on a trisomic chromosome, but with 
notable exceptions (47, 48) most of the experimental work was 
limited to the blood group systems (49 - 58)*
Since the onset of this investigation, information on the 
phenotype frequencies of a number of systems, both serum and
5
tissue, have become available, and although the literature 
on this field of work will be outlined in the particular 
section, one must quote the contributions of such investi­
gators as Laxova in amylase heterogeneity (59), Pitt and his 
colleagues in serum and red cell systems (60, 61) and the 
work of Riitner et al on the genetic predisposition to become 
carriers of the hepatitis antigen (62, 63).
. 6 -
METHODS
Statistical Techniques
Several simple standard techniques will he used, these in­
clude the mean and standard deviation (standard error), the 
students t-test* chi-square and correlation, but because 
these are so standard description will be deemed unnecessary* 
Non routine methods weres-
Gene Frequencies. Suppose we select from a large population 
a sample of n unrelated individuals* In this population three 
phenotypes G^ , G^ and.-G^ ’Gg are distinguishable, and evidence 
strongly suggests that these three phenotypes correspond to 
three genotypes G^ G^ , Gg Gg and G^ Gg where G^ and Gg are two 
alleles at the same locus* If in this population (if the 
Hardy-Weinberg law holds) the observed numbers were 
xGi G^ 4* yG^ G^ +' zG^ G^ then the estimate for the gene fre­
quency p for gene G^ and for G for gene G2 is given by:-
p = (2x + y) / 2n q = (y + 2z) / 2n 
and the standard error is given by
SEp o /p(l-p)/ 2n
- 7 -
These equations are given by Haldane (65).
Deviation from the Hardy-Weinberg Law (67). If x, y, z, p 
and q are as defined above then the deviation from the 
Hardy-Weinberg law is given by (67):-
2 2 chi square = n(y - 4xz)
(2x * y)^ (y + 2z)^
and the percentage excess of heterozygotes is - 200 (pq -^) 
with an
SE = 200 /p2 q2
n -
Haldaneb Log Ratio Test (65)
If in two populations one was found to contain y heterozy- 
goies and h homozygotes, and the other Y and H respectively, 
then the estimation of the log of the ratio of heterozygotes 
to homozygotes is given bys-
 ^ (2y * 1)(2H * 1) where Ln is the
uSvXlDCi wO S t«n , y — %. • \ / #ti * \ f m «
(2Y + l)(2h + 1) natural log.
with a SE - (b * y)(H -f Y) where N and n are the
Nn(N * n) two population sizes.
-  8 -
Arcsine Transformation
The term arcsine is synonymous for the inverse sine or 
sine and is a transformation particularly appropriate 
to percentages or proportions such as will be used in 
Section 3. The arcsine transforms used in this investiga­
tion were obtained from the tables of Noesteller and Youtz 
(66).
Linear Regression Statistics and G-Statistic
The equations of the linear regression, the estimate and the 
SE of the coefficient of regression and the G-statistic were 
all carried out as described by Sokal and Rohlf (63). 
Occasionally the G-statistic was chosen rather than the chi- 
square (which is similarly distributed) as it overcomes the 
problems of small numbers within cells. This G-statistic is 
given by:-
G s 2 ( ^  fLnf + N In N - 1 r Lnr)
where f and r are the cell frequencies and the row * column 
frequencies respectively and N is the sum of row and column 
frequencies.
- 9 -
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SECTION I
QUANTITATIVE AND QUALITATIVE STUDIES 
ON SERUM AND PLASMA PROTEINS
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Table 1
Review o f the literature on serum proteins in D own's syndrome
T est N orm al
i
Increased 1 D ecreased A bnorm al structure
T otal Carver e t al. (1959) ; - !
prote in D on n er (1954)
G reene et al. (1968) . i
P oszonyi and G ibson
(1963)
Stern arid Lewis i
(1957) | .
Albumin P oszonvi and G ibson | Carver et al.
(1963) i (1959)
Prilbam  c t al. (1963) ! D on n er (1954)
Skanse and Laureli i F luck (1962)
. (1962):. • Griffiths ct at. '
(1965) j
• H orvath (1955) ;
K apiitz et al. '■
(1964) i
Sobeli e t al. !
(1958) !
■ Stern and Lew is 1
! (1957) i
Torre (1958) |
rc a n d % -\  P oszonyi and G ibson : B orselii (1962) 
g lo b u lin s ; (1963) i
| Stern and Lewis (1957) ■
Y-
globulin
Griffiths ct al. (1965) 
Pritham et al. (1963) 
Carver and W elton  
(1961)
:
■
A ld e g h i(1960) 
A ppleton ct al. (1967) I 
Carver et al. (1959) 
D on n er (1954)
H orvath (1955)
K apiitz e ta ! .  (1964) 
M aderna e t al. (1961) 1 
Pritham  et al. (1963) 
R ovescnlli e t al.
(1965) : 
Sobeli et al. (195S) 
Torre (195S) 
Y okoyam a (1966)
A ppleton  et al.
! (1967)
1 Fluck (1962)
Fluck  and Pritham  
(1964)
Pritham  et al. 
(1963)
: R ow e c t al. (1966)
L ip o ­
pro te in
Benda and M ann  
(1955)
N elson  (1961) 
Sim on et al. (1954)
Stern and Lewis 
(1959)
(abnorm al pattern)
IgA
■
.
A dinolfi et al.
(1967)
K aldor and Pitt 
(1971)
A dinolfi et al. (1967) 
D yggve and Clausen  
(1970)
G reene e t al. (1968) 
Griffiths et al. (1969) 
(in m ales only) 
Stiehm  and Fudcn- 
berg (1966) 
Y okoyam a e t al.
. (1967) • !
.
■
.
(5•S? G reene et al. (196S) 
Griffiths et al. (1969) .
!
!
A dinolfi et al. (1967) ’ 
D vggve and Clausen  
(1970)
Stiehm  and Fuden- 
b erg(1966)
Y okovam a (1966)_______
M iller et al.
(1970)
(in new borns)
M iller ct al. (1970)
Ig M  |
. . 1
j
i
G reene et al. (1968) 
Griffiths e t al. (1969) 
Sutnick e t at. (1969)
!
i
i
A dinolfi ct at.
(1967) 
K ald cr  and 
Pitt (1971) 
Stiehm  and 
F a d e“berg 
(1966) 
Y okoyam a  
e t al. (1967)
.
'
Ig D  | . i R undle ct al. (1971) .
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INTRODUCTION
Many attempts have been made to demonstrate qualitative 
changes in Down?s syndrome by electrophoresis (l - 3), 
chromatography (4), ultracentrifugation (4) and other 
analytical methods (5, 6). An increase in gamma globulins 
and a concomitant decrease in albumin in institutionalised 
Down's subjects have been reported from many laboratories 
(2, 7 - 12) although there have been exceptions, normal 
albumin levels (l, 2, 13) and normal gamma globulin levels 
(l, 4, 15), The relevance of these findings to the intrin­
sic defect in Down's syndrome are questionable as they are 
not found in non-institutional Down's subjects (4). 
Quantitative studies on serum proteins have, in the main, 
been concentrated on the immunoglobulins and as was shown 
in Table 1, are somewhat contradictory* A particularly 
elegant study (14) by Rowe et al in a series of immunoelec- 
trophoretic studies of the serum proteins linked with 
adsorption or immunoidentity techniques failed to demonstrate 
any extra or missing bands but revealed concentration 
differences in the albumin, alpha lipoproteins, gamma globu­
lins, and the oxidase activity of ceruloplasmin higher than 
normal subjects but not higher than institutionalised
- 24 -
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non-Down's subjects. The increasing availability of 
commercial plates for the estimation of antigenically 
identifiable proteins by radial diffusion (12, 16) now alloi/s 
for 19 proteins to be estimated, a number in excess of any 
hitherto possible, and this together with the increasing 
sensitivity of methods such as electrophoresis on newer sup­
port materials, immunophoresis, counterelectrophoresis, 
microdouble diffusion techniques and rocket electrophoresis 
should advance the study of serum and plasma proteins in 
Down's syndrome considerably and perhaps eliminate some of 
the conflicting evidence in the literature.
- 25 -
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METHODS
Cellulose Acetate Electrophoresis* Routine electrophoresis 
on cellulose acetate membrane was carried out on all the 
Down's and control subjects* The method selected was that 
developed by Millepore in their Clinical Electrophoresis 
system (Millepore : Bedford Mass.) in which the separation 
Is carried out on support strips either 3” x 1" or 4” x 
in which the cellulose acetate is bonded to a semirigid mylar 
support* The sera are applied to the strip by means of a 
series of applicators consisting of two parallel welded 
strips which are separated to form a capillary space which 
will deliver 0.25 ^ ul t 0.05 yul. The serum proteins were 
separated in barbital buffer pH 0.86 = 0.075) for 20
minutes at 100 volts. The strips were air dried, stained 
with Ponceau S dye for 10 minutes, destained in three changes 
of ethyl acetate/glacial acetic acid (30 : 70) and heated at 
37° to dry. The cleared strips were scanned in a Phoroscope 
densitometer at 520 nm. The serum glycoproteins were 
separated in a like manner, stained with the periodic acid/ 
Schiff technique, washed three times in 5% sodium metabisu- 
phite, followed by two washes in tap water. After clearing 
in the ethyl acetate/glacial acetic the strips were scanned at 
560 nm.
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Fig. 1. Typical Serum Protein Fractionotions Following 
Electrophoresis on Cellulose Acetate.
Iramunophoresis. Irarounophoresis was used for the qualitative 
screening of serum proteins. The technique adopted was 
basically that described in the Gellman handbook (Gellman 
Instrument Limited Ann Arbor : Michigan). The separations 
were carried out on agarose strips (7.6 x 2.5 cm) in agarose 
gel (1% in barbitone : sodium barbiturate buffer pH 8.8). A 
standard well of 1.5mm and a trough width of 1mm was adopted 
with a diffusion distance of 2.1mm. Electrophoresis was 
carried out at room temperature for two hours at 3 - 5mA per 
frame of six slides. Diffusion against either whole human or
- 27 -
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specific antisera was allowed to proceed over night (16 
hours), and the resulting precipitation bands located with 
naphthalene black (for the lipoproteins 0.5% Oil red 0 in 50% 
ethanol had to be used owing to the faintness of the bands, 
this staining technique required at least two hours for 
optimum staining). Fig. 2 below shows the typical separation 
obtained by this technique.
Fig. 2. Immunophoretic Separation of Three Down*s 
Syndrome Sera (Whole Human Antisera)•
B - Lipoprotein (Low-Density Lipoproteinj. The low density 
lipoproteins were estimated using a commercially prepared 
pack (Boehringer Limited : London). This method involves the 
precipitation of the lipoprotein with a calcium chloride/ 
heparin mixture (25nM CaCl2i0.0125?S heparin:3.8nM NaCl), the 
subsequent solution of the protein precipitate in conc7 
sulphuric acid and the estimation of the lipoprotein
- 28 -
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as cholesterol at 580 nm with a cholesterol reagent (50mM 
dimethyl sulphonatc ; 7.0 M acetic acid : 6.5 M acetic 
anhydride)•
Serum Glycoprotein Estimations
IV Total Glycoprotein. Two methods were adopted to 
estimate the total glycoprotein, both involved an initial 
precipitation with perchloric acid and the subsequent precip­
itation of the glycoprotein with ortho-phosphoric acid (20) 
and their estimation either as tyrosine or carbohydrate.
Precipitation. In a 25ml conical flask, 0.8ml of serum was 
diluted with 7.2ml water, and 8.0ml 1.2?a perchloric acid was 
added dropwise with gentle shaking and the precipitation 
mixture allowed to stand at room temperature for ten minutes, 
after which it was filtered through Whatman No. 42 filter 
paper (5.5cm diameter). This procedure must be performed 
with great care to ensure reproducibility of results as some 
co-precipitation of the glycoprotein is bound to occur, and 
the extent of this depends on the amount of mixing, precipi­
tation time, filtration etc. (21).
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Estimation As Tyrosine. To 2.0ml of the above filtrate, 
0.4ml 5^ phosphotungstic acid in 2N HC1 were added, after 
mixing and allowing to stand for 10 minutes the precipitate 
was spun for 20 minutes at 2500 r.p.m. and washed with 1.5ml 
of the phosphotungstate. The precipitate was taken up in 
0.6ml 15/S sodium carbonate and 0.8ml water added. A tyrosine 
standard was' prepared (lOOmg in 100ml 0.1 N HC1, diluted for 
use 1:25 with 0.1 N HCl) and a blank of the 15^ sodium car­
bonate v/as prepared. To each of these three solutions 0.3ml 
Foiin and Ciocalteau reagent were added and this reaction 
mixture made up to 2ml with water. After mixing, the tubes 
were Incubated at 37° for 20 minutes and read at 700nm (lem 
light path)*
^aftjiosIneP1" = ^  Test. - ,p,Dr. Blank x S.g/lOO^l
0.D* Standard- O.D. Blank
Estimation as Carbohydrate. To.-2ml. of. filtrate, 0.4ml 
phosphotungstate was added as above, allowed to stand 5 
minutes, spun as above, washed with 1.5ml ethanol, dissolved 
in 0.3ml 0.1 N sodium hydroxide, and after complete solution 
1.7ml water added. A blank tube with 1.7ml water, 0.3ml 
0.1 N NaOH and a similar standard containing 25al of a
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carbohydrate solution (50mg each of mannose, and galactose 
in 100ml water) was prepared* All three tubes were cooled 
in ice for 15 minutes before adding 4.0ml of a 2% orcinol 
solution# After shaking, the tubes were returned to the ice 
bath for 15 minutes, after which time they were heated at 
80° - 0.5° for 20 minutes and the resultant colour read at 
505nm.
(a!°Lrbohvdratein = Q»D. Test - P.P. Blank * 25m0/lOOml 
corbohydrote) O.D. Standard - O.D. Blank
2. Serum Hexosamine. The total serum hexosamine was 
estimated by the method described by Weiden (21). To 0*2ml 
serum, 1.0ml N HC1 were added and heated at 100° for 6 hours 
under an air condenser. After cooling the contents were 
adjusted to pH 6.5 with 2N NaOB and made up to 20ml. The 
contents were filtered through Whatman No. 42 as above, and 
to l.Oral filtrate in an 8 x f" tube 1.0ml acetyl acetone were 
added, the wall© of the tube being carefully washed down with 
1.0ml water. The tubes were loosely stoppered and heated at 
100° for 15 minutes before rapidly cooling in ice. 9.2ml 
Ehrlich1s solution (1.5g in 75ml 95/S ethanol) and 25ml cone 
HC1 were added and the solution made up to 500ml with 95%
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ethanol. After standing in the dark for 30 minutes the 
colour was read at 515nm, and the concentration of hexosamine 
was determined with reference to a standard curve prepared 
from glucosamine HC1 (20 *-140 mg/lOOml).
3. Non-Glucosamine Polysaccharides (22). 0.2ml diluted
serum (1:2 with isotonic saline) was added dropwise onto 10ml 
ethanol. The precipitate removed by centrifuging and washed
with a further 10ml ethanol. To the precipitate 1.0ml cold
• ? ■ : '
1% aq. tryptophane was added with shaking and heated at 100° 
for 20 minutes. After cooling in ice, and allowing the 
solution to return to room temperature the mixture was read 
at 500nm, cmd the concentration of the non-glucosamine 
polysaccharides determined with reference to a standard curve 
prepared from equiconcentrations of d-galactose and d-mannose 
(0.02 - 0.16mg).
4. Sialic Acid. 2ml serum precipitated with 10ml 5% trich­
loracetic and the tubes refluxed at 100° for 20 minutes.
After cooling and filtering, in a tube 18 x 150mm 3.0ml of 
diphenylamine reagent (90ml glac acetic : 10ml cone sulphuric) 
was added to 1.5ml filtrate and heated at 100° for 30 minutes. 
After cooling in ice the reation mixture was read at 505nm,
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against a reagent blank and a serum blank.
Estimation of 17 Serum and 3 Plasma Proteins by 
Radial Diffusion
The proteins were estimated on commercially prepared plates 
(Behring: Mar.berg) which consists of 12 application wells con­
taining 5 jxl punched in an agarose gel containing standardised 
concentrations of specific antisera# The proteins thus 
estimated, their dilutions and running times are indicated in 
Table 2 below# The wells were filled with the diluted sera 
using 10 yuil syringes together with three concentrations of the 
protein per plate# After diffusion the precipitation rings 
were measured to 0.1mm in a special viewer and the unknown 
diameters compared to the log. of the three standards.
Protein
Table 2.
Cone. Ranae of Dilution Running
Plato {m/%). Time.
o^-Gcid glycoprotein 10 - 20 1 : 2 16 hrs.
o^-HS-glycoprotein 6 - 80 1 : 2 16 hrs.
o^-macroglobulin 20 - 230 1 : 2 16 hrs.
^-A-globulin 10 - 120 1 : 2 16 hrs.
Hemopexin 10 - 120 1 : 2 16 hrs.
^-glycoprotein 3 - 30 1 : 2 16 hrs.
- 33
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Protein Cone. Range of Dilution Running
Piote (mg/%). Time.
Haptoglobin 20 - 260 1 : 2 16 hrs.
Gc Protein - 40 1 : 2 16 hrs.
Prealbumin 3 - 40 1 : 2 16 hrs.
Transferrin : : 6 «• 75 1 s 10 16 hrs.
^-antitrypsin . .5 - 65 1 : 10 16 hrs.
o^-antithrombin . 3. ■ mm 30 Is 2 16 hrs.
yS^-E-globuIin 3 - 20 1 : 2 16 hrs.
Ceruloplasmin 3 - 30 1 : 2 16 hrs.
Fibrinogen 25 ~ 250 1 : 2 16 hrs.
Plasminogen .. 2 - 12 1: 2 16 hrs.
IgA 25 - 350 undil. 24 hrs.
IgG 15 - 200 1 : 10 16 hrs.
IgM 30 - 400 undil. 24 hrs.
IgD 2 M 30 undil. 24 hrs.
In order to obtain an accurate estimation of haptoglobin by 
radial diffusion it is essential to know the phenotype as 
equiconcentrations of the three haptoglobin types migrate at 
differing rates in agar. The method for the phenotyping the 
sera is given in Section three.
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Ouchterlonv Hicro-Double Diffusion
Double diffusion was carried out on microscope slides in 1% 
agar in Gelman high-resdlution buffer. The central well 
(antiserum) was surrounded by six sera wells at a diffusion 
distance of £mm (well diameters 3mm). Undiluted sera were 
allowed to diffuse against the antisera at room temperature 
for 16 hours, and the resulting precipitation lines examined 
for crossing of the arcs or for spur formation. In addition 
to the proteins in Table 2 the following proteins were 
screened
Albumin
glycoprotein 
c^-T-glycoprotein 
c/- lipoprotein 
^3-lipoprotein 
jB^-glycoprotein 1 
y62~SiycoProtein 11 
p 2-Qlycop.rotein 111 
Choiinesterase 
^ ‘esterase inhibitor 
Inter -c^~ trypsin inhibitor 
Uromucoid
o^-antichymotrypsin 
The specific antisera for this screening was obtained from 
Sehring: Harberg.
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IgG Hydrolysis by Papain and Examination of 
F ^  and F^ Fragments.
The papain hydrolysis method is basically that described by 
Porter (24)/ the purification of the IgG fraction is a mix­
ture of reported techniques described by Schultz© and 
Heremans (25)#
A 4H solution of ammonium sulphate was added to pooled sera 
from Down's subjects to a final concentration of 37.5^ in a 
cold room with constant stirring* The resulting precipitate 
was centrifuged at 5° at 18,000 r.p.m* The supernatant was 
removed and the precipitate washed with cold 37.5/£ ammonium 
sulphate. The precipitate was taken up in phosphate buffer 
pH 7.0 and checked by immunophoresis against monospecific 
IgG antisera and found to be predominantly IgG. Starch gel 
electrophoresis revealed some contamination with albumin and 
a purification stepwas introduced. Aluminium chloride 
(0.1 M) was added to the IgG solution in a 1.1 ratio at 0° 
(25) and the pH reduced to 4.7 with 0.1 N NaOH. After 5 
hours the resulting precipitate was removed at 0° and dis­
carded, the purified IgG precipitated by adding 95% ethanol 
at - 6°  to a final concentration of 25%» The precipitated 
IgG washed with cold 25% ethanol and after freeze drying
- 3d
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could be taken up in the phosphate buffer as above* Electro­
phoresis and iratnunophoresis could detect no appreciable 
contamination* Approximately Ig of the IgG was dissolved 
in the hydrolysis buffer (O.l M phosphate : 0.01 H cystein :
2 mM EDTA). To this was added 0*1 ml papain suspension 
(0*05 acetate buffer pH 4.5) and the volume adjusted to 20ml. 
Hydrolysis was allowed to proceed at room temperature over­
night, the reaction mixture dialysed against several changes 
of water for 48 hours and freeze dried. The resulting pre­
cipitate taken up in phosphate buffer pH 7.0 and examined by 
immunophorses and double diffusion against whole human 
antisera and against antisera specific to (v^ and fragments.
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RESULTS
Table 3
••Vy
Densitojnetric data on the scrum proteins and glycoproteins o f subjects with D ow n’s  syndrome and. 
V; • institutionalised control subjects,^after cellulose acetate electrophoresis
: r  r ... V
D own's ■syndKonie Controls
.vS  Test
N o .. M ean S .D . N o. M ean S .D .
t- tc s t  .
Scrum proteins (g/lOOml) 64 ' 6 -10 2 -0 4 91 7-80 1-40 4-80**
T otal protein  
A lbum in 64 2 -8 0 0 -0 6 91 4-08 2 -8 0 4 -OS**
otj-globulin 64 0 -29 0 -2 0 91 0-24 0 -0 7 1-66
a2-globulin 64 0 -7 4 0-21 91 1-02 0 -2 7 6-70**
P-globulin 64 0-93 0 -2 6 91 1-21 0 -2 4 6-15
y-globulin 64 1-48 0 -4 5 91 1-45 0-43 0 -4 0
Serum glycoproteins 
(%  o f  total)
Kj-glycoprotein 153 14-1 5 -8 154 16-06 4 -9 3-2**
a2-glycoprotein 153 4 0 -3 7 -4 154 38-9 6 -9 1 -7 .. .
-,v- p-glycoprotcin  
■&M y-glycoprotein
153 . 2 6 -0 4 -0 154 29-3 2 -3 s - g ^ - v ,
.V- ’*<•: 153 .I'"- l .S -9 ' . 6 -2 154 18-3 5 -4 0 -9
0.01 •i
Table 4
r •
Down4 s Group, 
Total Glycoprotein 
as
Tyrosine Carbohy­
drate
Hexosa­
mine
Down1* Group
Non-Glucosamine Sialic Acid
Polysac­
charide
(mg/ 100ml) (t»g/lOOml) (mg/lOOml)
(Optical 
Dens,}
5.2 6 19.2 84.2 108 0.091
6.31 ■21.5 124.8 152 0.108
4.01 21.6 118.7 94 0.083
3.40 18.9 122.6 104 0.069
4.36 22.4 108.1 92 0.141
4#99 23.3 90.5 98 0,122
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Down1s Group. 
Total Glycoprotein 
as
Down * s Group
Non-Glucosamine Sialic Acid
Tyrosine Carbohy­
drate
Hexosa­
mine
Polysac­
charide
(Optical 
Dens.)
(mg/100ml) (mg/lOOml) (mg/lOOml)
3.10 17.4 : : 82.2 106 0.065
5.44 24.7 87.9 , 141 0.113
9.82 28.2 ; ;94.-4 ■ 83 0.095
4.o4 17.3 121.1 111 0.072
5.82 15.2 130.6 124 0.091
8.26 29.0 89.3 99 0.131
3.91 18.6 95.8 138 0.081
7.15 24.2 115.7 106 0.130
5.50 19.9 111.2 102 0.099
3.13 19.7 119.2 120 0.133
7.28 22.4 93 115 0.126
Mean 5.48 24.2 104.2 110.5 0.103
SD1.77 3.5 15.6 17.8 0.023
Controls (n s 19)
Mean 4. 9 21.2 101.8 118.3 0.117
SD1.53 4.0 11.1 9.6 0.015
T-Test Between Groups ••
1. 1 2.0 0.62 1.65 2. 18
Reported Normal Ranaes
Mean 3. 3 21.8 101.5 114 -
SD1.0 6.3 11.0 3.2 mm
- 39 -
Section 1
Electrophoretic data on the serum proteins and glycoproteins 
are shown in Table 3, The significant reduction of total 
protein in the Down's group was surprising as one of the most 
consistent findings of other surveys is a normal total 
protein level (see Table 1)* The reduction in this total 
level is mainly due to the reduction in albumin levels, but 
significant reductions of the o^- and^B - globulins also make 
some contribution# The reduction in these latter two are in 
agreement with other surveys (l, 19)'.. No significant 
reduction in gamma globulins is in evidence, which confirms 
several other investigations (l, 4, 37)# Significant redue- 
tions in the percentage contribution of the andyB - gly­
coproteins can also be seen in Table 3# In the less sensitive 
paper electrophoretic survey Nelson et al (3) also reported 
a decrease of theJ3 - glycoproteins, but failed to show any 
changes in theo6^~ fraction. A similar finding to the reduc­
tions in these two fractions have been reported (26) but 
reference must be made to a report of the failure to detect 
any differences in the fractions when estimated as 
polysaccharides (4).
From the Down's group, eighteen subjects were drawn at random
40
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and a series of quantitative tests for glycoproteins were 
carried out as shown in Table 4, together with the same 
tests carried out on 19 control subjects also drawn at 
random and the t-test between the means for these two groups* 
In no instance could any significant difference between the 
two means be found.
Table 5 sets out the findings on the four principal immuno­
globulins in the two test groups and compares them by means 
of the t-test.
Table 5
•iv^Contpanson o f  the immunoglobulin levels in jp.o\vn!s syndrome subjects and institutionalised ’controis ’';:.y j
p.ImhniribglobiiUn 
[ - - (nigjW Q m l)
D ow n's syndrome.-*: Co ntrols N brtifd l y  J l  ’\  
(S/(>V//co 196S) |
\------—— —...........
N o. M ean S .D . N o. M ean S .D . t-te st Range M ean  j
IgA  
,• . IgG  ' 
if ^ ^ ' I g M
105
113
119
90
321-9
1520
119-8
7 -2
8 9-0  
522 . 
63 5 
3 9
99 
95 - 
lO f  
60 .
27 2 -4  
.1539 
131-9  
- 3 -0 9
109 
308 
4 3 -6  
3 -0 4
3-5  
0 -3 2  
1 -6  
7 -2
120-400; 
8.00-1800  
8 0 -1 7 0  • '
v;:-;194-; 
■V 1262^  
• > ; 12'3 -5
From the data in Table 5 it can be seen that the IgA and 
IgD are significantly elevated whereas the other two immuno­
globulins are within the expected range. Numerous surveys 
have suggested that a raised IgG level in Down's syndrome is
Section 1
common (see Table l) but as most of these rely on a compari­
son with non-institutionalised controls the finding in this i 
vestigation is probably a more accurate assessment of the sit 
uation* In Section 4 of this thesis the data on the immuno­
globulins will be assessed in the light of an abnormal immOno 
logical response in Down's syndrome*
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As no previous reports on the levels of IgD in Down's syn­
drome could be found, and there are several reports of a sex 
difference in the frequency of infections in Down's syndrome 
(see Section 4) the IgD data has been divided by sexes and 
the distribution of the data for the two sexes is shown in 
Fig* 3 below. The horizontal bar indicates the mean* No 
significant difference could be detected between the sexes 
(t = 1.51).
Fig. 3
.powns syndrome 
';fvta!e Female
Controls 
Male Female
Fig. 3 Distributions of Serum IgD Levels Between
Hale and Female Down's and Control Subjects
The quantitative data on 14 serum proteins in Down's syndrome 
are summarised in Table 6, together with data on the control
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groups for those proteins v/hich appear to deviate from the 
normal reported data. Comparison with the normal reported 
data (27, 41) failed to reveal any significant changes in 
fractions other than the ol^  -antitrypsin levels, a6^-acid 
glycoproteins, transferrin and haptoglobin. The interpre­
tation of the apparent abnormal levels of haptoglobin are made 
difficult by the differing proportions of the three pheno­
types found in different normal populations. Elsewhere I 
have shown that the three phenotypes are associated with 
differing levels of protein even when the changes in mobility 
are taken into account (28). In that publication I was able 
to show that the mean level of haptoglobins were :
Hp 1 : 1, 119.5 mg/lOOml (SD 32.1), Hp 2 si it was 208.2 
mg/lOOml (SD 71) and for Hp 2 : 2 it was 223.0 mg/lOOml 
(SD 71). When 94 subjects were selected from the control 
data having the same phenotype distribution as the Down's 
subjects in Table 6 the total mean haptoglobin was found to be 
209.3 mg/lOOml (SD 92.1) which does not differ significantly 
from Down's syndrome. Of the other three apparently abnormal 
proteins in Table 6 comparison of two of them (transferrin 
and oC ^ -antitrypsin) with the institutionalised control group 
failed to confirm the difference. The third, the o^-acid
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glycoprotein remained elevated (t e 7.2, F « 0*001}•
Although it is outside the scope of this thesis, it is in­
teresting to not© that compared with the non-institution- 
alised control subjects (normals) the o6^-aeid glycoprotein 
levels in the institutional controls are significantly 
reduced (t = 2.1, P = 0.05).
Table 7 summarises the levels of three plasma proteins in 
Down's syndrome and compares them with the control group and 
reported normal data. Comparison of the means fey t-test 
failed to reveal any significant differences between the two 
groups in any of the three fractions.
Table 7
Levels of Three Plasma Proteins in 59 Subjects with Down's 
Syndrome and 61 Institutionalised Control Subjects.
Protein Fraction Down's Control t-test Normal (27)
(mg/lOOml) Mean SD Mean SD Range SD
Fibrinogen 303.2 73.1 296.0 59.1 0*58 200-450 -
Plasminogen 17.1 4.4 18.3 3.05 1.05 15-20 17
oC 2~Antithrorabifi 33.4 10.1 36.2 8.2 1.7 / - ■
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Structural Changes* '
Comparison of the 33 proteins listed in the methods section 
between the Down*s and Control groups, double diffusion and 
immunoelectrophoretic failed to show any structural diffe­
rences, nor were any additional precipitation lines observed 
other than the transformation of the^3^-C- globulin to^B^-A- 
globulin which has been shown to occur spontaneously in 
normal sera (28). X n one reported study it was suggested 
that there are locational differences in both the o^-globulins 
and theo^-lipoprotein regions (14) but using the •short 
trough* technique this could not be confirmed* The Authors 
of that report (14) were in some doubt whether the locational 
differences were due to structural changes or were a concen­
tration effect* The double diffusion method confirmed there 
were no measurable changes in immunological response of the 
proteins studied, for as Ouchterlony has pointed out, 1 if the 
arcs fuse but neither cross nor spur the proteins are immuno- 
logically identical* (23). The above observations suggest 
that the locational differences referred to above are most 
likely due to concentration effects*
Structure of the IgG Fraction
There have been several suggestions on the structural change
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in the gammaglobulins in general and the IgG fraction in 
particular (see Table I), The mobility of IgG from the two 
test groups were compared by electrophoresis and imraunoelec- 
trophoresis and no such differences could be observed.
Fig. 4. Immunoelectrophoretic Patterns;Upper and Lower 
Well- Hydrolytic Product of Purified IgG from 
Down*3 Syndrom. Centre Well - Purified IgG 
from Control Sera. Upper trough - Anti-F Serum 
Lower Trough Anti-F^ Serum.
Fig. 4b. As in Fig. 4a but Controlhydrolysote. Centre Well 
Unpurified IgG.
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Pooled sore IgG from both groups was subjected to papain 
hydrolysis followed by immunophoresis with diffusion against 
antisera specific for the ,-F^.g and fragments. The results 
of this are shown in Fig. 4 even casual inspection shows 
that the increased mobility of the F^ fragment that has been 
reported (31) could not be confirmed.
4r ’
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DISCUSSION
On© of the major problems in assessing the value and validity 
of any survey on serum and plasma proteins in Down's syndrome 
is the difficulty is assigning any changes observed, to the 
syndrome per se or to the increased frequency of infections 
in the syndrome which itself may either be due to the cond­
ition itself or due to the -whole process of institutionalisa­
tion. Although increased frequency of infection is a general 
finding in most surveys (8, 15, 32, 34) the risk seems to be 
variable in the extreme, probably due to variations in success 
of instituting a satisfactory regime of hygiene. It is this 
variation in infectious rates which probably accounts for 
many of the divergent views put forward by previous investiga­
tors. One good example of this was the failure to find 
reduced levels of albumin in a sample of Down's subjects who 
had only recently been admitted from home (8). As will fee 
shown in Section 4, there is little to show that the elevation 
in the levels of IgA and IgD is other than the normal response 
to a chronic infectious situation, although it has been 
suggested that because the Down's subjects are so prone to 
infections that for this reason alone they are usually sub­
jected to a more rigorous programme of vaccination and it may 
fee this which contributes to the abnormal findings (8, 35, 36).
Section 1
The lack of differences between the protein levels of the 
t\*o groups investigated confirms similar findings elsewhere 
(37) and stresses the need for careful control of the 
'normal' subjects selected for comparison (38).
At first sight the results of the electrophoresis by cellu­
lose acetate and the estimation of the individual proteins 
by radial diffusion appear to be contradictory, with the 
former suggesting a lack in the OC^-glycoprotein whereas 
estimation by radial diffusion suggests the opposite. Such 
differences arise through the lack of sensitivity of electro­
phoretic methods and through non-availability of antisera to 
proteins known to exist in serum. The o4^-glycoprotein band 
by electrophoresis is known to contain not only theo^-acid 
glycoprotein and o(. ^ -antitrypsin estimated by radial diffusion 
but also<c^«P-glyeoprotein (easily precipiatable glycoprotein, 
Trp- ot^ -glycoprotein (tryprophane poor),o6^-X-glycoprotein 
and the post albumin 4.6 S PoS (25). It may be that the very 
divergence of the results obtained by the two techniques -will 
prove more interesting than the actual data and a search for 
differences in these lesser fractions is indicated. One of 
the earliest and still most consistent findings is the 
elevation in IgG levels, a finding not supported by this
- 50
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investigation, nor was the suggestion of structural differ­
ences in the F^ fragment confirmed. However, it should be 
noted that the suggested F^ , abnormality arose during studies 
in neonatal Down's subjects, and there is evidence that these 
neonates are atypical of Down' s subjects as a whole, depressed 
levels of IgG in newborn Down's have been reported (31) as 
also have abnormal immunophoretic patterns (39).
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INTRODUCTION
Ford has defined genetic polymorphism as "the occurrence 
together in the same habitat of two or more discontinous 
forms or phases in such proportions that the rarest of them 
cannot be maintained merely by recurrent mutation", (l). 
Although heterozygote advantage is thought to play an im­
portant part in maintaining this polymorphic balance, the 
roles played by specific diseases and clinical entities are 
only beginning to be explored. Although the search for 
unusual distributions of genetic markers in disease states 
is one approach to this problem of determining the factors 
which keep polymorphism in balance it is not appropriate for 
Down's syndrome since this condition is attended by a gross 
reduction in fertility.
There are, however, compensatory inducements for investiga­
ting polymorphism in Down's syndrome, among others, these 
include possible association with late maternal age, changes 
in frequencies resulting from the high mortality rate and 
possible association with the much-reported increased in­
fection rates.
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The earliest work on possible changes in the frequencies of 
polymorphic systems predate the discovery of the additional 
chromosome fey several years, and reported extensive investi­
gations on blood typing (ABO, MNS, Rh, P, Lewis and Kell)
(2 - 9) occupied a number of investigators for more than 
Half a century. Prior to the start of this investigation 
with the exception of felood grouping and one study on hap­
toglobins and transferrins (11) and a study of several 
systems on a very small population (iO) (both surveys which 
have been criticised on several counts) the information on 
this aspect of Down#s syndrome is surprisingly sparse.
This section will report on seven serum and nine polymorphic 
systems from red cells, and data on the phenotype frequen­
cies, gene frequencies, deviation from the Hardy-Weinfeerg 
law, genotype and phenotype association, and the effects of 
age and sex on these will be adduced. The systems to be 
investigated will fee;
Serum Haptoglobin. Three main forms of haptoglobin are en­
countered in most populations and these are due to the
1 2inhoritence of two autosomal alleles Hp and Hp which in 
combination give rise to the three principal phenotypes
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Hp 1:1, Hp 2:1 and Hp 2:2 (12, 13). Investigation of large 
numbers of individuals of various ethnic origin has revealed 
a number of quantitative and qualitative variants, all of 
which have a low frequency end represent sporadic mutation 
of the two principal alleles (14).
Serum Group Specific Proteins. The variability of a group 
of alpha-2-globulins, subsequently named group specific or 
Gc proteins was first recognised by Hirschfield (i960) (15)# 
and later shown to be a polymorphic system inherited as a 
pair of co-dominant autosomal genes giving rise to three 
phenotypes Gc 1:1, Gc 2:1 and Gc 2:2 (16). Although a number 
of variants have been described, these are very rare.
SeruinJB ^-Glycoprotein 1. Schultze et al (1961) (17) were able 
to demonstrate the presence in serum of an unknown jBg* 
globulin having a molecular weight of 40,000. Subsequently# 
Augener estimated the amount of this protein in the sera of 
normal adults and found a range of 23.5 i 4.4 mg/lOOml (18). 
Although the concentration of this protein is influenced by 
such external factors as age, sex, chronic liver diseases# 
pregnancy, etc., it has been shown to be controlled by a pair 
of autosomal genes giving rise to three phenotypes Bg N:N,
Bg NiD and BgD:D with the BgN allele being more common (19).
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Serum Leucine Naphthylamldase 8-Sand. Polymorphism of this 
enzyme (EC 3.4.1.1) is not under simple genetic control as 
in the above three examples. The sera of all normal sub­
jects exhibit a bond of activity, but some exhibit an 
additional slower running band (34) v/hich varies in concen­
tration from total absence to relatively high concentrations. 
Studies on twin and family data (7, 21) showed that this 
additional band (B-band) is partially under genetical con­
trol, but lack of complete concordance suggests that envi­
ronmental factors may influence its presence in the serum, 
as can compounds such as oral contraceptives (22) and drugs 
.'(21, 23).
Serum Cholinesterase (Pseudocholinesterase)« The analysis 
of the genetical control of the serum cholinesteraseshas made 
considerable progress in recent years, and it has become 
clear that there are o'number of loci involved (32 « 38) with 
a number of phenotypes requiring inhibition techniques 
(Dibucain, fluoride, Ro number) for their identification. In
1963, Harris et al (56) d escribed an additional phenotype 
v/hich they termed €r v/hich could be characterised by an 
additional band of activity moving slov/er on starch gel than 
the common band, and shoved that in a normal British
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population a frequency of 0.13 could be anticipated.
Red Cell Adenosine Deaminase. By means of a starch gel
electrophoresis and specific staining technique Spencer et al
(39) demonstrated the occurrence of three different adenosine
deaminase patterns in human red cells, and family studies
1 2proved that these were due to two alleles ADA and ADA". Some 
rare additional alleles have been described (40, 41).
Red Ceil Pyruvic-Glutamic Transaminase. Glutamic-pyruvic
transaminase (ALT) is one of several enzymes which exist in
both cytoplasmic (soluble) form and mitochondrial (residual)
form. In mature red cells only the soluble form is present
(42 - 44) and genetic polymor ph ism of this soluble enzyme
1 2representing two alleles AL1 and ALT have been described 
(44).
Red Cell PhosphoqlucQBiutcse. Phosphoglucomutcsse (PGT) is an
enzyme in which three structural gene loci affecting the 
molecular characteristics of the different PGT isozyme com­
ponents have been identified (46). Each PGT locus determines 
a characteristic set of two or more isozymes with none of 
these appearing to hybridise. A series of electrophoretic
-  68 -
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variants attributable to the occurrence of multiple alleles 
of each of the three loci have been identified (47). In 
most tissues PGT^ locus predominates and accounts for some 
90 - 95$ of the total activity; the PGT locus isozymes
account for some 5 - 10/S with less than 2% being contributed
3 . ^
by the PGT locus. The greater contribution of PGT is
possibly due to the differences in relative rates of syn­
thesis, but there is a distinct possibility that the diffe­
rent sets of isozymes differ markedly in specific activity.
I 2
In the red cells, the PGT and PGT loci both contribute
3 "about 50$ of the activity with no PGT products occurring 
possibly due to the instable enucleate state of the cell, 
although some instances of ’young* red cells exhibiting weak 
PGT activity has been reported (47).
Rod Cell Acid Phosphatase. Red cell acid phosphatase (AcP) 
is a phosphohydrolase and phosphotransferase with a low 
optimum pH v/hich has so far been detected only in erythrocy­
tes (47), differing in substrate specificity from the acid 
phosphatases existing in other tissues. Three principal 
alleles are known to exist at the red cell locus the A, 8 and 
C alleles giving rise to six recognisable phenotypes with the 
B allele most common and the C allele least common in British 
populations.
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Red Cell 6-Phosphogluconate Dehydrogenase. This enzyme 
system (PGD) was first shown to exibit polymorphism in 
erythrocytes (48), and studies have shown the three common 
variants to be due to a single-locus, two allele system 
(49). A number of uncommon variants have been described, 
including the Richmond and Hackney types (50) and the 
Frieberg variant (51), all of which are associated with 
bands of the A type, the two former variants having addi­
tional slower bands, and the latter a single additional 
faster band.
Red Cell Adenylate Kinase. (Al<) Adenylate kinase is a 
phosphotransferase:
2 ADR— — — > ATP * AMP
and is present in most human tissues with particularly high 
levels in red cells and skeletal muscles (46). Using starch 
gel electrophoresis it is possible to recognise three common 
European phenotypes due to the combination of two autosomal 
alleles at the AK locus (52).
- 70 -
Section 2
Glucose-6-Phosphate Dehydrogenase. (G-6-PD). THg discovery 
that primaquine-induced sensitivity was associated with 
G-6-PD deficiency in the rod cell (53) led to many investi­
gations with important results in the field of clinical 
medicine, genetics and anthropology. Subsequent investiga­
tions have shown many genetic variants to exist (enough to 
warrant a WHO publication (54) ). Some of these variants are 
associated with normal enzyme activity and have no clinical 
manifestations (e.g. the A variant in Negroes) while others 
are associated with haemolytic disorders in the presence of 
external factors (fava beans, drugs and infections). Most 
variants are rare but occasionally a variant is found to be 
common to a particular population (presumably due to 
selective advantage), examples of those are the Mediterranean 
and A -deficiency types which probably owe their survival to 
selective advantage vis-a-vis Falciparum malaria (55).
Isocitric Dehydrogenase. NADP-dependent isocitric dehydro­
genase (XCD) catalyses the oxidative decarboxylation of L- 
citrate to oL -ketoglutarate, and like the enzyme ALT referred 
to above exists in most tissues in tv/o forms a soluble and a 
residual form (85 - 88), and also like the ALT only exists 
in the soluble (cytoplasmic) form in the erythrocytes. Rare
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variants of this system have been reported with electropho­
retic patterns consistent with a dimeric molecular structure, 
with family studies suggesting that the enzymes structural 
locus is autosomal and distinct from the locus governing the 
mitochondrial forms of the enzyme (92).
ABO Locus and Haemoglobin. These two systems require little 
in the way of an introduction, the ABO locus is an interna­
tionally recognised genetic marker with reported normal 
frequencies in practically all conceivable populations and in 
most abnormal populations. Haemoglobin exists in two 
principal forms in the adult with a main A band and a slower 
migrating band, additionally in some electrophoretic 
systems the A band can be shown to be heterogeneous being 
capable of splitting into an additional band.
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METHODS
-Glycoprotein 1, The quantitative estimation of this pro­
tein is fully described in the first section of this thesis 
together with observed data on the two test populations* 
Cleve (19) suggested that individuals homozygous for the 
gene Bg N should be limited to those with serum levels of 
16 - 30mg, the subjects heterozygous for the genes BgN and 
BgD showed an intermediate level of 6 - 14mg and the homozy­
gous Bg D:D less than 5mg 3100 ml* Reported normal 
frequencies include a number of European populations but do 
not include a normal English frequency (19, 56, 91), and to 
rectify this a sample of 381 normal healthy adult English 
subjects were tested and the results of this survey are in 
Fig. 1 below.
Slight differences were shown in the English population# and 
the criteria for the three phenotypes that was finally 
accepted were:-
Type Bg D:D 
Type Bg DsN 
Type Bg MsN
less than 4mg/lQ0ml
4 - 14 mg/lOOml
Equal or greater than 
15 mg/100 ml.
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Serum Gc Proteins. Although a number of well documented 
electrophoretic methods are available for the phenotyping 
the Gc proteins, Immunoelectrophoresis v/as the final method 
of choice, as it combined the separation by electrophoresis 
with the specificity of precipitating antibodies. Details 
of the technique are described in the first section of this 
thesis.
ABO Blood Groups. Grouping was carried out by
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haemagglutination using commercially prepared antisera with 
sub-grouping of the A group not being carried out.
Starch Gel Electrophoresis. With the exceptions noted above, 
phenotyping was carried out on horizontal starch gels 
(15 x 0.6 x 15cms) in.batches'of 10 - 12 sera, the gels 
being prepared from 11^'starch in various buffers. The runs 
were carried out in a cold room at 5° overnight at 7 5 - 2 0 0  
volts depending on the system being used. After slicing the 
proteins were located using specific staining or substrate 
mixtures, either directly on the cut surface or incorporated 
in 1/S agar which was poured onto the cut surface and the 
locating agents allowed to diffuse into the starch gel.
Details of these techniques are given below:-
Locatina Agent Locating Technique
Aik. Phosphatase.
100ml 0.1M tris (pH8.8) -f 10 Direct on cut surface,
drops aq MgCl * lOOmg Na^3- Heat at 37° for 5 - 10
Naphthylphosphate *$• lOOmg Blue minutes.
RR salt.
75
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Locating Agent 
Leucine Naphthylamidase 
Solution A : lOmg L-leucyl-4- 
naphthylamide -HC1 in 25ml di­
methyl formamide, diluted to 
50ml with phosphate buffer 
pH7.0.
Solution 8 : 50mg Black K salt 
in 50ml phosphate buffer pH 7.0.
Haptoglobin
100ml water * 0.2g benzidene 
0.5ml glacial acetic acid.
2ml hydrogen peroxide (100 
vols.) added before use.
Phosphoglucomutase 
Stain Buffer : 10ml 0.2 H 
trisi HC1 pH 8.0 0.I7g
glucose-1-phosphate. 411^ 0 •!- 
2.2mg glucose 1.6 diphosphate. 
2H^0 *r 10ml buffer containing 
20.3mg MgCl^ * lOmg NADP * 80
Locating Technique
Direct. Develop at room 
temperature with soln. A 
for 2 hours. Replace with 
soln. B develop at room 
temperature.
Direct. Heat at 37° until 
bands are optimum.
In 75ml 2% aqueous agar 
overlay and incubated at 
37° until optimum bands 
appear.
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Locating Agent 
Phosphoglucomutase (contd.) 
units glucose-6-phosphate dehy- 
drog. + Img PHS + lOmg MTT.
Made up to 50ml with water.
C,. Esterase —5*— :--:----
lOOmg Fast Blue RR'+ 10ml tris 
HC1 (pH7.0) -r 3/0 Ma D^-ncphthyl 
acetate * 87ml water.
Haemoglobin
As for haptoglobin above.
Adenosine Deaminase
40mg adenosine * lOmg HIT
10mg phenazine methosulphate *f
0.16 units Xanthine oxideasc *
1.6 units nucleoside phosphory-
lase.
Glucose-6-Phosphate Dehydrog.
2mg -NADP 4- 2mg MTT * 2mg PMS 4- 
lOmg Nag Glucose-6-phosphate in
Locating Technique
Direct at room temperature 
for 30 minutes.
As for haptoglobin above.
In 100ml 2/o agar in 0.025M 
phosphate buffer pH 7.5. 
Incubated at 37° until 
optimum bands.
Soaked into filter paper and 
applied direct. Incubate at
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Locating Agent
Glucose-6-Phosphote Pehydrog, 
(contd).
10ml 0.5M iris HC1 pH 8.0.
Locating Technique
37 until optimum.
6-Phosphogluconote Pehydrog.
3 m g NADP + 6mg MTT + 1.2mg PHS In 1% agar overlay. Incubate 
4* 30mg Na^-6-phospho-gluconate in at 37° until optimum.
10.5ml 0.5H tris HC1. Dilute to 
30ml.
Acid Phosphatase 
0.163g phenolphthalein 
diphosphate in 50ml 0.05H 
citrate buffer pH6.0.
Adenylate Kinase 
6ml 0.5H tris HC1 pH8.0 4- 
3.0ml 0.1 M MgClg 4- 60mg 
glucose 4- 15rag ADP 4- 7.5mg 
NADP 4-4.5 units G-6-PD + 9 
units hexokinase 4- 7.5mg HTT 
4- 7.5mg PMS.
Soak into filter paper and 
apply to cut surface. Wrap 
in plastic film and incubate 
at 37° for 4 hours. Sprinkle 
NH^OH on the filter paper.
Soak onto filter paper 
apply direct incubate at
37°.
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Locating Agent 
Glutamic-Pyruvic Dehydrogenase 
0.3564 g 1-alanine + 0.0254 g 
cA-ketoglutarate + 0.0124 g 
NADH2 in 20ml 0.1 M tris HC^ 
pH 7.6
Locating Technique
Soak onto filter paper and 
apply direct. Incubate at 
37° for 4 hours examine gel 
under UV light (354nm).
Isocitrate Dehydrogenase 
As for G6PD but pH 7.8 and use 
7.8 mM d, 1 citrate as sub­
strate.
As for G6PD.
The condition for the preparation and running of the starch 
gels were:-
System Gel Buffer
PGT 0.1M tris:0r01M 
maleic: 0.001M 
EDTA. pH 7.4 
ADA 0.01M phosphate
pH 6.4 
AK 0.01H phosphate
pH 7.3
Bridge
Buffer
As gel
Volts/cm Reference
12
As gel
Anode:0.22M
phosphate
pH6.35
Cathode:0.33H 
Phosphate pH6.45
10
96
39
51
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System Gel Buffer BridgeBuffer Volts/cm Reference
ALT 0.1M tris cit­
rate pH 7.5 
PGD As AK
AcP 0.02511 phosphate:
0.015 M citrate 
pH 5.9
G-6.PD, 0.05M tris EDTA
boric acid pH 8.0 
Hp 0.076 M tris:
0.005M citrate 
pH 8.6 
AlkP As Hp
LNA As Hp
Cg 0.01M sucinate:
0.0184M tris pH 
6.0
Hb tris; EDTA pH8.6
1CDH 1:10 dilution of
bridge buffer
As gel 10 45
As AK 10 51
0.245 Phos- 4.5 46
phate: 0.15 10 93
citrate 
pH 6.45.
As gel 10 93
0.3M borate: 14 93
0.05 M Na)H 
pH 8.0
As Hp 13 94
As Hp 13 95
M Na0H:0.41M 12 10
citrate pH6.0
As gel 14 93
0.1 M tris- 10 92
citrate pH 7.0
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RESULTS 
Serum Polymorphic Systems
Haptoglobin, Table 1 summarises the frequency distribu­
tion of the three principal haptoglobin phenotypes in the 
two test groups with the two sexes analysed separately and 
combined. Also included in Table 1 are the gene frequencies 
and estimates and standard arrors of the % excess of 
heterozygotes (58).
~ --------------------------__---------..    ...------  Minwm.------> ji ___________  ..„...........     . ____________________________________________________
: N ' +  " Table 1. Haptoglobin phenotype frequencies iri the Down’s and control groups ’ !
Sample No. of
cases
Haptoglobin
phenotypes ;.'r+6‘
\ Gene •
' frequeiicy
Excess
heterozygotes (%)
1:1 2:1 2:2 Hpl Hp2 estimate S.E.
Down’s male 141 24 70 47 0.418 0.582 +  0.98 4.10
Down’s female 113 21 53 39 0.420 0.580 — 1.8 4.58
Down’s combined 254 45 123 86 0.419 0.581 — 0.27 3.0
Controls male 655 92 353 210a 0.410 0.590 +  5.4 1.8
Controls female 198 30 95 73 0.391 0.609 +  3.8 3.4 •
Controls combined 853 122 448 283 0.404" 0.596 +  2.1 1.6
a ^2 :^ 8t5 (p =  0.01).
Neither group when the sexes were combined deviated signi­
ficantly from the Hardy-Weinberg law, but the male controls 
did deviate significantly at the P = 0.01 level as indicated 
in Table 1. The ge ne frequencies of both groups were well 
within the range of frequencies reported for normal Europ­
ean populations (59 - 62), Ball et al (63) have reported a
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decrease in the proportion of Down's subjects heterozygous 
for haptoglobin, and although the data in Table 1 would seem 
to contradict this the data was subjected to Haldane's log 
ratio test (64) :
0.164 i 0.14
i.e. no such deviation occurred in this sample.
The data on the % excess heterozygotes in Table 1 is also in 
direct contradiction to that of Ball et al (64).
Group Specific Proteins. Table 2 compares the group 
specific protein frequencies of 166 subjects with Down's 
syndrome and 255 control subjects. The Down's subjects show 
a considerable excess of Gc 2 : 1 type an excess which by 
Haldane's log ratio test (64) is significant 
(0.457 t 0.201, P= 0.01).
The percentage of heterozygotes in excess of the 
Hardy-Weinberg law is also significant (*f 4.8%, SE 2.39).
Ln 2 : 1
1 : 1 + 2 : 2
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Table 2
Comparison of the Group-Specific Protein Phenotype 
Frequencies in 166 Subjects with Down’s Syndrome & - 
255 Control Subjects.
Control Down * s Down*.s' Syn-
Sub Sects* Syndrome drome Expected
■ 1 .- 1 . .128 63  ^ 83.3 "
2 - I 108 91 70.3
■ "2 - 2 , ' ■ • 19 : - 12 12 *4
Totals 255 166 166.0
D.S. 0.666 control 7^ = 0.714
The frequency of the Gc allele Gel for the combined control 
group of 0.714 does not differ significantly from the reported 
frequencies of several European and America (Caucasian) popu­
lations (59, 67, 97), and the frequencies of the three pheno­
types in the control group do not differ significantly from
/ 7 -t h e  Hardy-Vieinberg expectation = 0 . 3 6 ) .
Table 3 compares the means and standard deviations of the 
serum levels of the Gc proteins in 119 cases of Down’s 
syndrome and 55 control subjects. There is a slight reduction 
in the mean levels of the Down's group v/hich is just signifi­
cant at the 5/b level. To check if there v/as any bias to 
these results due to the three phenotypes migrating at
Section 2
differing speed (by analogy with the haptoglobins) this data 
has been sub-divided in Table 3 by phenotypes, and although 
there appears to be a slight increase due to the Gc^ allele, 
this is not significant at the 5% level.
Table 3. Comparison of the serum levels of group-specific proteins (mg/100 ml) of 119 cases 
of Down’s syndrome and 55 mentally subnormal controls
N  Mean (mg/100 ml) Standard deviation
Down’s syndrome 119 29.9 8.96
Control subjects 55 32.8 9.1
t =  1.96 P  =  0.05
Down’s syndrome 45 30.22 9.57
(type 1—1)
Down’s syndrome 57 29.7 8.4
(type 2—1)
Down’s syndrome 10 26.7 3.8
(type 2—2 ?)
Leucine Naphylamidase Isoenzymes 
Fig. 2 
series 
runnin 
the ot!
Fig. 2.
shows a photograph of starch gel electrophoresis of a 
of sera containing varying amounts of the slower 
B -band. The two outer sera contain no B-band, while
S.tfx,r,ch. qe,l, fd f\c. t,rnphare s i s .jaJ. jfl. i ,th
i n.g, o.f. .thjs.. Xftur.i nft., jua.ph.th y.l am i d n s ft B^hnad
^lower bandit From left to right these were TatarI.
Q, 1, 2, 3, 4f Q J.i^ tensjLtieA.
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Table 4 compares the frequencies of the intensities on the 
four point scale of the serum leucine naphylamidase B-bands 
for Down's and control groups. Also included in this Table 
are the normal data on 147 Swedish subjects (21).
Group N o .1 V;7 2  +  / .3. • Low (0+1+ 2) High (3+4)
Down’s 160 81 56 " '‘7 16 153 7
Controls 83 48 ■+.' 21 11 v ■ 3 , • a 80 3 :•+:
Swedish 147 137 10
Compared to the Swidish data there appears to be a decrease 
in the frequency of the high intensity subjects in both the 
Dov/n*s and control groups, but the rating is highly subjec­
tive and this difference probably arises from ratings 2 and 
3. Taking the four point rating there is no significant 
difference between the two test groups (x =5.3) nor is 
there any difference when classified as low and high inten­
sities (x2 = 4.8).
In one Down's subject (male aged 42 years) an additional band 
of activity running slower than the B-band was encountered 
and Fig. 3 shows the starch gel electrophoresis of this sub­
ject compared to sera containing no B—band and B—band inten­
sity 3.
- 85 -
Section 2
Fig. 3. Starch gel electrophoretic patterns of serum 
leucine naphylamidase isoenzymes. From left 
to right : control serum with B-band intensity 
3, control serum no B-band and Down's subject 
with an additional slower running band.
To investigate this unusual pattern some 800 sera from normal 
subjects referred for liver function investigations were in­
vestigated and a number of unusual patterns of the isoenzyme 
were found in addition to the two normal patterns.
A representation of the most common patterns are shown in 
Fig. 4 below.
Zone 
B -*
1 2  3 4 5
Fig. 4. Five types of leucine naphylamidase isoenzyme 
patterns in subjects showing clinical indica­
tions of acute liver disfunction (iaundice^"!^
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The type 3 in Fig. 4 above was found in 23 cases and closely 
resembles that of the unusual Down* s subject. It is probably 
the same pattern as that reported elsewhere (90) in six 
cases of acute infective hepatitis. Subsequent testing of 
this serum for the hepatitis associated antigen (see 
Section 4) confirmed this as a diagnosis. In all the cases 
of type 3 pattern this additional slower band is always 
associated with the presence of high intensity B-band and 
preliminary studies (23) have suggested that they are not of 
pancreatic origin as both are inhibited with methionine.
Serum Alkaline Phosphatase. Table 5 summarises the frequency 
distribution of the two principal alkaline phosphatase types 
in 241 sub jects with Down * s syndrome with the Pp2 types also 
segregated according to their ABO blood group.
—Isyg—y.  .— .———  —  -----   .---- -- --- —..    __________________ _• ____ .. -
| -; '-.Serum alkaline phosphatase isoenzymes andblood groups in 241 subjects with Down’s syndrome ,V
i ;: • ;Blood group Type Ppl Type.Pp2.C ;• ;v/ f  Percentage of type Pp2 :
found expected found expected this investigation Beckman (1964) . '
87 90.3 23 19.6 21.0 30.4
82 73.1 7 15.9 7.7 2.3
25 30.4 12 - 6.6 t 1. ;: 32.4 30.5
4 4.1 1 ; d • • : : ;’:20.0 15.2 : '
198
The overall frequency of 17.8>o for the Pp2 type does not 
differ from that reported in normal subjects (Beckman (65) ) 
(x~ =1.96). Segregation by ABO blood groups shows a decrease
o
......... A
/ •v -  B
: a b
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of type A in Pp2 subjects over type B with type AB falling 
intermediate between them. This general trend has been well 
established for normal populations and comparison of the 
test data with that of Beckman (65) in Table 5 shows the 
similarity between normals and Down1s subjects in this 
respect.
^ ^-Glycoprotein. 1. Pig. 5 compares the ^ ^-glycoprotein 1 
distributions of 91 control subjects and 98 Down's subjects. 
Comparison of these distributions with those of normal sub­
jects shown elsewhere in this section (Fig.1) should be made 
In Fig. 5 the vertical bars indicate the phenotype mean and 
the horizontal bars are - 1SD from this mean. Since liver 
disfunction is known to affect the levels of this protein
data on 45 jaundiced normal subjects are included in Fig. 5
i  D ow n’s Syndrome >
12 -
Controls
10
. Jaundiced Serum
5 15 20 25 j
12
8
4
;  Serum levels o f  B2 glycoprotein I (mg%)
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From the t-tests shown in Table 6 there were no significant 
differences between., means--either for the two test groups 
combined or between the phenotypes of the two groups. The 
frequency of Bg N gene was found to be : for the Down's sub­
jects 0*944 (SE 0*016) and for the control group 0.939 
(0.018) a difference which is not significant. Neither 
groups deviated from the Hardy»Weinberg lav/ (x = 0.346 and
0.376 for Down's and control groups), and the gene frequen­
cies of both groups are similar to that reported for normal 
German (0 .953) (56) and English populations (0.941) (6 6 ).
Table 6
Down’s  Controls
Phenotype No. Mean SD No. Mean SD T-test
H : D 11 11.34 2.3 11 11.56 1 . 2 0.30
N ; N 87 18.96 2.1 80 18.81 2.38 0.43
D : D 0 - - 6 -
Combined 98 18.10 '2.16 91 17.9 2.30 0.3
Serum Cholinesterase C,.
. 0
Serum cholinesterase Crb typing was carried out on 1 0 0 sub
jects with Down's syndrome (19 of whom were positive) and 95 
control subjects (17 of whom wore positive). This frequency 
difference was not significant.
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Red Cell Polymorphic Systems.
Haemoglobin, Isocitrate Dehydrogenase and 61ucose-6y PD« In 
the presentation belov/ these three systems will not be inelud 
ed. In 150 subjects examined for the ICDH system all were 
found to be phenotypically 1 : 1 as would be expected for a 
Caucasion population. Ho examples of the rare haemoglobin 
types were encountered, and one rare variant of the A type of 
G-6 PD was found, and this will be described elsewhere*
The phenotype frequencies of the remaining six red cell poly­
morphic systems are given in Table 7 below.
To investigate whether or not there is either sex or age 
effects on the distribution of these phenotype systems the 
Down's sample was sub-divided by sex and into three age cate­
gories, 0 - 18 years, 19 - 2 8  years, 29 - 63years. The data 
from Table 7 so subdivided is presented in Table 8 below.
Section 2
Table 7. Phenotype frequencies of six red cell
polymorphic systems in Down's subjects 
and in control subjects.
P h e n o ty p e  fre q u e n c ie s  o f th e  D o w n ’s an d  c o n tro l s u b je c ts
r r eq u e n c ie s
!Enzyme .P h en otyp e D ow n’s  syndrom e  
Found • E xpected
C ontrols  
Found E xpected
PGT
(m ales)
PGT
! (fem ales)
!
ADA-^ ' v (*>;•
i1 * v » t1 ‘1 *'■’ • • ’ ’
AKX.1/
i  thf-rK' > - v
i
6PGD
ALT
1:1 70 71.4 114 118.2
2:1 CO 57.15 82 73.4
2 2 10 11.45 7 11.4
140 203
1:1 72 71 124 ' 125 8-
2:1 36 37.9 77 .*726
2:2 - 6 • . 5.1 '• 8 ■ ’ ,’1? ^
114 * 209 •• V.
1:1 221 • 219.2 374 370 9
2:1 30 33.5 40 45 6
2:2 3 1.28 4 1 40
> 254 418
• \ ‘
• ■" -r i
1:1 228 227.2 169 172 8
2:1 12 13.6 11 1381'
2:2 1 0.2 0 0 03- «-»i *
241 180
AA 47 * 49 51 56.2
AB 115 113.5 192 181.0
BB 66 65.8 141 145.7
AC 13 11.1 7 7.2
BC 11 12.9 10 11.6
CC 1 0.6 1 0.23
253 402
r --
AA • , 234 234.3 167 167.5
AB 11 10.5 11 10.3
BB 0 0.1 0 0.16
245 178
1:1 44 45.8 34 ... 38.3 -
2:1 118 110.9 98 : 90.0 :
2 2 62 67.3 49 . ’52.8 ■*
224 181
£/i
The expected frequencies are based on the system obeying 
the Hardy-l.’einborg'lav/.
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Table 8
System
PGT].
ADA
AcP
AK
PGD
ALT
Phenotype frequencies in Table 7
sub-divided by nqe and sex*
Pheno­
type
0-18 Years 19 - 28 29 - 63 0 - 63
Female iale Female Hale Female Hale Female Male
1 : 1 11 5 20 11 41 54 72 70
2:1 4 10 10 13 2 2 37 36 60
2 : 2 2 0 2 4 2 6 6 10
total 17 15 32 28 65 97 114 140
1 : 1 15 ' 14 1)0 26 35 82 99 1 2 2
2:1 1 1 4 2 tj 16 1 1 19
2 : 2 0 0 0 0 3 0 3 0
total 16 16 32 28 65 98 113 141
A ' 4 ■ .4 5 4 11 19 20 27
AB O • 0 7 1 2 13 32 43 52 . 63
B 2 2' 11 9 18 24 31 35'
AC 1 1 2 2 3 4 6 7
BC 1 1 2 0 2 5 ■ 5. ' o
CC a 0 0 0 0 I 0 1
total 16 .15 32 27 66 96 114 139
1 : 1 16 13 27 23 60 89 103 125
2 : 1 0 1 0 ’ 3 6 2 6 6
2 : 2 o 0 0 0 1 0 I 0
A 16 1 2 29 25 64 8 8 109 125
AB 0 O 2 1 2 3 4 7
B 0 0 0 0 0 0 0 0
total 16 15 31 26 6 6 91 113 132
1 : 1 0 1 7 7 14 15 21 23
2 : 1 10 9 1 2 1 0 30 47 52 66
2 : 2 2 4 6 8 18 24 26 36
total 1 2 14 25 25 62, uu 99 125
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With the exception of the PGT^ system no significant effects 
of either age or sex could be detected. Comparison of the 
combined males x combined females for the Down’s subjects 
revealed a significant increase in heterozygote frequency 
(x = 10.5, P = 0.01) and it can be shown that this is 
entirely due to the younger age group (0 - 18 years)
(x2 = 16.7, P = 0.001) with the other two age groups showing 
no difference (x = 2.14 and 3.24).
In Table 9 below the distribution data from Table 7 has been 
subjected to further analysis
i If
• 
.'-'.V'S.
. . rrrr— r*. •" • " ~.v -
D ow n’s' syKdfShiP • i ^* -T- . ..
'v> •''<■»'/* *
^■■44 \ He.terozygptes^ >4 .4 ? .+  4  
* • %* .y. ' . 'V;.
G ene D eviation
Enzym e A lle le freq u en cy s .e .  E stim ate s .e . from H-VV fr
. PGTi - PGT’, 0.714 0.027 2.02 1 . 7 . 0.35
(m ale) PGT2! 0.2S6
PGTi. PG T i 0.789 0.027 - 1 . 7  1.55 0.205
(fem ale) P G T , 0.211
ACP A 0.44 0.021 + 5 .8  2.97 1.03
B 0.51
C 0.05
ADA ADA1 0.929 0.011 ' - 1 . 4  0.83 2.70
ADA2 0.071
AK AK1 0.971 0.008 -  0.6 0.36 3.311
AK2 0.029
6 PGD PGD1 0.978 0.007 + 0 .18  0.28 5.23*
PGD2 0.022
ALT ALA1 0.452 0.023 + 3 .2  3.32 24.19***
ALA2 0.548
i
,.V K \  - 4 - .
'4; '• V .  *
■t - '-s
.e 9* Analysis of the frequency distributions
of six red cell polymorphic systems.
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Comparison of the gene frequencies of the two groups failed 
to reveal any differences, and with the exception of the 
ALT system there were no differences between the Down's 
group and the reported gene frequencies for normal European 
populations (67 - 69). In a recent review, the gene fre­
quency of ALT^ allele was shown to vary in European popula­
tions from 0.48 to 0 .54 (70) which is in agreement with 
American data (70), and this is somewhat higher than either 
the Down’s or control groups in this investigation.
In addition to the failure to detect any differences between 
the gene frequencies in Table 9 no differences by the 
Haldane log ratio test could be detected. A slight reduction 
of the proportion of heterozygotes from that expected by the 
Bardy-l/einbera lav/ was found in the AK system and in the 
PGD systems of the Down's subjects.
Tables 10 and 11 summarise the possible first order inter­
actions among the phenotypes of the six red cell systems and 
the Gc and Hp serum polymorphisms. These were carried out 
using the G-statistic as outlined in the Introductionary 
section (72). Significant associations could be detected 
between the PGT and AcP genes in the Down's group and between
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the Hp/AcP and Hp/ADA in the control groups. This investi­
gation failed to confirm t h e  report (99) of an association 
of AcP allele A'with age in the Down's subjects, but did 
confirm a report (73) of a significant association between 
AcP and Hp in the control subjects v/hereas no such 
association existed in the Down's group.
T  a b l e  1 0
.• G -te s ts  fo r  th e  d e g re e  o f a s s o c ia tio n  b e tw e e n  p h e n o ty p e s  o f th e  D o w n ’s .s u b je c t s •
' ■   ;   ■’:
'V:>
....
AT A . 
vV;T:.Ar
i l l !
i.1
ADA ACP AK PGD ALT Hp G c ABO
PGT 8.6 22.2** 4.1 4.6 2.07 4.00 3.5 3.89
ADA 10.91 4.57 3.13 8.25 3.27 3.9 1.95
ACP 4.36 9.78 5.92 1.64 . 7.0 7.27
AK 3.8 3.60 1.40 0.66 4.03
PGD 0.47 4.35 1.99 0.41
ALT 4.6 1.8 8.60
HP 4.15 2.03
Gc 2.28
** P  =  0.01.
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Table 11
’G ^ e s rts;y(or.<the d e g re e  o f a s s o c ia tio n  b e tw e e n  p h e n o ty p e s  o f th e  c o n tro l s u b jep ts ; j 
PGT ADA A C r A A L T  PGD Hb G c ;
*' **>GT 506 4 .2 6 : A t.& V.';' 0.52 4.43 8.26 2.3
(4) (10) ' (4) (4) (4) (4) (4)
ADA 5.5 1.96 7.8 5.7 9.5* 1.4
(10) (4) (4) (4) (4) (4)
ACP 7.96 1S.2 10.8 5.4** 1.74
(10) (10) (10) (10) (4)
AK 4.32 7.12 7.5 2.88
. . (4) ( 4 ) .  (4) ( 4 ) - .
ALT 8.76 2.24 0.12
(4) (4) (4)
PGD 0.64 0.94
. (4) (4)
ASQ Blood Group System
Table 12 below compares the blood group distribution of 
the 256 Down’s subjects in this investigation with a number 
of surveys previously reported,,
Table 12
t V t p  -A B O  b lo o d  g ro u p  d is tr ib u tio n  s y n d ro m e  c o m p a re d  •witb;. ^ : '  "I
T i A A ' A -  re p o rte d  f r e ^ u e d c i e T , ^  , ' J ? / I
Popqlatipfr Total A .. :tA B ; . /
. • \ : , V
:S  A 5 * 0 R eferen ces  "  " ' ■"* •
A ustria 44 21 7 1 15 Y es Orel (1927)
Germ any 26 14 1 0 11 Y es Manitz (1932)
England 166 83 14 3 66 Y es P en rose  (1932)
U .S.A . 125 48 12 5 60 No B enda & B ixby (1939)
England 100 48 9 3 40 Y es E ngler (1949)
England 148 . 53 9 5 .. 31 No Lang Brown et al. (1953)
59 24 7',/'.';, ii ■ A eT :?4 Y es H aeck el (1954)
y.S;A^ld' ' 793 349 94:T - :T ! P25>.. ■J/;325 Y es Shaw  & G e rsh p w itr“(1962)
290 118 34T  I t ; p ^ :'123 No Kaplan et a l.-d 9 6 4 )v ;7 :. ’
Enro la h d ’ . 256 104 321p l - T ^ .^ { 1 ^ 1 3 No P resen t investigation-'V
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Even casual inspection of the data in Table 12 shows the 
divergent findings of both Penrose (5) and Lang Brown (2) 
with that of this investigation, although all three samples 
were drawn from the same geographical area. The frequency 
of type B in the present sample is much greater than that 
found in the two surveys quoted and is similar to the data 
of Shaw and Gershov/itz (8). Using the method of least 
likelihood (74) the frequency of the A gene was found to be 
0.305, the 0 gene 0.08 and the 0 gene 0.615,
Rare Variants Detected
Several rare variants among the control sample were detected 
during the course of this investigation, these included 
several examples of abnormal haemoglobin, one example of the 
AK phenotype 3 : 1, but further investigation of these were 
outside the terms of reference for this thesis and will not 
be reported upon.
In the-Down's group, reference has been made above to an un­
usual pattern of leucine napiiylamidase isoenzymes which was 
possibly due to liver damage. Several examples of reduced
haptoglobin levels were encountered which could be interpre-
0ted as examples of the silent Hp gene, but as has been shown
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elsewhere (75) these are more likely to be cases of hypohapto- 
globinoemia secondary to liver disorders than heterozygote 
for the silent gene.
One example of PGT locus 2 type 3 : 1 was detected in a male
subject with Down*s syndrome, and subsequent investigation 
of the family failed to detect this variant in either the 
mother or the presumptive father and presumptive sibs. Some 
doubt on the parenthood of the propositus was cast and co­
operation of the family for full blood grouping to establish 
paternity was refused. Fig. 6 below shows the photograph of 
the starch gel for the ^GT2 locus, haemolysate a, b and d are
all 1 : 1 and haemolysate c is the 3 : 1 variant.
Fig. 6
O r i g i n
(a)  (b)  (c)  (d)
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Fig. 7 is a starch gel electrophoresis of the G-6PD system, 
haemolysates a, b and d are the common variant (type B) 
whereas sample c constantly showed an additional band of 
activity running faster than the B variant and is probably 
the A variant common in coloured populations. Investigation 
of the family proved abortive as they were reported to have 
'gone abroad1 and as some doubt is cast on the Caucasian 
origin of this subject all data on this person was removed 
prior to analysis of the Gown's group.
Fig- 7
in one Down's subject (female aged 50 years) an unusual 
variant of the PGD system was detected. Two bands of activity
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were detected which differed in mobility from the position 
of the AB homozygous form. Fig. 8 below compares electro­
phoretic patterns of this subject (haemolysate b) with the 
common phenotype PGD A : A (samples a, c and d) and the 
rarer homozygous PGD A : J.
Section 2
Fig. 8b above is a diagrammatic representation of the PGD 
patterns in Fig. 8 sample e is the unusual variant, sample 
b is PGD type A : B and the other samples are the common 
type A.
Examination of the literature has failed to produce another
example of this variant. The parents of this subject are
* ' 
now deceased, but one normal sib and several relatives
(cousins, aunts, etc.) all failed to reveal this variant and
the mode of inheritance, whether an inherited variation or
a sporadic mutation remains conjecture*
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DISCUSSION
The finding of a normal phenotype distribution in the hap- 
toglobin system confirms the work of earlier investigators 
(10, 11), but fails to confirm the observation of Brackenridge 
et ai (73) of an excess of type 1 : 1 in male Down's when 
compared with female Down's subjects, within their sample 
the males hotorozygotes exceeding the control sample by 
10*5/£* One possible explanation for this divergence in find­
ings was suggested by the observation of an apparent maternal 
age effect on the proportion of heterozygotes for hapto­
globin in male Down's subjects but not in female Down's 
subjects (63)*
This aspect will be investigated in depth in Section 4*
The data on the leucine aminopeptidase patterns is more com­
plex than the simple genetic control as shown by most of the 
systems investigated* The presence of this B-band is only 
partially under genetic control, and is affected by external 
factors such as the administration of oral contraceptives 
(22), and drugs such as the phenothiazine and barbiturate 
derivatives (23, 65)* The hypothesis that the 8-band is a
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sensitive indicator of altered liver function (22) is hard 
to reconcile with the finding of normal B-band intensities 
in the Down's subjects in this investigation, as Down's 
subjects are known to be more susceptible to liver damage 
resulting from increased susceptibility to infections such 
as the long-incubation period form of hepatitis (discussed 
further in Section 4).
The significant shift of the phenotype frequencies of the 
Gc proteins in the Down's group is suggestive, at first sight, 
of the location of this system on the trisomic 21st chromosome. 
However, if one were to propose a simple dosage effect one 
could anticipate a 50/5increase in the quantitative levels 
of this protein in the serum which is manifestly not the 
case* Further evidence against locating the Gc proteins on 
the trisomic chromosome can be evinced from the data on the 
albumin levels in Down's syndrome. In Section 1 the litera­
ture on the levels of serum proteins was surveyed, and per­
haps the most consistent finding was a reduced albumin level, 
a finding true of the present sample. The locus for the Gc 
proteins has been shown to be closely linked with that of 
albumin (80) which should be elevated if the two loci were 
located on chromosome 21* To propose that the Gc locus is on
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the 21st chromosome would require some unjustified hypothesis 
that the appearance of the phenotypes in the blood origina­
ting in the liver (81) must be under some unusual form of 
control in the Down9s subjects* There are three possible 
mechanisms which may account for the appearance of an excess 
of the heterozygotes in the blood without recourse to sugges­
ting the location of the locus on the trisomic chromosome*
The first possibility is that the frequency of the heterozy­
gotes are in some way affected by the maternal age of the 
subjects (by analogy with the haptoglobin system as will be 
shown in Section 3), this possible mechanism will be invest­
igated in Section 3* The second arises from the observation 
of possible association between the Gc 1 : 1 phenotype and 
the presence of long-incubation hepatitis virus in Down9s 
syndrome, this possibility will be considered in Section 4* 
The third possibility follows the observation on family data 
by Reinskou (83) that the Gc genotype may influence the 
survival of the foetus and in a condition such as Down9s 
syndrome where pre-natal and peri-natal death rates are high, 
even a marginal advantage could cause selection by mortality* 
This possibility will be investigated in Section 5,
The genetic mechanisms for the appearance in the blood of the
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intestinal form of alkaline phosphatase (Pp2) requires not 
only the interaction of the ABO locus and the secretor 
status, but also the presence of other unspecified 
•genetic factors* (28) and the correct response to the effects 
of diet (29). The evidence of this investigation suggests 
that although there may be slight changes in one or more of 
the individual mechanisms listed above the overall effect is 
neutral*
The failure to detect any differences in the frequencies of 
the red-cell systems investigated confirms the findings of 
several surveys published after the start of this investiga­
tion (10, 77) but it should be noted that in a more recent 
communication (73) one of these authors have shown a decrease 
in the proportion of heterozygotes for the PGT system in 
female Down*s subjects compared with either male Down*s or 
control females* The sample of Dawn*s subjects in this sur­
vey also showed this slight decrease (31*6^ against 42*8^)*
The increase in proportion of PGT type 1 : 1 in males under 
18 years probably reflects age trends shown by other sur­
veys (73, 71), and the mechanism for this is not clear but 
a recent report has been made of an excess of heterozygotes
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found among children, but not their parents, in Danish,
German and English families and that the PGT locus is sub­
ject to selection (77)*
The finding elsewhere of a significant decrease in females 
with Down's syndrome of red cell acid phosphatase type AG 
and an age trend associated with a decrease in type A with 
increasing age (73) could not be confirmed* However, if the 
age trend is true, then a fortuitous selection in ages of 
the Down's subjects may counteract the former effect*
Probably the most interesting feature of this section was the 
observation of an apparent association between the acid 
phosphatase and haptoglobin in the control group but not in 
the Down's group, an observation confirmed elsewhere (84)*
It has been suggested (84) that the association between these 
two systems may be an example of conditional heterozygote 
advantage with heterozygosity in one system being favoured 
by heterozygosity in the other* This, however, is pure 
speculation, but it is known that at least the two loci are 
not closely linked (85, 86).
Considerable interest has been focused on the possibility
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that the ABO locus may be situated on the G chromosome (87). 
Shaw and Gersbowitz (8) showed a deficit of group 0 and an 
excess of Group A and B, a situation which could arise from 
the contribution of two alleles from one parent. The con­
firmation of this by observing an AB child from 0 and AB 
parents is still not forthcoming and it is still necessary 
to rely on changes in phenotype frequencies to strengthen 
or weaken the case. Normal ABO frequencies in England (88) 
from a study of more than 190,000 individuals analysed by 
the technique of Fisher and Taylor (89) showed a frequency 
of 0 gene 0.688, B = 0.06 and A = 0.257. Adopting the same 
technique the frequencies in this investigation for the 
Down*s group yielded: 0 = 0.653, A = 0.257 and B = 0*087,
i.e. an excess of group B at the expence of group 0 
(significant at P =0.05). Of the nine surveys quoted above, 
six have shown an excess of group A over 0, and two the 
reverse. It should be noted however that Down1s subjects 
have been shown to be more compatible with their mothers 
than fathers and selection against ABO incompatible offspring 
is highly likely (79). If this is so, further family 
studies may yet provide valuable information on the causa­
tion of non-disjunction and its possible relationship to 
specific phenotypes.
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THE EFFECT OF PARENTAL AGE ON SOME 
PHENOTYPE FREQUENCIES IN DOWN'S SYNDROME
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INTRODUCTION
The association between Down's syndrome and parental age 
has been known for some time, with Fraser and Hitchel 
(1876) (1) being credited with first producing evidence of 
late maternal age effect, and subsequently Penrose (2) and 
Jenkins in the same year (1932) (3) showing that the age 
of the father was irrelevant. Two years later Penrose was 
able to show that the maternal age effect was independent 
of parity (4).
Recently Richards (5) has been able to point out "statisti­
cal enquiries have contributed greatly to our understanding 
of mongolism during its one hundred years history, but it 
is doubtful if much more information can be squeezed out of 
the available data by its use. What we require is more de­
tailed information about the biology of the mother, particu­
larly about oogenesis and the surrounding physiological and 
pathological events". Burch (6), from an analysis of log- 
log graphs of the relative frequency of births of Down's 
subjects in control populations against maternal age for 
English and Swedish populations has deduced that at least 
ten random events initiate the pathogenic processes respon­
sible for most offspring with Down's syndrome born to
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mothers of late maternalage.
In their analysis of polymorphic frequencies Ball et al (7) 
observed a positive linear regression of the proportion of 
male Down's subjects heterozygous for the haptoglobin system 
on maternal age, and more recently the same laboratories (8) 
reported similar positive regressions for the PGT system*
It may be possible that one or more of the random events as 
outlined by Burch (6) may involve either the phenotype of 
the offspring or possibly maternal/foetal incompatability*
In this section, the possible relationship between parental 
age and five polymorphic systems will be considered, and an 
analysis to assess the possible foetal/maternal incompata* 
bility will be attempted*
Family Data ,
The age of the father and mother of all the subjects invest­
igated in this section was obtained to the nearest year from 
the required form completed on admission of the subject to 
hospital* In those cases where these were either incomplete 
or equivocable, additional information was requested from 
next of kin* From similar sources the number, sex and birth
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order of all sibs (including still births and miscarriages) 
were obtained* Of the original sample of 256 Down * s sub­
jects, reliable information was obtained on 221 cases*
During the course of this investigation, blood was obtained 
from the parents of 94 subjects with Down's syndrome*
Selection of Parental Age Groups
In an attempt to minimise bias, cumulative frequency curves 
for both paternal and maternal ages was drawn up for both 
the Down#s and control groups. The parental age groups 
were then selected in terms of the tenth percentiles rounded 
off to the nearest whole year providing ten approximately 
equal groups*
Regression of Heterozygote frequency on Parental Age*
In order to make the analysis comparable with that reported 
elsewhere (7) the proportion of heterozygotos to homozygotes 
was transformed into the arc-sine transformation as outlined 
in the introductory section. The subsequent equations of 
regression, the 95% confidence limits and the deviation of 
the coefficient of regression from zero were carried out 
using standard procedures (9).
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Estimation of Parity Effect*
The effect of parity on the frequency of the heterozygote© 
for haptoglobin in Down's syndrome via© determined using the 
method described by Penrose (4). Unfortunately, without 
phenotyping the haptoglobins of all the sibs (some 900) a 
complete analysis of the data could not be performed* As 
these 900 sibs were distributed throughout the whole United 
Kingdom such a survey was outside the scope of this thesis.
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RESULTS
Table 1 shows the distribution of the sibships in the sub-
sample of 221 Down,s subjects* Using the method of Penrose
2
(4), a birth order effect could be detected (x s 64.8,
P s 0.01) but as Penrose has suggested (9) this birth order 
effect is probably secondary to the late maternal age effect.
Table 1
T able 1. P arental age
P osition N um ber o f  sibsliip P o u n d  E x p .’
in sibsliip 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
1 23 22 11 G 1 63 82.4
2 —  28 8 3 4 1 44 59.4
3 —  — 33 5 — — — — — — — — — — — — 38 34,4
4 —  — —  15 — 2 — — — — — — — — — — 17 17.1
5 —  — —  — 11 1 — — — — - — — — — — — 12 9.85
“ 6 —  — —  — — 11 — 1 ■ — — — — — — — 12 6.6
7 —  — —  — — — 8 — 1 — — — 1 — — — 10 4.15
8 —  — —  — — — — 7 2 — ■ — — — — -— — 9 3.03
9 —  — —  — — — — — 5 — 1 — — — — — 6 2.03
10 —  — —  — .— — — — — 3 2 — — — — — 5 1.13
11 — 0 0.8
12 —  — —  — — — — — — — — 3 1 — — — 4 0 .5
13 0 0 .23
14 0 0 .06
15 0 0 .06
16
23 50 52 29 16 15 8 8 8 3 3 3 2 0 0
1
1
1 0 .06
23 25 17.3 7.2 3.2 2 .5 1.1 1 0.9 0.3 0.3 0 .27 0 .17  0 0 0 .06
. 221
Tables 2 and 3 below shows the data in Table 1 sub-divided 
into sibships in which the Down*s subject is homozygous or 
heterozygous for haptoglobin.
131 -
Section 3
| b , •; T able 2. Sibsh p o f  m ongols horhazVgbus 4or h aptoglob in
p ositio n ';* N um ber o f  sibsliip F 6ij«< F E lp .
m .sibsh ip ; 1 •> 3 4  5 6
* «•*" ••■• * ’■
,9 .  • Ip" lb . 4 2  13 14 15 16 :/v .
1 14 11 6 ___  ___ ___ _ _  ___ ___ ___________ __________ ___  ___ ___ 31 45.98
2 — 17 5 1 2 25 31.8
3 — — 20 3 — — —  — —  —  — —  —  —  — — 23 17.8
4  
! 5 
6
7
8
---
—
5 —  
—  7
—
—  — —  —  — —  —  —  —
--- 5
7
7.53
5.28
— — — —  —
7
4 —  
—  5
1 —  —  
1
—  —  —  — —
7
5
6
0.48
2.33
1.76
9 — — — —  — — —  — 2 —  — —  —  _  — — 2 1.14
10 • — ----- — —  _ —  — —  2 -2 —  ■ __ _• —  • 4 0.70
11 0 0.80
12 ■ — — • — —  — — —  — —  —  — 2 1 —  — — 3 0.68
13 1 1 0.52
14 28 31 9 9 7 4  5 4  2 2 2 1 1
14 14 '10.3 2.2 -1.8 1.1 0 .6  0.6 0 .4  0.2 0.18  0 .16  0 .0 8 —  — 0.06 119
T able 3. S ibsh ips o f  m ongols h eterozygou s for haptoglobin
P osition N um ber o f  sibship F oun d E x p .
m
sibship
1 2 3 4 5 6 7 8 9 10 11 12 13 14
1 9 11 5 6 1 —  32 36.4
2 — 11 3 2 2 1 — — — —  _ — — —  19 27.42
3 — — 13 2 — — — — — —  _ — — —  15 16.42
4 — ' — — 10 — 2 — — — —  - __ — — —  12 9.42
5 — — — — 4 — 1 — — —  — — — —  5 4.42
6 4 1 5 3 .02
7 — — — — — — 4 — — —  — — 1 —  5 1.86
8 — — •— -— — — — 2 1 —  .— — — 3 1.0
9 — — — — — _ — — — 3 1 — -— 4 0 .75
10 — — — — — — — — — 1 — — — —  1 0 .64
11 0 0.24
12 1 —  1 0 .15
, ;.A rv; 9 22 21 20 7 7 w ■:2 ; . r - 4 i 1 1 —
9 11 7 5 1.4 1.16 0.8. ' B ’;0:1 .0 .1 .  0 .09 o . o s 0.07
!»•*.«• ••••• V 102 r ‘‘ ,\AV
A birth order effect similar to the combined Down*s group 
could bo detected for both the samples homozygous and heter- 
ozygous for haptoglobin (Tobies 2 and 3) (X = 23.9 ond 28.5 
respectively, P = 0.001).
The correlation between parental age and frequency of Down*s
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syndrome was estimated and found to be, for paternal age 
r = 0*22 (SE 0*17) and for maternal age r e 0*49 (SE 0*09) 
and the intercorrelaiion between maternal and paternal age 
to be t = 0*73 (SE 0.09). Partialling out the effect of 
paternal on maternal age, no significant effect of paternal 
age on the frequency of Down*s syndrome could be shown 
(partial t « 0.12).
Fig. 1 below shows the distribution of the ages of the 
mothers and fathers of the Down*s subjects.
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Parental Ages and Haptoglobin Frequencies
Figs. 2 and 3 below show the effect of parental ages on the 
haptoglobin frequencies (as the arc-sine transform) of the
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males and females with Down's syndrome treated separately 
(Fig. 2) and combined (Fig. 3). Both the male and female 
subjects with Down*s syndrom© show similar distributions 
against both paternal and maternal ages, i.e. a bimodal 
distribution with the modal point at about 35 years for the 
maternal age and 40 years for paternal age. Fig. 3 also 
includes the data on 120 control subjects similarly treated 
(broken curve), and no bimodality can he detected.
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A bimodolity such os has boon shown to occur above causes 
considerable analytical problems, for example correlations
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require linearity. The two modes can be compared with test 
such as the Haldane log ratio test with some expectation of 
reliability (10) and the data for such a test is shown in 
Table 4 below.
T able 4 . -Maternal age
M at. age group N um ber o f  D .S . su b jects N um ber o f  D .S . subjects T ota ls
(years) h eterozygous for H p . h om ozygous for H p.
17— 30 33 24 57
3 1 - 4 6  74 89 163
107 113 220
‘ Xurnbers o f  D ow n 's syndrom e su b jects liom ozygous and h eterozygous for serumyjuipfp-! 
..globin .for tw o  m aternal age groups 17— 30 >;y6ars find 31— 46 years. ’vy.'
From Table 4 the estimate of the log ratio test was found to 
be 0.49 ($E 0.077) i.e. the difference between the two modes 
was significant at P = 0.01. With less reliability, each 
mode could be considered as a homogeneous group with a 
linear relationship between the arc-sine transform and
t  ;
pdrental age, for example in the combined Down*s group, for 
maternal age mode 30+> the regression equation can be shown 
to bes-
arc-sine transform = 1.39 age - 12.3
and the correlation between maternal age (30+) and the transform 
to be r = 0.93 (P = 0.001).
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Forentol Age ond Other Phenotypes
Figs. 4 7 show the regressions of the arc sine transforms
of the serum Gc protein, red cell acid phosphatases, red cell
PGT and ALT systems,_on age.
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In Figs. 4 - 7 the unbroken lines indicate the equation of 
the regression and the broken lines the 95/5 confidence limits 
of this equation* The data from which these equations are 
derived are shown in Table 5 below* and as can be seen from 
the t-tesf for significance of the regression coefficients in 
this Table in none of the four systems is there a significant 
deviation from zero. This finding is further supported by 
the lack of correlation between the arc-sine transforms and 
maternal age. For comparison the haptoglobin for maternal 
age 30*?- was shown to be r s 0*93# for the other system© the 
values of r were 0* 07 (AcP), 0.42 (Gc), 0.16 (PGT) ond 0.31 
(ALT), none of which are significant at P a 0.05.
’ ’ , .*‘l- ■ +
T pbl e/5,..Pure ntal age
if*" A c.P . V Gc G PT  / '
• ' ' ' ' . M at, P at. P a t. M at. P a t. M at.' rP at.
R egression  
coeffic ient (b)
—  0.09G —  0.003 —  0.202 —  0 .08 —  0.225 —  0 .44
....
—  0.2  IS — 0.0m
y  —  in tercept 50.3 47.4 46.8 3S.G 55.9 53.6 55 .0  49.7
Significance o f  b 
(t-test d f — 8)
0.247 0.27 0.39 0.36 0.19 0 .24 0 .30  0.7'
M ean o f  arc sine  
transform  \y)
4G.97 47.28 39.8 34.6 48.2 49 .0 47 .35  45.7
s;E : o f  y 1.87 2.1 2.95 2.83 1.43 1.85 2:28’. 4 ’
| • ■ ’.^um m ary o f  the data o f  the regression o f  the arc-sine transform ation  o f  th e  heterozygous/hem 
I v v. '-zygdtis frequencies o f  one serum  (Gc) and three red cell polym orphic sy stem s. > ' , *
Family Phenotype Data
Table 6 shows the phenotype distributions of 94 parents of 
Down8s subjects for the red cell acid phosphatase system to­
gether with the expected frequencies based on the normal data 
of Hopkinson & Harris (11)*
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Table 6
Mating ; Frequency
Mother Father Found Expected
A sA x . As A . 2 ■ 1.83
A; A ■ X AsB . 6 5.98
A: A ■ X ' BsB . 3 ■/ 4.9
A:B : X As A 5.98
As 8 ■ X ■ AsB 13 19.63
AsB ;.x BsB 19 16.09
BsB X As A 5 4.9
BsB X AsB 19 16.09
BsB X BsB 16 13.18
AsB X A:C 0 2.72
A:C X AsB 0 2.72
The chi square test failed to reveal any significant varia­
tion in the mating frequencies of the parents of Down*s 
subjects as might have been expected if severe maternal/ 
foetal incompatability was the major cause of the syndrome 
(r.2 = 10.33).
In Table 7 below the mating frequencies of the Gc, PGT and 
Hp systems are shown*
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Table 7
Hating Gc PGT Hp
Mother Father Found Expected Found Expected Found Expected
1:1 X 1:1 31 24.4 ' 34' . 32.9 2 2.6
1:1 • x 2:1 16 ; 19.6 17 19.5 7 5.46
1:1 X 2:2 4 ' ' 3.9 2 2.99 4 7.7
2:1 X ; 1:1 17 19.6 : : 22 19.5 15 11.5
2:1 ' X 2:1 12 15.7 15 12.0 7 5.5
2:1 - X 2:2 2 ■: 3.1 1 1.84 17 16.0
2:2 X 1:1 6 3.9 2 2.99 5 7.67
2:2 X 2:1 ; 4 3.14 1 1.85 16 15.9
2:2 x 2:2 , ’ -l ': : 0.63 0 0.28 21 21.9
Chi-square 5*8 3*13 4*75
As indicated by the chi-squares in Table 7 above in none of 
these systems is there any evidence of deviations from the 
normal expected frequencies.
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DISCUSSION
The distribution of age of mothers at the birth of a Down*© 
child is now very familiar, having the peculiarity of being 
bimodal or at least bitangential, which has been interpreted 
as being the result of two classes of affected subjects, the 
first not subject to maternal influences forming that part 
of the curve which resembles that for the general population 
and those subject to maternal influence* These two classes 
hove been termed class A and class 8 respectively (14) with 
class>A varying from one third to one half of most samples 
examined. This distinction of class does not imply a dif­
ference between the two classes of Down’s subjects themselves, 
but rather differences in possible causation of the non- 
disjunction giving rise to the syndrome. In fact both 
classes of Down’s subjects when investigated are found to be 
chromosomaliy and clinically indistinguishable or occasion­
ally a small proportion of class A being chromosomaliy 
different (usually in the form of translocations), class A 
subjects are smaller in number than class B and are not 
homogeneous for cause. An important aetiological distinction 
to make is that between subjects whose condition arise 
primarily from meiotic error in the mother and those in whose
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cose a chromosomal anomaly was already present in the somatic 
cells of the mother. It would appear at first sight that the 
selection of Down’s subjects limited to those trisoraic for 
chromosome 21 would have eliminated those cases in which a 
balanced translocation occurred in the mother, but as will be 
seen later this is not necessarily so. It has been suggested
(15) that there is a general tendency to meiotic errors in 
some families, if so it would be heritable and therefor© show 
itself by a familial tendency and such Down’s subjects would 
be class A maternal age independent. In a collection of 
reported data (15). on Down’s subjects with similarly affected 
relative© it has been shown that when the relative \/as 
related on the mother*© side the mean maternal age of both 
affected subjects (although raised above the normal) failed 
to reach that of the condition in general, but there was no 
such weakening of thematernal age effect when they were re­
lated on the father’s side. Those observations suggest a sex- 
influenced or sex-limited genetical tendency towards th© 
occurrence of meiotic errors. A survey of 130 Down’e subjects
(5) showed an incidence of D/G translocations and thre© 
families with one subject as a D/G translocation and another 
with trisomy. It thus appears that class A subjects may be 
caused by translocation carriers or by sporadic translocations
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or by some heritable tendency. A further cause may be 
maternal translocation 'which has been shown to occur but is 
difficult to detect chromosomaliy. 'Penrose (16) judging by 
the results of dermatoglyphs has estimated that about 10% of 
all Down’s subjects might have mothers who are themselves 
mosaics as indicated by a raised atd angle. Such subjects 
born to mosaic mothers are class A so the mean maternal age 
should be the same as for the general population. However 
the evidence available (17) is suggestive of most mosaic 
mothers starting as regular trisomics which in early erabryo- 
genesi© underwent a meiotic error, leading to mosaicism, 
i.e. the mothers themselves started life as class 8 so the 
mean grandraaternal age is raised. Burch (6) has presented 
log-log graphs of the relative frequencies of Down’s births 
in three populations, all of which showed the same general 
features, age dependence is slight from 15 to 25 years but 
after 30 years fh© relative frequency (P) of Down’s births 
rises with a high power of age. Each of the three sets of 
data presented can bo described by the sum of two mathemati­
cal functions, the first attaining a plateau at t = 20 years,
10the second obeys the relationship Pott up to 40 years, 
beyond w h i c h  the steepness of age dependence declines slightly. 
P can be regarded as proportional to the age specific pre­
valence of women who are likely to produce an affected child
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and probably the 'two mathematical functions relating F to t 
represent particular cases of a general lav (20, 21)* The 
same author has shown that the age prevalence of many 
diseases (Pt) and ageing condition of the so-called auto­
immune (auioaggressive) disorders can be described by the 
general stochastic equation
Pt ss 'S (l - (exp-ktr) )n ..**..*.*** (1)
where is the age specific and sex specific prevalence of 
initiated .disease at time t, S is equal to or proportional 
to the fraction of the general population predisposed to the 
disease at birth, r is a positive integer from 1 to 5 (20)*
From these equations Burch (6) offered a unified interpre­
tation of'the effect of maternal age on the frequency of 
Down*s syndrome* Within the population there are two sub­
groups and Sg (Class A and B of Penrose) which are pre­
disposed to produce offspring with the syndrome* In the 
younger mothers the penetrance of the condition is effect­
ively complete by 20 years although the number of random 
events required to initiate the condition cannot be deter­
mined by present data* Probably ten random events arc
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required to initiate the pathogenic process responsible for 
most of the offspring barn to the older sub-group of mothers 
(class 8), i.e. the value of n (or more likely nr) in 
equation (1) above is 10. An average interval (latent period) 
of about 2.5 years elapses between the last initiating ©vent 
and the first expression of the disorder in the form of non- 
disjunction.
Any adequate theory on the cause of Down*s disease, particu­
larly with reference to the maternal age effect must be able 
to account for several apparently unrelated observations, the 
effect of maternal age on the haptoglobin phenotypes shown in 
this section, the high prevalence of thyroid disease and 
thyroid antibodies in the mothers of Down * s subjects (the sex- 
limited or sex-influenced tendency outlined above), the 
increased risk of a second affected child subsequent to the 
birth of o Dov?n*s child, etc. The raised thyroid antibodies 
level is confined chiefly to the younger mothers (18) and 
Fialkov's studies support the suggestion of the two classes 
of mothers. Predisposition to Hashimoto* e disease is inherited 
with one or more genes associated (a) with thyroid disease and 
(b) with early onset of the production of a child with Down*© 
syndrome. Interpopulation differences between the sizes of
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the classes A and B Will be largely due to differences in 
the frequencies of the predisposing genes. According to 
the Unified Theory of Growth and Disease (20, 21) idiopathic 
autoimmune disorders arise in genetically predisposed persons 
as the result of spontaneous somatic gene mutation in mcsen- 
chymai growth-oontrol stem cells. The mutant stem cell 
propagates a 'forbidden clone* (18, 19) of cells which pro­
duce humoral or cellular (but non-immunoglobulin (20, 21) ) 
autoantibodies. Primary antibodies are better described as 
mutant mitotic control proteins (HGP). In its non-mutant 
configuration each specific HCP regulates normal growth of a 
specific target tissue, whereas the mutant HCP carries out an 
autoaggressive attack on the specific tissue it normally 
regulated. All tissues external to the central growth 
control system are, by definition, target tissues and it has 
been predicted that at least one autoaggressive disorder will 
be associated (with the appropriate genotype) with each dis­
tinct target tissue (20). Germ cells cannot for any theore­
tical reason be exempt from this generalisation and it has been 
argued that chromosomal non-disjunction usually results from 
such an autoaggressive attack on the germ cells (6).
Henderson and Edwards (22) were able to examine oocytes in 
mice of different ages, they counted the number of chiasmata
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noting their position and also counted the number of uni­
valents (i.e. chromosomes that have no chiasmata, under 
which circumstance they may fail to pair properly and thus 
drift apart). They found a decrease in chiasmata count and 
an increasing frequency of univalents with increasing age.
From these observations and from scanty evidence in humans 
they consider a failure of chiasmata formation at the first 
meiotic division leads to unequal segregation of the uni­
valents at anaphase. They present two hypotheses to explain 
the decline in chiasmata formation, in the first the 
gradients could be present in the foetal ovary at the time 
of chiasmata formation and these lead to differences in "‘the1 
production of the oocytes. Because the complex dependence 
of Devon's birth on maternal age agrees well with the auto­
aggressive theory and because other chromosomal disorder© 
show poorer age dependence. Burch (6) doubts this hypothesis. 
The alternate theory is that chiasmata may form normally 
during foetal life but be lost during dictytene.
Extrinsic factors such as infective agents (23) might promote 
the separation but the regularity and detailed mathematical 
form of the frequency: maternal age statistics conflict with 
this theory that chance infection could directly effect
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specific chromosomal non-disjunction at any stage of .'dieto'- 
iene or meiosis* Nevertheless, an appropriate infection 
often precipitates or exacerbates a latent autoaggressive 
attack (6) and specific intrinsic factors such as mutant 
HCP could con^Sl^able abrogate a potentially dangerous 
situation. Gob and Summers (24) have recently demonstrated
a non-viral agent in the plasma of irradiated subjects that
lN
induces chromosomal breaks in normal cultured leucocytes.
In this section two possible factors have been investigated, 
the possible change of frequencies associated with patenbal 
age and possible incompa^^ility between the foetus and 
mother. The former investigation was successful, there does 
seem to be a relationship between the frequency of hapto- 
globin phenotypes ini|the class A and class B v T h e  
necessary limitations imposed by time and cost has limited 
the scope of the incompat^ility studies. The whole problem
' V  s  ' ■ ;
of detecting such - incompatibility has been adequately 
summarised by Cohen (25). Reed (26) after a study of several 
thousand families had to conclude that ‘'it Is important to 
assume that selective effects of these blood groups (he 
tested a number)...... on reproduction are absent or
negligible. A mating type effect on a number of pregnancies 
of as much as 5 - IO/S of the mean might not have been recog­
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nised as a real effect....Studios to data have not tested 
adequately for the existence of o weak effect,t. The sample 
in this investigation is far too small to detect any pos- 
sible incompatibility, a much larger sample, together with 
much more detailed reproductive and mating information would 
be required to conclusively prove or disprove any maternal/ 
foetal Incompatibility involvement. There is little doubt 
that such incompatibility does exist within the ABO and Rh 
systems, and this, together with the observations on the 
haptoglobin system in this series makes interesting the ob­
servations that there is considerable interaction between 
the two systems (27, 28).
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SECTION 4
INCREASED RATE OF INFECTION AND ITS 
POSSIBLE RELATIONSHIP TO CHANGES 
m  SERUM AND TISSUE PROTEINS
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INTRODUCTION
It is generally regarded that Down's syndrome is accompanied 
by an increase in susceptibility to infections, and deficient 
antibody'.formation has been suggested as the possible cause. 
Several studies on the response of Down's subjects to 
immunisation has produced conflicting conclusions. Penrose 
(l) quoting the findings of Donner (2) considered that they 
showed no differences in this respect, a finding supported 
by the studies on tetanus immunisation (3, 4) and v/hooping 
cough agglutinins (5), although contrary data is available
(6). Although an anatomical basis has been postulated for 
the frequent respiratory infections incurred by Devon's 
subjects (7) it has been shown that both cellular and humoral 
immune systems differ from those of normal individuals. 
Impaired delayed hypersensitivity reactions to several 
antigens have been described (8) whilst some investigators 
showed that the in vitro response of circulating lymphocytes 
to phytohaemagglutinin was reduced except at very low con­
centrations (9). In a study on the lacrymal proteins (10) 
it was shown that an overall increase in protein concentra­
tion in Down's syndrome of an -globulin type found only 
in neonates* These authors suggested that abnormalities of
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transport of proteins across coll membranes could be a 
possible explanation of their finding although similar ab­
normalities have been shown to occur in tears of normal 
persons with respiratory infections (11).
An ideal tool for the study of the various aetiological 
factors in the increase of infection rate in Down’s syndrome 
became available after the initial observation that these 
subjects exhibited an increased prevalence of the so-called 
Australia antigen (Au, HAA) or hepatitis associated antigen 
(12 - 14). It is outside the scope of this introduction to 
assess the merits of the case for and against the assumption 
that the HAA protein is part of the original long-incubation 
(B type) hepatitis virus, and the natural history of this 
infection has been admirably summarised elsewhere (15). For 
the purposes of this investigation it will be assumed that 
the presence of the antigen in the blood of a subject 
implies that that subject has recently been exposed to the 
infection. The original observation on the increased 
frequency of the antigen has been confirmed by a number of 
subsequent investigations which are summarised in Table 1 
below.
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Table 1
Refer- Hospital Down’s Subjects Control Subjects* 
ence Environment Number % Positive Number % Positive
1968 14 Large 810 27.7 188 3
Small : i ? . 33 ; ■ . '3*0 . V : ; -
H  . Borne. / .  43 0 - 10 0
1970 15 Large 130 27.0 299 20
1970 18 Large 130 35.1 134 17.2
1971 41 Large 74 31 74 3
Small 18 11 79 3
1972 22 Large 160 18 ~
1973 42 Large 115 20 91 4.4
1973 43 Large 26 12 - ~ ~
IhiS *• ... Large 246 28.8 305 3.4Investigation
It must be noted that the samples in Table 1 above are not 
strictly comparable as age and sex differences have been shown 
to affect the overall frequency of the antigen, with males 
showing a higher frequency than females and a decrease in 
frequency in both sexes with increasing ago (15).
Although there is an increase in the frequency of the antigen 
in Down’s subjects over their institutionalised peers, this
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does not automatically imply an abnormal immune response*
It has been suggested that a more likely explanation may be 
the retention, by Down8s subjects, of the agent chronically
(16) resulting from some inherited immunological defect, 
possibly involving impaired lymphocyte function.
Blumberg (21) has proposed an Interesting hypothesis that 
the HAA agent could be construed as a polymorphism with two
X 2
alleles Au and Au with the Aul:Aul genotype open to sub- 
clinical persistent infections. If such a gene was located 
on the trisomic chromosome then there would, by the 
Hardy-Weinberg law, be an increase in these Aul:X types 
(albeit as the unusual Aul:l:2) at the expence of the other 
two homozygous forms. There are come indications in the 
literature on how these mechanisms could be studied. For 
example treatment of the purified antigen with the detergent 
Tween 80 showed it to partially dissociate into soluble com­
ponents which appear to be serum proteins (igG, light and 
heavy chains, complement, beta-lipoprotein, transferrin and 
albumin) (20). Blumberg (21) further proposed that if the 
HAA acted as a polymorphism then the host protein may not be 
the same as that of the person it subsequently reinfects,
i.e. it acts as an iso-antigen and one could predict circum­
stances in which antibodies may or may not be produced
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depending on the phenotypes of the recipient and original 
host, an hypothesis which goes a long way to explain the 
findings of Hollinger (22). A second suggested line for 
investigation is found in the studies on the relationship 
between the ABO system and HAA in normal populations, some 
of which have shown a relationship to occur (23, 24) al­
though one study failed to support them (25). More 
recently the possible relationship between HAA and tissue 
type (HLA system) have proved promising with a proponderence 
of HLA types W27, V/17, HL-A3 and W19 being reported (28) 
although a^more recent study on a larger sample failed to 
confirm any increase in frequency of 28 alleles at the two 
HLA loci.
In this Section 53 Down's subjects positive for the antigen 
will be compared with HAA negative Down* s subjects for serum 
protein levels and for some of the polymorphic frequency 
distributions.
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METHODS
Detection of Hepatitis-Associated Antigen
At the start of this investigation the most practical test 
available for the presence of the antigen was the counter- 
electrophoretic method. However, during the course of the 
investigation a commercial haemagglutination test became 
available (Hepanosticon : Organon Limited) followed by a 
second haemagglutination test (Welcome Limited), and 
although a larger proportion of the data in this investigation 
is based on these agglutination tests, only some 30 positive 
patients (i.e. those detected by the less sensitive electro­
phoresis) could be followed for four years*
The two haemagglutination tests are very similar, with the 
Organon system based on the agglutination of sheep erythrocytes 
while the Welcome are based on turkey cells. The former test 
was used as standard with the latter being employed only as a 
confirmatory test. The instructions of the manufacturer were 
carried out: the erythrocytes were suspended in normal saline, 
a round bottom tube was filled with 500 yul of this suspension 
and 10 yul of serum added and after thorough mixing incubated 
at room temperature for three hours, the sedimentation pattern 
was read by means of an angled mirror with a negative reaction
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being indicated by a sharply outlined ring at the bottom of 
the tube* All positive tests were re-tested by the Welcome 
test and by prior absorption on the Hepanosticon absorption 
kit and re-testing. This absorption step is based on the 
removal of interfering compounds by fixed sheep cells coated 
with IgG without anti-HAA activity. A flow chart of the 
total procedure is given in Fig. 1. This technique has been 
the subject of a communication (30) in v/hich no false nega­
tives were found in 4960 blood donors, and which showed the 
technique to be much more sensitive than the counter­
electrophoresis, or radial diffusion methods.
Counterelectrophoresis
The technique was based on that of Colliford (31), 25ml of a 
Ifo agarose in barbitone:sodium barbiturate buf fer (pH 8.8) 
was poured onto plates 130 x 80mm, and after cooling, wells 
2mm diameter were cut in pairs 2mm apart. One well filled 
with the test serum and the other (cathodic to the first) with 
specific anti-HAA sera (V/elcome Limited). Electrophoresis 
was carried out at 40mA for 30 minutes at room temperature 
and a precipitation line mid-way between the two v/ells at 
right angles to the current indicated a positive result.
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Fig. 1. Flow Chart for the Identification of HAA
Positive Sera.
  ' .....  , , .. , ( 4 tests 2.2 ml.
Resuspended reagent in normal saline j 20 tests 10 5 ml
Serum or plasma Shake until homogenous
TO micro litres 500 micro litres
Shake until homogenous' (1 5-30 secs.)
Leave undisturbed at room temp. (3 hrs.)
; Read result
w  j* irP.T*’-
V, /'I.
'v- -
j Positive 
) •] Negative 
I Pos. Neg.
=t
If the result is positive the fo llow ing  absorption 
procedure m ust be performed.
•f*'- 
- .„ _  :
-os. v
i ' '  A
resuspend absorbent in saline
absorbent suspension 50 ml 
centrifuge
10 m l saiine 
per tube
5 min. 1200xg
test fluid 0-010 ml
sediment supernatant
discard
add 0-10 ml saline' 
shake 
incubate 
add 0-30 ml saline 
resuspend 
centrifuge
sediment supernatant 
discard (about 0-4 ml)
1 hr. 37°C  
(shake at 30 
. and 60 mih.) 
16-20hrs. 2-8°C
5 min. 1200xg
resuspend reagent _ . . _ Ar /
in saline for 4-test tube 0-45 m l
fo r20-test tube 2-1 m l
reagent suspension 
0-10 ml
shake 15-30 sec
read pattern after 3 hrs
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Serum Alkaline Phosphatase
Serum alkaline phosphatase was estimated at pH 10.5 
(0.05 M glycine buffer) using 0.0055 M p-nitrophenyl 
phosphate as substrate, and the resulting colour estimated 
at 405mm.
Liver Enzymes
A number of liver enzymes were estimated at 340nm using 
test kits obtained commercially (Boehringer U.K. : London).
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RESULTS
Of the original sample of 256 Down’s subjects, 30 were 
found to be positive by the counterelectrophoresis. These 
subjects were re-tested at approximately yearly intervals 
and the data on this is summarised in Table 2 below.
Table 2
Year No. Positive Per Cent
0 30 100
1 24 80
2 18 60
3 12 40
4"* 8 (Strong >) 27
6 (Weak *) 20
Table 2, Re-test Data at Yearly Intervals of 30
Down’s Subjects Shown to by HAA Positive 
by Counterelectrophoresis. "by Haemaqglu- 
tination.
As can be seen from Table 2 a considerable number of the 
positives remained as active carriers up to four years after 
the original detection. During this time there was no 
evidence of re-infection by type B virus, but re-infection
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at sub-clinical levels could not be discounted. Re-testing 
the sample using the more sensitive haemagglutination test 
revealed a further 41 cases were shown to be positive making 
a total of 71 cases {77*7% of the sample). Using the latter 
technique 304 control samples were made and 10 v/ere found 
to be positive (3.04%).
Immunoglobulins and HAA Positive Sera
Table 3 compares the four principal immunoglobulins in 40 
HAA+ Down's subjects with a number of control subjects and 
Down's subjects negative for the antigen. Included in 
Table 3 are the t-tests between the positive Down's and both 
negative Down's and control groups.
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Table 3
Test Sample No. Mean
Down's + 
IgA Down's — 
Controls
SD
(mg/lOOml)
40 319.4 112.2
66 309.1 140.6
99 272.4 109.0
T-Tests
HAA*:- x HAA- 
Down' s
0.41
HAA* x HAA- 
Controls
1.76
Down's + 
IgG Down's - 
Controls
40 1452.9 393
70 1384.1 375.1
95 1539.0 308.0
0.89 1.23
Down's + 42 127.0 53.5
TgM Down's - 82 131.0 64.7
Controls 101 132.0 43.6
0.37 0.54
Down's + 40 6.9 3.3
IgD Dove's - 62 7.9 5.9
Controls 60 3.1 3.0
1.02 5.95
P = 0.001
Table 3. Comparison of the Four Immunoglobulin Levels 
in Down's subjects Positive and Negative for 
HAA. and Control Subjects Negative for HAA.
From the t-tests in Table 3 there is no significant differen­
ces between the Down's subjects positive for the antigen and 
either the negative Down's subjects or the control subjects
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for XgA, IgG or IgM but. a significant Increase in IgD 
levels could be shown with both groups of Down's syndrome 
.whencompared with the control groups but not between the 
two Down's groups.
Liver Enzymes and HAA
In Section I of this investigation the elevation of IgD in 
Down*s subjects was noted, and in passing it was postulated 
that this was probably due to the chronic infectious state 
of the Down's subjects, and this hypothesis was tested by 
carrying out a series of specific liver enzyme estimations 
in the two sub-groups of Down's subjects (i.e. HAA * and 
HAA -) and control subjects. These enzymes included serum 
alkaline phosphatase (ALP), lactic dehydrogenase (LDH), 
isocitric dehydrogenase (ICDH), aldolase (ALD), glutamic- 
oxaloacetic transaminase (AST), glutamic-pyruvic transa­
minase (ALT), leucine aminopeptidase (LAP), and glutamic- 
lactic dehydrogenase (GLDH)• The raw data on these tests in 
the three groups are shown in Table 4, and the t-tests 
between groups and the correlations v/ith the four immunoglo­
bulins arc shown in Tables 5 and 6.
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Table 4
Controls Down* s Down *Q <$* ■ Dawn815 -
Test Bean 5D Mean SD Mean SD Mean SD
ALP 64* 9 19.0 58 :14*4 ;■■>56;" 24.2 59.5 '24.6
LDB 189.2 68.0 .165.6. ■ ■ ■69.0 169.2 ' 64.0 162.2 66.1
ICDB 5.2 8.3 5.1 2.7 5.0 2.9 5.2 2.9
ALD 1.01 0.74 - 1.65 1.0 1.7 1.41 1.55 1.28
AST ' 13.6 8.1 ■15:. 7 7.0 13.2 8.3 17.7 ; 6.9 ,
LAP 22.0 6.0 16.6 4.2 18.9 3.9 14.9 4.3
GLDH 1.18 0.84 .. .0 .'61 0.38 0.6 0.36 0.6 0.39
Table 4, Comparison of Several Serum Enzyme Levels
in a Control Sample (n « 20) end in 
a Downs sample (n = 70) v/ith the Downes 
'Sample also Divided into those Positive for 
HAA (n s' 30) and those Negative for the
The t-tests in Table 5 below show a number of significant 
deviations from the control group (ALD, ALT, LAP and GLDH) 
but in all these but ALT the significant deviation© were found 
in both Down1s sub-groups* Comparison of the two Down*s 
groups confirmed significant differences in AST, ALT and LAP, 
but a© the deviation of the AST is in favour of the Down®© 
subjects negative for tho antigon it was folt that this finding 
made no contribution to, the problem of liver function and the 
defective immune response mechanism* The other three sign­
ificant tests suggest that in both the Down*© group thore is 
a significant deviation from the control level but this
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deviation is enhanced in the HAA * subjects*
Table 5 
Controls x
Test Down's
(Combined)
Down's + Down's - Down's * x Down's
■’ALP 0,93 ■ ^ 1.12 0.94 0.59
LDH 1.05 1.04 ■ 1.46 0.45
TCDH 0.11 0.23 0.06 0 . 2 2
ALD 2.10*
A ** .
■ ■ 2.52**"" 2.07* 0.70
AST 0.85 / 0.17 ■ 1.93 ■ 2.40**
ALT 2.43** At 1.99 2.40**
LAP 3.20***
•s
.
O«Csl 4.74*** 4.05***
GLDH 2.70*** 2.70** 2.98^ 0.55
Table 5. T~Tests between the Three Groups of Data
Shown in Table 4.
*P = 0.05, **P = 0.02, ***P =0.001
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Table 6
(Coefficients of Correlation)
ALP LDH LCDH ALD AST ALT LAP GLDH
IgA 0.12 0.08 0.32 0 . 2 0  0.02 0.07 0.09 0.23
IgG 0.18 0.12 0.21 0.08 0.14 0.09 0.14 0.27 Controls
0.23 0.19 0.09 0.03 0.09 0.21 0.38 0.19
IgD 0.18 0.09 0.25 0.15 0.30 0.19 0.16 0.17 = 20\
0.35 0.27 0.13 0.09 0.30 0.41 0.31 0.17
IgG 0.46 0.31 0.19 0.31 0.51 0.53 0.35 0.24 Down's
IgH 0.12 0.13 0.2c 0.20 0.18 0.19 0.19 0.38
(n = 2 0 )
0.43 0.39 0.15 0.19 0.49 0.52 0.31 0.22
IgA 0.130.39 0.31 0.21 0.40 0.31 0.06 0.14
IgG 0.43 0.61 0.43 0.13 0.56 0.61 0.33 0.29 Down's
IgH 0.19 0.18 0.18 0.15 0.32 0.29 0.23 0.37 ^HAA*)
(n = 2 0 )
IgD 0.51 0.41 0.24 0.28 0.64 0.59 0.28 0.11
The correlation matrix in Table 6 above shows there are no 
significant relationships between the four immunoglobulins 
and the various enzyme levels in the control groups# but 
several correlations do exist in the Down's subjects (under­
lined). A series of z-transformations were carried out on
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these significant correlations and the two Dov/n8 s groups 
compared* No significant t-tect between the z-traneforma- 
tions between the two Down's groups could be detected* The 
overall impression gained from the.data in Tables 4 - 6  is 
that there is an increased number of correlations betv/een 
the liver function tests and the immunoglobulins (particu­
larly IgG and IgD) in the Down*s group positive for the 
antigen compared with that negative for the antigen# but 
either extended samples or more sensitive techniques would 
be required to confirm this. It should be pointed out how­
ever# that in a matrix such as is illustrated above# a 
number of chance correlations could be expected to arise#
In Table 6 some 96 correlations are listed and by chance 5 
significant correlations at the 5% level# 2 correlations 
significant at the 2% level and one at the 1% level could 
be expected. The suggestion that the correlations listed in 
Table 6 as being significant (i.e# underlined) are true and 
not simply chance observations is strengthened by the 
observation that with the exception of the one involving LDH 
and one involving ICDB the majority of significant correla­
tions is limited to the three enzyme systems ALP# AST and ALT*
The relationship between haptoglobin levels and hepatic
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disorders is now well documented (33) end reported differen­
ces in the literature on the frequency of hypohaptoglobin- 
aomia probably result from the failure to recognise that 
the detection methods are crucial in the diagnosis of 
hypohaptoglinaemia# and that the reduction in haptoglobin 
levels can vary from time to time depending on the state of 
hepatic decompensation and the presence of biliary obstruc­
tion (32). Storiko has shov/n (34) that the mean concentra­
tions of haptoglobin in six cases of cirrhosis to be 
lOOmg/lOOml (normal mean 160mg/l00rnl) which is less severe 
than the has been reported elsewhere (35) but Storiko does 
report a mean of 41mg/l00ml in four cases of cirrhosis with 
portacaval anastomosis. Similarly the reduction of the Gc 
protein level In the serum of persons v/ith liver disease has 
also been reported (36 - 39). The serum levels of these two 
proteins (Gc and Hp) were shown# for Down’s syndrome as a 
group# to be within normal levels in Section 1 of this 
investigation. In view of the possible increase in liver 
abnormalities in those subjects positive for HAA this data 
has been re-evaluated in Table 7 below.
- 173
Section 4
iample
Table 7
Gc(mc3/Q Correlation of Hp Correlation of Gc
Mean SO Mean , SD , I g A I g G I g H I g D _ IflA ,. IfiG Xal'i laD
228 104 32.6 8.9 0.28 0.08 0.17 0.06 0.03 0.08 0.16 0.08
232 124 35.9 9.2 0.16 0 . 2 1 0.38 0.35 0 . 0 2 0.24 0.41 0.13
,236 ;119 -34.3- 10.4 0.32 0.19 0.24 0 . 2 1 0.14 0.31 0.09 0.24
A
8 .
Sample A Control Subjects (n = 20}
Sample 8 Down’s Subjects (HAA - ) (n = 20)
Sample C Down’s Subjects (HAA * ) (n = 20)
i-Tests
Hp
A x  B 0.10 
A» x C 0•44 
B x C 0.10
Gc
1.15
0.55
0.52
Table 7. Means and Standard Deviations of Hp and Gc (rog/o) 
of Control Subjects and Down’s Subjects Positive 
for HAA and Negative for HAA. Also Shov/n are the 
Correlations of the Hp and Gc levels v/ith the 
Four Immunoglobulins for the Three Groups and 
T-Tests Between Groups for Mean Hp and Gc Levels.
The data in Table 7 above failed to reveal any statistical 
difference in either Hp or Gc levels between the three groups
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(t-tests) nor could any significant correlations between the 
two proteins and the immunoglobulin be detected in any of the 
three groups. It is suggested that these findings indicate 
that there is no lowering of either the Hp or Gc levels due 
to abnormal liver function which might invalidate the state­
ment in Section 1 of this investigation that these two pro­
teins are within normal limits in Down’s syndrome.
HAA and the ABO Locus
Table 7 compares the ABO blood group distribution of 71 
Down’s subjects positive for HAA and 156 Down’s subjects 
negative for the antigen.
Table 7
Croup A B AB 0 Total
■f 30 u  7 2 32 71
- 61 22 3 70 156
Total 91 29 5 1 0 2 227
larison of the two groups in Table I2 failed to show any
significant change in blood group frequencies (G = 0.96). In 
their original report, Arndt-Hanser et al (23) detected an 
association in normal subjects between the ABO groups and
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the presence of the antigen by combining groups-A .and B 
and comparing this with the combined AB and 0. When the 
data is treated similarly no such significant association 
could be detected (G =0.02).
Australia Antigen and Serum Phenotype Frequencies 
Table 8 summarises the phenotype frequencies of the three 
serum polymorphic systems Gc, Hp and -glycoprotein 1 in 
the control subjects and Down's subjects either positive 
or negative for the Australia antigen. The expected fre­
quencies in Table 8 are based on the assumption that the 
Hardy-Weinberg law is operative in these three groups.
The data on these three polymorphic systems can be analysed 
by carrying out using the Haldane Log ratio test for 
heterozygotes between groups and this data will be combined 
with similar analysis on a number of red cell polymorphisms 
in Table 10.
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System Pheno­ Down* s HAA -s- Down* s HAA - Control© HAA-type Found Exooctcc Found Expected Found Expected
1:1 -■ 1 2 10.3 29 32.9 1 2 2 147
Hp 2:1 23 26.1 96  ^' 91.1 448 405.8
2:2 18 16 • e " 62 62.9. " 283 280.2
1 si 14 ■ 15.1 ,' 46 • 51.1 128 128.5
Gc 2 : 1 20 •' 17.7 66 55.0 108 105.0
2 : 2 . 4 ■ r 5.3 13 14.8 19 21.4
N :N 40 39.2 41 41.9 80 80.4
/ y a p N:D . 4 4.8 6 '• '5.1 1 1 1 0 . 6
D:D 0 0 0 0 0 0
Table 8 . ■ Frequency Distributions of Three Serum Poly­
morphic Systems for Control (HAA ~) Subjects
end for Down’s Subjects Either HAA »k or HAA -
Australia Antigen and Red Cell Polymorphic Frequencies 
In Table 9 the frequency distributions of six red cell poly­
morphic systems for a control group and for two groups of 
Down* s sub jects (positive and negative for HAA) are compared. 
The expected frequencies are based on the Hardy-VJeinberg law, 
but in the case of the acid phosphatase system the expected
Section 4
frequencies are limited to the 
Table "9
two most common alleles
System
Phono- Down8 s HAA * Dov»n#e HAA - Controls HAA
typo . Found Expected Found Expected Found £xpect<
1 : 1 26 28 .2 : 1 1 2 110.3 238 244.3
POT ■ 2 :1 ■23' 20.9 66 .' ■69.7 ', 159 :146.0
2 : 2 4 3.9 13 1 1 . 0 15 2 1 . 8
1 : 1 45 44.8 165 161.6 374 369.3
ADA 2 : 1 . 8 ■ . 7.8 2 2 28.1 40 ; 47.2
2 : 2 0 0.3 4 1 . 2 4 1.5
A 1 0 7.8 ■ 32 28.2 51 55.4
AB 17 21.4 66 75.0 192 181.0
B 17 i>< • CO 55 49.7 141 147.6.
ACP AC ■4 . « 8 . ' m 7 - .
BC 3 . - 7 - 1 0 -
C o - 1 - X -
1 : 1 48 47.1 . 176 ' 173.1 169 169.4
■AK 2 : 1 ■ 4 5.7 7 10.7 11 10.4
2 : 2 1 0 . 2 1 0 . 2 0 0 . 2
A 49 ■49.0 183 181.6 167 167.5
PGD AB 1 1 10 10.17 11 10.4
B 0 0 0 0.17 0 0 . 1
1 : 1 1 0 1 1 . 0 29 32.7 34 38.3
ALT 2: 1 26 24.0 91 83.3 98 90.0
2 : 2 1 2 13.0 49- 53.0 49 52.7
Toble 9. Observed and Expected Frequencies of Six Red Cell 
Phenotype Frequencies in Control Subjects and in 
Down°s Subjects Positive and Negative for HAA*
-178
Section 4
Down's
Tabl
(-:•)
e 1 0
Down8s (-) Controls {-)
System Estimate SE Estimate ■ . :SE Estimate ■ . SE .
Hp •5*88 6 . 8 2 . 6 3.3 5.06 1.69
Gc 6.01 7.6 9.04 4.14 1.17 2.58
l-Gp 4.87 3 »68 5.12 4.03 2.15 1.98
ADA 0.37 2 . 0 2 •3.2 1.07 •1.7 0.55
AGP •10.08 ; 7.38'' . -6.16 3.8 3.27 2.4
AK -3.7 1.55 •2.01 0.43 0.29 0.43
PGD 0.02 0.30 0.64 0.42 0.36 0.44
ALT 4*24 7.3 ■■ 4.56 3.79 4.46 .3.69
PGT 3.98 5.44 • 1.93 32.64 3.17 1.75
Table 10. Percentage Excess Heterozygotes Over that
Expected by the Hcrdy-Weinberg law from the 
Paid in Table 6 and 9.
In the Down*s+subjects in no system did the percentage excess 
exceed tv/ice the standard error of the estimate and this 
suggests that no heterozygote advantage could be detected* In 
the Down's subjects negative for the antigen however there v/as 
a slight but significant decrease in heterozygote frequencies 
in both the ADA and the AK systems, but as these two systems 
are the ones in which the lowest heterozygote frequencies 
could be expected and a slight sampling bias would distort
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the final result, it was felt that the significance of this 
observation is open to some doubt. The excess of the 
haptoglobin heterozygotes in the control series has been 
shown previously.
In Section 3 it was possible to shov/ a relationship between 
the haptoglobin frequencies and maternal age. This relation­
ship was reinvestigated to include the presence and absence 
of the Australia antigen, as in Table 11.
Table 11
Homozygous Heterozygous
Group No. Mean SE No. Mean SE T-Test
Down1s + 18 33.17 6.4 20 32.76 7.66 0.18
Down •s - 80 35.63 7.54 75 36.18 7.50 0.16
Table 11. Means and Standard Deviations of the Maternal 
Ages of 193 Down8s Subjects Homozygous or 
Heterozygous for Haptoglobin with and without
HAA.
The data in Table 11 failed to reveal any significant rela­
tionship between maternal age, haptoglobin phenotype and the 
presence of HAA.
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DISCUSSION
The data in this section has mainly confirmed the observa­
tion of a relationship between the frequency of HAA and the 
Gc phenotype, and the lack of such relationships v/ith the 
acid phosphatase and alanine aminotransferase systems (26). 
The only significant deviation from the Hardy-Weinberg lav/ 
was that reported elsewhere in this investigation in the 
haptoglobin system for the control group.
No evidence is available that the maintenance of the chronic 
state of hepatitic type B is associated v/ith any particular 
phenotype, nor is there any evidence that the Down * s subjects 
not chronic carriers are subject to the protective influences 
of heterozygosity at least in the systems investigated.
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CHANGES IN PROTEIN LEVELS AND FREQUENCY DISTRIBUTIONS 
RESULTING FROM SELECTION BY MORTALITY
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INTRODUCTION
Several studies have been made on the mortality experience 
of Down's subjects (summarised by Lillienfeld(l) )* The 
life table in general confirm the clinical impression that 
although the use of antibiotics has decreased the frequency 
of respiratory infections in infancy and childhood, it still 
appears that about 25 - 30 per cent of affected Down's sub­
jects die within the first year and about 50 per cent with­
in the first five years (a detailed consideration of the 
mortality of Down's syndrome is given in the appendix). As 
the majority of Down's subjects in this investigation are 
five years or older it was considered as possible that 
changes in both the levels of serum and plasma proteins and 
the frequencies of the polymorphic phenotypes may arise as a 
result of selection through mortality. It was also felt 
that some useful information might be gained if a group of 
subjects with a similar pattern of mortality could be com­
pared with the Down's and control groups in this investiga­
tion.
Tuberous sclerosis is an autosomal dominant condition but 
with a varied clinical picture, characterised by mental
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retardation, sebaceous adenoma* calcific cerebral deposition 
and epilepsy. The congenital malformations affect all three 
embryonic layers with a predisposition to those organs 
arising from the ectoderm. The frequency of the condition 
(which hereafter will be referred to as T.S.) is probably in 
the range of 33 — 44 x 10~^ (2* 3) and in those cases of 
familial appearance, dominant inheritance has been observed 
with full penetrance of the T.S. gene, but sporadic cases, 
probably due to fresh mutations appear in at least half the 
analysed families (3).
Although T.S. can be compatible with a long life and normal 
intelligence (4 - 11), the course of the disease is often 
progressive with most subjects living less than 25 years 
(12) and some 30 per cent die in the first five years and 75 
per cent by the twentieth year (8). The comparison of 
mortality experience is considered in detail in the appendix.
The choice of T.S. to compare with Down®s syndrome offers 
several advantages, in addition to the similar pattern of 
mortality, both conditions give rise to mental subnormality 
and thus both groups can be drawn from the larger mental 
hospitals with similar problems of hygiene, similar regimes
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of vaccination etc. Both groups of subjects show similar 
patterns in the cause of death with infectious disease 
(particularly respiratory disease) being one of the major 
reported causes, and finally both groups of subjects are 
likely to have been subjected to intensive investigations 
making for a reasonably accurate diagnosis.
In this section the serum and protein levels and the full 
range of phenotype frequencies in a sample of 54 subjects 
with T.S. will be compared with the data on the Down's 
group previously described.
All the methods used to investigate the T.S. subjects are 
those described in the previous section.
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RESULTS 
Toble 1
T.S* Down's Controls
Moon SD H Heon SD H Heon SD
278.8 51.4 105 322 89 99 272 109
1309 272.0 113 1520 522 95 1539 308
222 54 119 120 63 101 132 43
4.7 3.3 90 7.3 3.9 60 3.1 3
Table 1. Serum Immunoglobulin Levels in 54 Cases of 
Tuberous Sclerosis. 119 Cases of Down's 
Syndrome and 101 Mentally Retarded Controls.
Table 1 compares the levels of the four principal immunoglo­
bulins in the three groups of subjects. Table 2 compares the 
densitometric data on the serum proteins and serum glycopro­
teins of the three groups of subjects and Table 3 compares a 
number of serum and plasma proteins (radial diffusion) of the 
three groups. The analysis of the data in Tables 1-3 are 
shown in Table 4.
One of the T.S. subjects was found to exhibit an additional 
band of protein in the beta-gamma region on cellulose acetate 
electrophoresis, which was subsequently shown to be an IgG
Immuno­
globulin 
(mg/l00ml) N
IgA 54
IgG 54
IgM 54
IgD 54
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melanoma protein, and the protein 
subject were deleted from Table 2.
Table 2
Protein T.S. -
(a/ml) N Mean SD N
Albumin 53 4,28 0.52 254
^-globulin 53 0*22 0*74 254
<^ 2*"Siobulin 53 0*90 0.12 254
p -globulin 53 1.11 0*26 254
^-globulin 53 1,28 0.46 254
glycoprotein (%)
Alpha1 54 14.8 4.7 253
Alpha2 54 42.1 6.4 253
Beta 54 29.8 2.8 253
Gamma 54 18.9 6.1 253
fractionation data on this
Down* s Controls
Mean SD H Heon SD
2.8 0.O6 91 4.08 2.08
0.29 0.20 91 0.24 0.07
0.74 0.21 91 1.02 0.27
0.93 0.26 91 1.21 0.24
1.48 0.45 91 ■1.45 0.43
14.1 5.8 91 16.0 4.9
40.3 7.4 91 38.9 6.9
26.0 4.0 91 29.3 2.3
18.8 6.2 91 18.3 5.4
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Table 3
Protein T.S • Down* is Controls
(rag/nil) H Mean SD n Mean SD N Mean SD
Fibrinogen 64 303.22 73.7 59 303 73.1 61 296 59
Plasminogen 54 15.0 4.4 59 17 4.4 61 18.3 3.9
o<2~*mtithrombin54 33.4 10.2 59 22.4 10.1 61 36.2 8.2
Gc Proteins 54 29.4 7.6 147 34.5 10.5 55 32.8 9.1
^-lipoproteins 54 518.0 137.0 120 443.6 72.0 28 399.1 101.0
o^-antitrypsin 54 279.0 57.0 147 353.0 98.7 53 319.0 144.0
^-A-globulin 54 94.8 23.9 147 93.8 66.0 - -
Transferrin 54 192.3 79.0 147 257.9 99.2 53 265.5 99.4
o^-acid Glycop.54 84.5 41.6 133 103.7 23.0 56 71.7 14.0
Haptoglobin 54 79.1 19.8 147 234.2 118.5 - -
Ceruloplasmin 54 37.4 7.8 147 34.2 10.0 - mm
yG^-E-globulin 54 37.3 9906 147 29.0 11.3 - 'mm
yB2-glycoprotein54 21.6 3.5 147 17.4 4.2 - -
c^g-HS-glycopr. 54 52.4 17.9 147 53.4 18.1 - -
Prealbumin 54 31*4 15.1 147 28.2 10.8 - mm
o^2~n,acr09l°k* 54 347.3 62.1 147 287.0 79.4 -
Hemopexin 54 119.1 19.7 147 120.7 42.0 -
196 -
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Table 4
p  ' .  T - T e s t s ____
x Down's T.S, x Controls Down&s x Controls
Fibrinogen 0.013 0.57 0.58
Plasminogen 2.27* 4.6*** 1.05
-antithrombin 0.0 1.7 1.7
Gc Proteins 2.75** 2.5* 0.9
r\ « • jl * n  f*B-liprprotem 3.5 5.5
^-A-globulin 0.73
1,8
^-antitrypsin 9.3*** 2.4* 1.2
Transferrin 4.47*** 4.8*** 0.38
o^-acid-glycopr. 2.9** 2.2* 7.2***
Haptoglobin 8.8*** 8.6*** -
Ceruloplasmin 2.1* - -
yB^-E-globulin 4.1*** - —
yBg-glycoprotein 10.7***
o<2-HS-glycopr. 0.45 - -
Prealbumin 1.5 - -
o4y-macroglobulin 14.5*** 4.2** -
Hemopexin 0.63
IgA 3.5** 0.67 3.5**
IgG 3.3** 7.4*** 0.3
IgM 10.3*** 10.6*** 1.6
IgD 1.3 2.3* 7.3***
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Table 4 (contd)
Protein
Albumin
T-Tests
T.S. x Down's T.S. x Controls Down's x Controls
-globulin
c^ 2*“Sl0bulin
'^ 3-globulin
^■-globulin
o^-glycoprotein
c^-glycoprotein'
JB-glycoprotein
^'-glycoprotein
2.1 
0.52 
2.85 
0.92 
1.76 
0.66 
1.29
0.1
0.86
1.05 
1.07 
1.89
0.17
1. 
4.1
1.5 
0.58
4.1
1.66
*t5s<5»
6.7 
8.6 
0.4 
3.2
1.7
8.8
0.9
'p = 0.05 **P = 0.01 ***9 = 0.001
The analysis of the data in Tables 1 -3 is shown in Table 4. 
In several instances control data was not obtained as the 
Down's data was obviously within normal limits and the cost 
of such investigations for the sake of completeness was not 
Justified. In two instances where control data was not 
available the T.S. subjects significantly differed from the 
Down's subjects (haptoglobin, t s 8.6, P = 0.001 and 
macroglobulin t = 4.2, P = 0.01). Comparison of the T.S.
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levels of these two proteins with normal reported data (13) 
showed the haptoglobin to be significantly lowered (P = 0.01) 
and the ^ -.macroglobulin to be significantly raised 
(P r= 0.001). The data in Table 4 although illuminating is 
still open to severe mis-interpretation, what is being looked 
for are changes in the Down's proteins when compared with the 
control subjects which are repeated in a comparison of T.S.
and control subjects. The comparison of the Down's and T.S.
subjects, when such a comparison yields a significant 
difference, is much less interesting although it could be 
argued that in some instances this could be interpretated as 
the genetic abnormality exerting a pressure contrary to the 
mortality effect in one group of subjects but not in the other. 
Only in the two fractions c^~acid glycoproteins and IgD are 
concordant abnormalities found and it is doubtful if either 
of these are indicative of selection by mortality. As has
been shown previously, the IgD elevation in the Down's group
is probably the result of the chronic infectious state. The 
elevation of the o^ -. acid glycoprotein is much more difficult 
to interpret. This protein is known to be raised in conditions 
leading to an inflammatory state, but in these circumstances 
it is usually accompanied by elevations in such fractions as 
the antitrypsin and haptoglobin (14), all three of which
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are elevated in the T.S. sample but not the Down’s sample.
In those cases of increased glomerular permeability, a 
common feature is albuminuria often accompanied by the pre­
sence in urine of ck ^-acid glycoprotein. The results suggest 
that the reduction in albumin levels in the Down’s group is 
not due to increased renal filtration but is specific to 
Down’s syndrome. Whether the elevation of the °^-acid 
glycoprotein is due to specific changes arising from 
selection by mortality, or secondary to the chronic infec­
tious state is still in doubt but the weight of the evidence 
favours the latter. The other features of serum proteins in 
Down’s group are not repeated in the T.S. group and this 
strengthens the suggestion that they are not due to selection 
by mortality but due to the syndrome per se. Table 5 - 8  
summarise the frequency distributions and analysis of the 
data on serum and red cell polymorphic systems, and compares 
them with the data reported in Section 2.
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Table
Table 5
System Phenotype'".'-Frequencies
" , V . ; tuberous 
• V* * sclerosis
control
Adenosine deaminase 1:1
2:1
2:2
49
5
0
374
40
4
0.5
n —  54 418
Adenylate kinase 1:1 53 169
2:1 1 11 1.61
2:2 0 0
n =  54 180
Phosphoglucomutase 1 1:1 29 238
2:1 21 159 1.8
2:2 4 15
n =  54 412
Glutamic-pyruvic 1:1 6 34
transaminase 2:1 27 98 0.94
2:2 14 49
n —  47 181
Phosphogluconate A 52 167
dehydrogenase AB 2 11 0.46
B 0 0
72. =  54 178
Acid phosphatase A 5 51
AB 26 192
B 18 141 3.04
AC 2 n
BO 3 10
c c •-.•I 0 1 •-
■ ,. n =  54 402 ;
* frequencies of 6 Red Cell Polymorphic Systems 
in 54 Subjects with Tuberous Sclerosis Compared 
with Mentally Retarded Controls,
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Table 6
System Phenotype .. Frequencies
tuberous
sclerosis
control
" 7? .
Haptoglobin 1:1 7 122 4.0
2:1 22 448
2:2 25 283
n == 54 853
Alkaline phosphatase Ppl 41 198 1.14
Pp2 13 43
n == .54 241
/?2-gIycoprotein 1 N : N 52 • 337
D : N 2 43 3.06
D : D 0 1
n == 54 381
Gc protein 1:1 4 128
2:1 42 108 50.6*
2:2 8 19
n == 54 255
Leucine aminopeptidase 0 } 31) 48 11 MOW 12 >52 21 >80 0.01
2) 9 J U  J
3 ) 2 ) 312} high : . ■ o r o ) 3
n -- 54 83 ;;': f  ! ".r;
1 * 
: 
1! 0
 
©
 
© 1
Table 7
'•System Deviation 
from the 
Hardy-Wein- 
berg law 
(T.S.)
Haldane’ 
ratio tes1
estimate
s Log. \ 
S .E .r
Gene frequencies
T.S. group controls
estimate S.E. estimate S.E.
Adenosine 0.12 0.041 0.5 ADA1 0.99 0.01 0.942 0.01
deaminase ADA2 0.01 0.058
Adenylate kinase 0.005 0.0871 0.104 AK1 0.99 0.01 0.96 0.01
AK2 0.01 0.04
Phospho- 0.05 0.173 0.29 PGM1 0.73 0.043 0.77 0.015
glucomutase 1 PGM2 0.27 0.23
Glutamic-pyruvic 1.56 0.051 0.33 GPT1 0.414 0.051 0.46 0.026
transaminase GPT2 0.585 0.540
Phosphogluconate 0.04 0.358 0.78 PGDA 0.98 0.013 0.97 0.01
dehydrogenase PGDB 0.02 0.03
Acid phosphatase 1.0 0.128 0.28 AcA 0.352 0.374
- AcB 0.601 0.002 0.602 0.017
AcC 0.047 0.024
— — '
AnflJbtfA.S—g£-  RecL£ eJJL Polymorph 1 sms
SJiOMP_Jln Table S.
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Table 8
System Deviation Haldane’s Log * ■ Gene frequencies
from the 
Hardy-Wein- 
berg law 
(T.S. group)
ratio test . ' T.S. group controls ■
estimate S.E. ' • estimate S.E. estimate S.E.
Haptoglobin 0.370 0.470* 0.28 Hpi 0.333 
Hp2 0.666 0.045
0.045
0.595 0.012
Alkaline
phosphatase
— 0.422 0.36 — — — —
Glycoprotein 0.02 0.336 0.74 BgN 0.963 
BgD 0.007 0.008
0.941
0.059 0.008
Gc protein 16.9** 1.605** 0.076 Gc1 0.458 
Gc2 0.542 0.051
0.710
0.290 0.02
^Leucine — 
. aminopeptidase
0.61 0.93. . — — — —
P  =  0.05.
, ’ **p  =  0.001.
Of the eleven polymorphisms described in Tables 5 and 6 a 
significant deviation could be shown only in the Gc proteins, 
which group of proteins also showed a significant deviation 
from the Hardy-Weinberg Law (Table 8), and a significant 
difference in the ratio of homozygotes to heterozygotes by 
the log ratio test.
The only other point of note is the slightly significant log 
ratio test for the haptoglobin system.
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DISCUSSION
The approach selected in this section for testing for 
selection by mortality by using a group of subjects with 
similar high rates of mortality and similar patterns of 
cause of mortality can be criticised on the grounds of non- 
comparability on purely genetic grounds, one group being a 
single dominant gen© defect and the other a multigene 
(chromosomal) defect* Additionally, the expression of the 
two genetic defects are totally dissimilar with both renal 
and hepatic defects in the T.S* group adding complications 
to the interpretation of the data. However, failing a long­
term follow-up investigation of a number of Down's children 
from birth, an indirect method such as outlined here is 
essential.
The information given by the quantitative estimations of a 
number of serum and plasma proteins is little, but on the 
whole tend to suggest that in the quantitive aspects of these 
proteins mortality plays very little part. The phenotype 
distributions of the T.S. group, however, have proved more 
enlightening. These were found to be abnormal in the two 
serum systems haptoglobin and Gc proteins, both systems which 
have proved to be of considerable interest in the pathology
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of Down's syndrome.
The observations on these two systems in T.S. is hitherto 
unreported and will require further follow-up studies which 
are outside the scope of this investigation. However, con­
sidering the observation of a parental age effect on the 
haptoglobin frequencies in Down's syndrome, it would be 
interesting to collect a sufficiently large sample of T.S. 
to carry out a similar study. In the relevant section on 
parental age, Burch (15) suggested a unified law for 
autoimmune (autoaggressive) disorders, and it is interesting 
to speculate whether or not the similarity in the Gc and Hp 
systems between the two genetic disorders in this section 
gives some hint of a similar (if not the same) unified law 
for genetic defects.
The finding of an abnormal Gc distribution in the T.S. group 
strengthens the suggestion made earlier that the abnormal 
distribution in Down's syndrome is not due to the loci on the 
tricomic chromosomes but some other selection, such as 
mortality, is operating.
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THEORETICAL STUDY ON THE APPLICATION OF POLYMORPHIC 
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INTRODUCTION
There is already an extensive literature on the application 
of the phenotype shift to the investigation of the possible 
location of the blood group system on the trisomic 21st 
chromosome in Down’s syndrome, and limitations on the grounds 
of chance have been pointed out by Lawler (4) when applied to 
the use of blood group phenotype shifts*
Theoretical models for the distortion of the phenotype ratios 
have, in part, been established (l, 3, 5), with the latter 
two studies providing models for the shift in the case of a 
single pair of alleles showing dominance, lack of dominance 
and dosage effects assuming that the non-disjunction occurred 
at the first meiotic division* It has, however, been pointed 
out (4) that this concept becomes more complex if the non- 
disjunction occurs at the second meiotic division or post- 
zygotically. Goodman (6) extended the model to include 
crossing-over, the possible admixture of first and second 
meiotic non-disjunction and post-fertilisation non-disjunction 
assuming that these were independent of parental genotypes*
For purely theoretic reasons, the application of electropho­
retic techniques to the investigation of the phenotype shift
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should hold considerable advantages, in these techniques it 
is the structural gene which is being studied through its 
direct product, eliminating (with some reservations which 
will be dealt with below) the difficulties arising from dom­
inance and dosage effects. In addition to eliminating those 
problems, the technique will allow the investigator to in­
crease the number of potential gene markers. It has been 
estimated that some 30>'j of all genes will exhibit polymorphism 
(7) although there is no evidence that the electrophoretic 
mobilities of the aberrant forms will always differ suf~ 
fic^ typing. One of the major disadvantages
of the electrophoretic approach is the possible incorrect 
assessment of trisomic heterozygotes, i.e. with a two allele 
system it might not be possible to differentiate between, say 
AB and ABB.
Development of a Model for use with Electrophoresis 
The model outlined by Goodman (6) for a two allele system is 
adequate (if failure to differentiate between heterozygotes 
is taken into account).
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Table 1
Table 1
‘•^ T J ir p e  ’a l l e le s  a t o n e  lo c u s .  R e s u lt s  o f  th e  p o s s ib le  m a t in g s  w h e r e  c  =  th e  fr e q u e n c y  . 
“O b 'cro ss in g  o v e r  a n d  t =  th e  fr e q u e n c y  o f  s e c o n d  m e io t ic  d iv is io n  n o n -d is ju n c t io n , p, q
a n d  r a r e  th e  n o rm a l f r e q u e n c ie s  fo r  th e  th r e e  a l l e le s  v
Mating f AAA AAB AAC ABB j’.'.'-j ABC BBC
AA x  AA P4 P4 - -
AA x  AB 2p3q p3q p3q - jy v, - -
AA X AC 2p3r P3r p3r -
AA X BB p3q3 - p3q2 1 — -
AA X BC 2p’qr - P3qr P3qr — :. X • “ -
AA X CC p3r2 - — p3r3 I - -
AB X AA Pp3q (V jC + t-3/2Ct)p3q (— 3/ ic —2t—3/3ct) p3q (V2C + t - 3/2Ct)p3q; i 3-;'. • -  ■ ■
AB X AB 4p3q2 (V2C + t - 3/ 2Ct)p3q3 (2— V2C —3/2Ct)p3q3 — ( 2 - V 2 c - t + 3/2ct)p3q2 -
AB X AC 4p3qr (V2C + t - 3/2Ct)p3qr (2 -V 2 C -2 t+ 3/2Ct)p3qr ('/2C +  t - 3/2Ct)p3qr (V2C + t - 3/2Ct)p3qr ■ t ,.(2 -c -2 t4 -3 c t)p 3qr (V 2c4-t-3/2Ct)p3qr
AB X BB 2pq3 - (V2C-H —3/2Ct)pq3 ' — ( 2 -c -2 t+ 3 c t )p q 3V |/j&  - -
AB X BC 4pq3r . - ('/2C + t - 3/2Ct)pq3r (V2C + t - 3/2Ct)pq3r (2 — c —2t+ 3ct) p q3r- l v ' ( 2 - c —2t+3ct)pq3r ('/2c4 -t-3/2Ct)pq3r
AE X CC 2pqr3 - — ('/2C + t—3/2Ct)pqr3 ' 1 * :(2— c - 2 t - f  3ctjpqr2 ('/2C4-t-3/2Ct)pqr3
2p3r ('/2C + t - 3/2Ct)p3r — (2 -c -2 t4 -3 c t)p 3r -
4p3qr (’/2 C 4 t-3/2Ct)p3qr ('/2C + t - 3/2Ct)p3qr (2—c -2 t+ c t ) p 3qr [ :v (2 -c -2 t+ 3 c t )p 3qr -
A C / x A c y ; ^ 4p2r3 (V2c + t - 3/2Ct)p3r3 — (2 -V 2 C -t+ 3/2Ct)p3r3 - [ '< ;  ~  - ■ -
2pq3r - ('/2C + t - 3/2Ct)pq3r — ~ [f. (2 - c - 2 t+ 3 c t )p q 3r -
^C4*;B &(£'.:■- 4pqr3 - (V2C+ 1 - 3/2d ) pqr2 (V2C+ 1 - 3/  2d ) pq r3 “ j.- (2—c —2t4-3ct)pqr2 -
AC x  jCG, ;/; 2pr3 - — (V2C + t - 3/ 2Ct)pr3 [% ■ -
p3q3 - - p2qJ l : A  " -
O’
; 
q.
CM - - pq5 -
2pq3r - - pq’r ;;- I • > ’ rf y- ■ pq2r
BB, tx. BB j • q4 - - • • ,:'v ' -
B B lx B C y / ' 2q3r - - | v ; ' : q3r
BB X .CC ' ■ q3r3 - - ' q3r3
BC X AA 2p3qr - - (V2C -i-t-3/2Ct)p3q r ' i (2-^-c--2t4-3ct)p3qr -
BC X AB 4pq3r - - (Vjc + t —3/2Ct)pq3r . k ; (2 -c -2 t4 -3 c t )p q 3r (2 -c -2 t4 -3 c t)p q 2i
BC x  AC 4pqr - - O 7 O 
; 
■O f2 -c -2 t4 -3 c t)p q r 2 (V2C4-t-3/2Ct)pqr3
BC X BB 2q3r - - — • • * • ; v  - ( 2 - c - 2 t 4 - 3/2Ct)q3r
BC X BC 4q3r3 - - - (2 - V : C -t+ 3/2Ct)q
BC X CC 2qr3 - - (V2C4-t-3/2Ct)qr3
CC X AA p3r3 - - -
CC X AB 2pqr3 - - y: * & : - -
CC X AC 2pr3 - - •■w 1 -
, Q.C- .><.^ BETr; I.'- q*r*
j CC Vx^a^V 2qr*
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Table 2
T a b le  2
S u b st itu t io n  of k =  c +  2t -  3ct in th e  f r e q u e n c ie s  g iv e n  in Table 1
Mating
AA X AA
AA X AB 2pJq
AA X AC 2p3r
AA X BB p q
£
X BC 2p2qr
X CC p2i2
\B X A A 2p3q
AB X AB 4p2q2
AB X AC 4p’qr
r -x EJC 4pq2r
2pqr2AB X BC.
AC. X  A ( \ \ V  2P’r
AC, X AB : 
AC*X AC
4p2qr
4p2r2
AC X BB 2pq2r
AC X B.CX.
L*.;' f
AO X CC y;
4pqr2
AAA AAB AAC
ABA ABC '4' 1 ABC
pq
P r
(Vik)p3q
('/2k)p2qJ
('/2k)p2qr
AB B B ; /■ : \  • 2pq3
(V2k)p’r
(V2k)p2qr
(V:k)p2r2
p3q *: i':"' • _
P r
pq
p2qr p2qr
P r
(2—k)p3q ’/2kp3q
(2 - ’/ 2)p2q2 (2 -.V 2k)p2q2
(2—k)p2qr (V2k)p2qr (V2k)p2qr
(2-k )p 2qr
(V2k)pq3 (2—k)pq3
(V2k)pq2r (V2k)pq2r (2 —k)pq2r
(2—k)pq2r - /(2 - k )p q 2r
(V2k)pqr2 (2—k)pqr2
(2-k )p 3r
(’/ 2k)p2qr (2—k)p2qr
(2—k){p2qr)
(2 - V 2k)p2r2
(Vik)pq2r
(2—k)pq2r
(’/ 2k)pqr2 (V2k)pqr2
(2—k)pqr2
(V2k)pr3
(2-'k)fjqr2
(2 -k ) (p 2qr)
.(2 -k )p q 2r
' (2— k)pqr2 ,
BBC
(Y2k)p2qr
C/2k)pq2r
(V2k)pqr2
BB. x J A A , P2qJ
BB X  ‘ABt 2pqJ
B B X A C .. , - .  2pq2r 
BB x q4
BB X'BC. 2q3r
BB X CC
BC X AA 2p2qr
BC x  AB
L_------ -
BC X AC
4pq2r
4pqr2
EC- X BB 
Jb C X BC  
E C  X CC 
b e  X AA 
je e  X AB 
|CC X AC 
CC'X BB ; .  
'CC X .BC  
c c  x  CC' ■
2q3r
4q2r2
2qr3
p2r2
2pqr2
2pr3
q2r2
2qr3
P q
pq
pq r
(’/ 2k)p2qr (2—k)p-’qr ( 2 fk )p 2qr
('/2k)pq2r (2—k)pq;r i.(2 :-k }p q 2r
(V2k)pqr2 (2—k)pqr2 : :(2 -k )p q r2
~TT
pq r
q r
q2r2
(2 -k )p q 2r
(’/ 2k)pqr2
(2 -k )q 3r
(2—V2K)q2r2 
(V2k)qr3
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But it fails to take into account more complex systems such 
as a triallele system like acid phosphatase or a system with 
a 'silent* allele like haptoglobin.
Three Alleles at one Locus
Consider three allele A, B and C at one locus on the trisomic 
chromosome .with frequencies p, q and r where p * q 4* r = 1,
If c is the frequency of crossing over and t is the Frequency 
of second meiotic division non-disjunction the heterozygous 
parents will produce non-disjunctional gametes in the pro­
portions :
Gamete 1st Division 2nd Division
Non-Pis j unction Non-Pis i unction
AA, BB, CC (1 - t) (£c) - h)
AB, BC, AC (1 - t) .(1 - ic) ct
The results of such 36 possible matings arising from these 
gametes are given in Table 1.
i
If, as suggested by Goodman (4) these resulting mating fre­
quencies are simplified by substituting k = c + 2t - 3ct then 
the frequencies simplify to those shown in Table 2, The sum 
totals of the various trisomic frequencies from Table 2 become:
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:'.Phenotype F requency ' ' .
A A A y - ' P  3 4- H  k p - (1 —;p ).: •
'AAB-' , 3p2q 4 -H k p q ( l—; 3 p ) .
'A A C 3 p2r 4- Vz kp r( 1 — 3 p)
A B B 3pq24- Vz k p q (l ~  3q)
A B C 3pqr(2 — k)
BBC 3 q2 r 4- Vz kqr (1 — 3 q)
C C C r34 -}4k r2( l — r)......
B C C ' A 4 ;; , 3qr24 - H k q d lH ‘3,r)^4 V
B B B p c C '
I A C C ; '(- • '' 3pr24 -K  kpr(k“ 3 r ) .
But, as has been pointed out some of these may be indistin­
guishable in which case the frequencies above will become:
! P lien o ty p l* ;  F req u en cy  , ■ . j
I ;  '• P3+ H k p 2( l - p )  ' \y  !
j A B  (A A B + A B B ) p q (3 (l — r ) ( l -  C l ) 4  k )v  f 
j A C  (A A C 4 A C C ) p r (3 ( l—r )(l — F j k)
B C  (B B C + B C C ) q r(3 (l — r ) ( l •— yz k )4- k)
I ’‘-tv.-1 q34 - ^ k q 2( l - q )  . . ,  , I
C C C .  • r 34 - M k r 2( l ^ r ) . / , ‘: ' . y y ; '  (
A B C  6 p q r ( l -  >yk) . .vy‘- . - J
Unfortunately, the variant ABC will vary in mobility dependent
on the mobility of the three constituent electrophoretic bands 
and may be indistinguishable from any of the other heterozy­
gous forms.
Post-Fertilisation Effects.
If m is the proportion of trisomics whose non-disjunction
arises after fertilisation, then the frequencies of the above
phenotypes become:
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A,fiiend-;;‘
• type ^ "Frequency
A A A  ' (p3+ / ^ k p - ( l —p ) ) ( l—m )-f-m p2 
A B  (3 p q ( l—r ) ( l  — £ < k )-rk p q )(l — m )+ 2 p q m  
A C  (3 p r ( l—r )(l — 3-'2k)+pkpr)(l—m )+ 2 p r m  
B C  (3 q r (l—r ) ( l  — ^ k ) -r k q r ) ( l—m )+ 2 q r m  
B B B  (q3+ H k q 2( J - q ) ) ( l - m ) + m q 2 
. jC G C / i’-{ir3-r 3 ^ k ( l—r ) ) ( l—m )H-mr2 I 
'vAi3.C’.'1'(,6p q r(l — % k )(l — m )+ 2 p q r m  ;;
If a triallelic system such as acid phosphatase in which 
the normal (disomic) population is v;ell established i.e. 
p = 0.36.q = 0*59 and ■x/ = 0.05 for an English population (8) 
then these can be substituted in the general case (case 1 
Table 3) and it should be possible to obtain a general 
equation involving a chi square test between the normal 
(disomic) population and the theoretical trisomic population 
in terms of U (number investigated), k and m i.e.
: X~
.N'
Y  (g jr(P2m+(p«+^Kp^l -nVi A
p2 +
i2pr£M!Ha^i2£^^K)+Kpq)fl-.m))=
• ■: •••• '• 2p<i
etc- for all
)es.
seven possible phono- y*
For a significant shift to have occurred then for P = 0.05 at 
df c 6 then 54*“^  11.0. So for various values of K and m it 
should be possible to derive a series of curves involving N
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for that particular enzyme. For example in the red cell acid
phosphatase with p# q and r of the value shown above and 
2 \
x jj 11.0the above equation becomes:
| X ? % = 0 - 0 5 3 m 2 -0 .2 4 2 m + 0 .1 8 4  fo r  k - W
fo r  k=='0.5-' 
fo r  k = ijb 'r; C;. 
fo r  k 4 o \  •/
These equations for values of ro from 0 to 1.0 will give a 
series of curves as shown in Fig. 1 below.
5000 »• k-- l.o
k - 0 .5
Si. 1 0 0 «
£  50
0  0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1.0
Frequency of post-fertilisation Non-disjunction (m)
Fig. .IrtSdr.ies of curves relating the size 6f.:a: tps^nitc | 
PQjaul,it;oriVrequired to establish a significant^hhVqq- I 
type shift' Under differing conditions of crossing'-p^er, 
posf' fertilisation non-disjunction and 2n d i-rttetptic ! 
. 'cltvjsioh' non-disjunction. .; j
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Bi-Allelic System :
Goodman has derived the general case for a bi-all^iic system 
with alleles A and B:
Frequency
3 , 2 .
P * ip m
3p^g -t- ipqk (l -* 3p)
3pq 4* i pqk (l - 3q)
3 1 2.
q Hh 2 p q  I;
Combining the two heterozygote frequencies as before then a 
chi-square equation can be obtained as before:
ipq (1 - m)(l - ik)^
\diich will give a sorios of curves such as are shown in Fig.
-2. V . ;
2x
tf
Phenotype
AAA
AAB
ABB
BBB
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Fin. 2
i
3000
2000
1000
500.
200
Frequency of most common allele 
F ig. 2. S er ie s  o f cu rves relating the s iz e  of a  tr iscm ic  
p opu lation v required ’ to ,'estabfish ' a. .pheiid type sh ift for 
bi-a il,e!ic‘ § e n e s ; ita-differ3ngi''conq*itrorfs‘ of cr o ss in g -  
over; p o st-fer tlisa tion van d ; 2 n d ■-rriei’otiC: d iv is io n  n on-
Three Alleles - One ’Silent*
The theoretical frequencies derived in Table 2 would still 
hold, but with a silent gene it may not be possible to diff­
erentiate between, for exam pie AAA and either A00 or AA0, or 
between BBB and BB0 or B00 (assuming the C allele was silent)• 
Similarly ABC becomes ABO and will be indistinguishable from 
AB.
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Taking into account these possibilities and using the no­
tation as above, the frequencies of the tri-allelic system 
ABO where 0 is silent become;
F req u en cy  • '
A Q  ( A 6 ° )  p rm -{-(1—m )(3pr2+ ]A k p r(l — 3rj)
A &  ( A ^ A + A A O )  p 2m + p r m + ( l - m ) ( ( p 3+ 3 p 2r ) ( l - y2k)+J ^ k p f p i f r f' 
2 p q m + ( l —m )(( l — r)(3pq) -  (1 -  3r)Q <kpq))
p r r a + ( l- m ) ( ( 3 q r 2) + K k q r ( l - 3 r ) )
B B  J (B BB B B O) q2m -f-q r m + (l - m ) ( ( l  -  K k )(q 3+ 3 q 2r))
.p O .(Q O Q ) r2m -F (l —m )(r3+J'<kr2( l —r))
Application of the Theoretical Model
Table 3 belo\* shows the general and selected cases for a 
three allele system with the locus on the trisomic chromosome. 
Cases 4 and 6 are indistinguishable, but has been pointed out 
elsewhere (6) these, on a priori grounds, are most unlikely* 
Case 2 is the simplest with no crossing over, all non-dis­
junction occurring at the first meieotic division again on a 
priori grounds most unlikely* Unfortunately it is exactly 
these conditions that most investigators have assumed prior 
to comparing a disomic with a irisomic population. Applying 
the above derived equations it should be possible to arrive 
at a more realistic evaluation of the data and also to obtain 
for any gene frequencies an estimate of the minimum size of 
an experimental group required before significant differences 
can be established*
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Table 3
 ..........- '     ~  T a b le  3 “  ~ ‘ ■ 7
T h e  g e n e ra l a n d  s e v e ra l s e le c te d  s p e c ia l c a s e s  fo r  th e  f r e q u e n c ie s  .o f  a. th re e  a lle le  
s ys te m  w h e re  k =  c  +  2 t — 3 c t, c =  f re q u e n c y  o f c ro s s in g  o ver, t ^ t h e  .fre q u e n c y  o f 
s e c o n d  m e io tic  d iv is io n  n o n -d is ju n c tio n  a n d  m =  th e  p ro p o rtio n  o f . tr is p m ic s  w h o s e  n o n ­
d is ju n c tio n  a ris e s  d u rin g  p o s t-fe r t ilis a tio n  • " " '
C a se C ond ition s AAA AC AB BC BBB CCC ABC
1.. -V
0 < c < 0 .5
0 < t< 1
> 0< m <1
pJm +  [p3+ V 2Kp’ 
( 1 - p ) ] [ 1 - m ]
2prm +  [p r(3 (1 -r) 
(1 -]< /2) +  k r][1 -m ]
2pqm  +  [pq(3(1 — r) 2qrm +  [q r(3 (1 -r) q ’m +  fq’ + ’AKq2 
(1 — k/a)“ kpq]t1 — m] (1 — k /2) +  kqr][1 — m] ( 1 - q ) ] [ 1 - m ]  ,
[rJm + r 5+ V 2Krl
( 1 - r ) ] [1 -m ]
[6pqr(1 —k /2)] 
[1 —m]
c - 0
2.-. • ... ;V ;t= o  
;■ m = o
P3 3p3r+ 3prJ 3p3q + 3 q 7p 3qrJ+ 3 q 5r q 3 ; • 5 r3
3;
1 w  , .
c = 0  
■ .0 < t< 1  
• 0 < m < 1
p’m +  fp’ + p ’t 
(1 — P)J [1 — m]
2prm +  [3p r(1-r) 
(1 - t )+ 2 p r t ] [1 -m ]
2pqm  +  [3 p q (1 -r )  
(1—t)+2pqt][1 —mj
2qrm +  [3qr(1 —r) 
(1—t)+2q rt] [1 —m]
q3m,+ [q3+ q 3t ~
(1 - .q ) ] [1 -r o ]  :•
rJm +  [r3+ r 3t 
(1 —r)](1 -m ]
[6 p q r (1 -t)][1 -m ]
1 ,7 .;': : ; 'V = o _ : ■
4 '*•.
• 0 < m < 1
P7 2pr 2pq 2qr q5 : r3
5 : - '. :
; '  o < c < o .5  
• ;  t= 0  
0 < m < 1  ■
[(p3 +  p’c ( 1 - p ) ]  
[1 - m + p Jm]
2prm +  [3p r(1 -r) 2pqm +  [3p q {1 -r) 2qrm +  [(3q r(1-r) q3m i-[{q 34;q3c  
(1 - c / 2)+ c p r ][1 - m ]  (1 - c / 2)+ c p q ] [1 - m ]  (1 - c / 2) +  c q r ][1 -m ]  (1-.q)3[1 —mj
r3m +  [r3+ r 3c  
( 1 - r ) ] [ 1 - m ]
[6pqr(1 — c/2)]
[1 - m ]
c = 0
B
i
m = 1  
t =  0
P* 2pr 2pq 2qr q5 .- :-. • . . . ;  . rJ
i
7
0 < c < 0 .5
t= 1
;0 < m < 1
p’m +  [p5( 1 - c + p c )  
(1 —r)3] [1 — m]
2prm +  [3 p r (2 -c  
(1—3q) +  pr(2—2c)] 
If —m]
2pqm  +  [3 p q (2 -c )  
(1 —3r) +  (2—2c) 
p q )[1 -m ]
2qrm +  [3 q r (2 -c )  
(1 —3P)][1 — m]
q Jm +  [q5(1—c) , 
( 1 - q  +  q3] [ 1 - m ]
r3m +  [r3(1—c +  
rc)][1 — m]
6 p q r c (1 -m )
' y c = o 
7^ t  =  0 
•" .v 0 < m < 1
p’m +  p ^ l - m ) 3pr(p +  r )-p r m  
(1 -3 r )
3pq(p +  q -  
pqm (1—3r)
3qr{q +  r)~  
qrm (1 — 3 r)
q 5m + q ’( i “ m) . r3m + r 3(1 - m ) 6 p q r (1 -m )
Use of Multiple Gen© Frequencies
Consider two bi-allelic genes, one of which is presumed to 
be located on the trisomic chromosome, AA(p ), AB(2pq) and 
BB(q^) andCCC/CDD/CCD/DDD (C = r, D = s); the frequencies of 
the various combinations are shown in Table 4. Also shown in 
Table 4 are the frequencies if both gene loci are located on 
the trisomic chromosome (in italics).
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From Table 4 it is possible to derive an equation to establish 
the minimum number of tests to confirm that the gene is 
located on the trisomic chromosome;
2
~ = 2(1 - m)^( (r^ + i rsk)^ + rs(i(l-k)^) ....... 1.■ :
for df ss 8, P = 0.05 when x^ = 15
Comparison of the above equation with that of a single gene 
analysis:
£rs (l - m)^ (l - k)^ ••••••• 2.
for df s 2, P = 0.05r x^ = 6.
It is of interest to note that in equation 1 above, the fre­
quencies of the disomic chromosome are eliminated and only 
the trisomic chromosome contributes to the final value of N^ *"
With the tv/o equations for any value of. gene frequencies it 
is possible (using a limiting value of k and m) to establish
and For example for the Gc proteins with r = 0.7, if
k = 1.5 and m = 0 then (two genes) = 1278 and Ng (one gene) 
= 932.
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Selection of Limiting Values of k and m
In the proceeding derivations and curves a limiting value 
of k = 1.5 has been taken. To apply the derived equations
t
some limiting value must be accepted but this need not be 
an arbitrary value. There is some evidence in the reported 
literature on this problem.
Lejeune (9) has shown that if the effect of crossing over
is ignored, and that if the gene products are quantitative
2and additive then for a bi-allelic system with AA(p ),
2-AB(2pq) and BB(q ) it follows that the expected mean for the
2gene product would be 2(pA + qB) with a variance 2pq(A-B) 
and thus the ratio' V/M for normals would be:
For trisomics with non-disjunction occurring at the first
2pq(A - B)2 
2(pA - qB)
meiotic division the frequency of the phenotypes would be
3
given by the expansion ot AP + q) with a mean 3(pA - qB) and
2
a variance 3pq(A - B) * i.e. for trisomics the ratio V/M 
would be:
3pg(A - B) 
3(pA + qB)
2
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i.e. if the non-disjunction occurred at the first meiotic 
division the ratio of V/H would not be changed. If the non­
disjunction occurred at the second meiotic division the mean 
would be:
3(pA *r qB) and V = 5pq (A - B)^
i.e. the value of V/M for the trisomics would be 5/3 times
higher than the normal disomic counterpart.
Lejeune claims to have analysed data on alkaline phosphatase, 
galactose uridyl transferase and urinary kinurenine and shown 
the ratio V/M to be significantly higher in the Down* s group 
pointing to a second division error with t 1.0 in v/hich 
case m 0. The effect of the crossing over will be to 
reduce the increase in the value of the V/M ratio. Thus with 
k = c + 2t - 3ct then the overall limiting case will be in
the region of k = 1.5 when m = 0.1. This estimate finds
confirmation in the analysis of blood group data by Goodman 
( 6) who suggested that non-disjunction arose post-zygotically 
or during second meiotic division with k = 1.31 with an upper 
limit of c = 0.35.
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Value of a Mathematical Model
The usefulness of a mathematical model will depend on its 
ability to predict possible mechanisms or in its use to 
correct the design of experimental procedures. Reverting 
to Fig. 2 above, if we •■assume the limiting values of k = 1.5 
and m = 0.1 then for any gene frequencies it is possible to 
establish the number of Down’s subjects required to 
establish a phenotype shift.
In Table 5 the minimum number of Down’s subjects are shown 
for eleven gene systems of varying origins and it will be 
seen that much greater numbers than has been hitherto sus­
pected would be required to detect the phenotype shift by a 
simple chi square test, numbers that have never been achieved 
in any investigation (including this one).
This lack of statistical power of the chi square test has led 
to the use, throughout this investigation of the Haldane log 
ratio test, the validity of which will be tested in the next 
paragraph.
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Table 5
. . T r.b !6  '5  .
T h e  m in im u m  n u m b e r  o f ! t r is 6 m ie M r i8 $ i3 u a ^  p re s e n c e  o r  a b s e n c e
o f a  ''pi/fiAqtypp^s'hift in -Uvo l im if in g ^ ’ori'd itiohs
Polym orphic system S o u rce
Frequency  
o f m ore  
com m on  
a lle le
Minimum num ber of su b jec ts  
required to  e stab lish  a 
p h enotyp e shift 
k = 1 .5  m = 0 .1  k = 1 .0  m - 0
R eferen ce
|G rou p -sp ecific
proteins
Serum 0.71 1166 233 H irschfield  (1962)
Haptoglpbfn.;- Serum 0.618 1008 202 H oglund, Heiken. .& Hairge' 
(1970)
phdspfidc/luco-
rn.utas'e^.-.t3,:,:’
R .B.C. 0.74 1232 • 249 H opkinson & Ha'rris! (1^68j
Phosph'ogluco- 
m uiase.-*- 1
R .3 .C . 0.76 1299 263 H opkinson & HdLrrl#;f.(1966)
A d en osin e' d eam in ase R.B.C. 0.94 4202 851 S p e n c er , H op k in son '/^ H arr is  
(1968) ,
;Adeny{at9‘;< k inase R.B.C. 0.955 5517 1115 R apley et al. (1957) - '"'
A m ylase T Saliva 0.96 6250 1250 Laxova & Kamaryt (1970)
A m ylase -  2 P an creas 0,955 5517 1116 Laxova & Kamaryt (1970)
B -p hosp h oglu con ate
d eh y d ro g en a se
R.B.C. 0.967 7427 1505 F ild es & Parr (1963)
'
G1 utam ate-pyruvate  
tran sam in ase
R .B.G v; V . 0.504 : 960 .. 192 C hen & G ibteit (1971)
P e p s in o g en U rine, i-' ■ .•'•••0.62 i r>. 0 i9 -‘ •“ -  • 2U4'-‘ ' Sam loff & T ow nes (1970)
Testing Jor Phenotype Shift Using Log Ratio Test*
If out of H affected persons H had characteristic a and iC 
had character b* and in n unaffected persons the correspon­
ding frequencies were h and k then the log test is given by s
Ln (2h * 1) (2K+ 1) 
(2H-.+ 1) (2k 4* 1)
with a variance 1 * 1 4 1 + I
H K h k
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From the equations derived above in a population of N tri­
somics the number of heterozygotes (AAB 4* ABB) (bi-allelic 
system) would be:
N( (l—  ni)(pq(3 - 7) + 2pqm) ) 
and the number of homozygotes (AAA 4- BBB) would be:
(l - m)(p^ 4- q^  4- ipqfc) 4-m (l - 2pq) )
and for the control (disomic) the corresponding frequencies 
would be:
n(2pq) and n(p^ 4- q^).
Applying these four equations to the Haldane log ratio test
S- '^f?N((p3 + q3 + Hpqk)(l—
' v 2pq)) +  l)(4pqn+$)*■■ - r
L!a ' i-il r,— - - - - - - - T T o  1 / 1  . o  1 .q \ ;-(2N(pq(l — m)(3 — y2 k-t 2pqni)) 'r ] )
(2n(p2+ q 2K  I ) " ' - '  *•
variance
1
v (p:i +  q3+  2^p q k )(l~ in ) +  (l — 2pqk) 
1
- ni)(3 -  y2k)) 1 2pqm • ,
- + -— 1  ‘ *, *V
: ; " , :;;n(p3t:q 2) n(2pq) ' j.
These two equations, although appearing unwieldy, enable the 
investigator to predict for any number of controls and trisomic
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the minimum number of trisomics required to establish a 
phenotype shift.
For example, in the haptoglobin system reported in Section 2, 
it was found that on a sample of 254 Down's subjects the
1 2
frequency of the Hp gene was 0,419 and Hp 0.581 such data 
applied to the top curve in Fig. 2 (k s 1.5, m s 0.1) would 
suggest a minimum number of 1000 Down's to establish a pheno­
type shift by chi square (see also Table 5). Applying the 
same data (assuming N = n = 254) to the above equations the 
Ln estimate (assuming haptoglobin was located on chromosome 
No. 21) would be 0.437 i^ ith a variance of 0,13, Lc. with such 
a gene frequency 254 cases would be sufficient. However when 
the log ratio test is applied the estimate was found to be 
0.164 with a variance o f 0.14, i.e. there is no significant 
phenotype shift.
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SUMMARY
In this section a critical evaluation of the use of the 
phenotype shift in the gene location on the trisomic chromo­
some has been made. It has been shown that when such factors 
as crossing over, post fertilisation non-disjunction, etc. 
are taken into account, the use of the simple chi square 
requires much larger numbers of subjects that were hitherto 
believed. It was also shown that the use of two gene in the 
calculations aggravated the problem. Finally it was possible 
to shovf that the use of the Haldane log ratio test consid­
erably reduced the numbers required, and this v/as success­
fully applied to on the haptoglobin data.
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SECTION 7
SYNTHESIS .
" ail the business of life is to endeavour to find 
out what you don't know by what you do, that's 
what I called guessing what was on the other side 
of the hill.”
Duke of'Wellington*
- 233 -
Section 7
In this final section an attempt will be made to summarise 
the findings of this investigation and to point out those 
areas in which further investigations might be profitable*
In the first section, quantitative and qualitative data 
were presented on a number of serum and plasma proteins and 
glycoproteins* No evidence of structural changes in the 30 
proteins investigated could be detected, nor could a report­
ed change in the fragment of the IgG component be con­
firmed* The literature on the levels of serum proteins was 
reviewed and shown to be, for the most part, in conflict.
By careful selection of control subjects from among their 
institutionalised peers, the subjects with Downfs syndrome 
were shown to deviate much less than might be expected after 
a superficial search of the literature* Contrary to expec­
tation a significant reduction in total protein was noted, 
principally due to the low levels of albumin encountered, but 
the contribution of the lower levels of the - and p - 
globulins was seen. A significant reduction in the levels 
of the ■ - and J3 - glycoproteins was observed, a finding 
contra-indicated by the observations on the quantitative 
levels of these proteins by radial diffusion* The diver­
gence of findings by the two techniques was suggested to be
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mainly due to technical difficulties with the electropho­
retic bands being heterogeneous for a number of proteins 
for v/hich no anti-sera are available. Two of the four 
immunoglobulins investigated were found to be elevated 
(igA and IgD), and four of the specific proteins appeared 
suspect when compared with reported normal data 
( c^-antitrypsin, transferrin, c^-acid glycoprotein and 
haptoglobin) but comparison with mentally retarded control 
subjects eliminated all but the o(^-acid glycoprotein.
Section 2 dealt'with "-a number of serum and red cell poly­
morphic systems, and in addition to comparison of the fre­
quency distributions, the data on these were analysed for 
a number of factors (age, sex, etc.). The most significant 
finding in this section was of an altered frequency distri­
bution of the Gc system, with an increase in the proportion 
of the heterozygotes at the expense of both homozygous forms. 
Reference back to the previous section on the quantitative 
levels of these proteins v/as made, and this, together with 
the reported linkage between the Gc proteins and albumin 
cast considerable doubt on the location of the Gc system on 
the trisomic chromosome. In section two a number of pheno­
type association studies v/ere made with little success, and 
a number of frequency changes in several systems reported by
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other investigators was not upheld. An interesting sex 
difference in the phosphoglucomutase system was noted for 
the Down's subjects and an apparently abnormal distribution 
of haptoglobin frequencies in the control subjects but not 
the Down's subjects confirmed a similar finding reported 
elsewhere.
Section 3 investigated the effect of parental age on five 
polymorphic systems suitable for such an analysis, and a 
bimodal distribution in the frequency of the haptoglobin 
heterozygotes was observed. This bimodality was in evidence 
for both paternal and maternal age, but by analogy with 
previous studies it was suggested that the paternal age effect 
was the resultant of a high maternal:paternal age correlation. 
The possibility that this observation was due to sampling 
errors v/as reduced by the failure to find a similar bimoda­
lity in the other polymorphic systems investigated.
In section 4 the much-reported increased rate of infection in 
Down's syndrome was investigated, and a high frequency of 
hepatitis-associated antigen (Australia antigen) was en­
countered. Using this antigen as a criteria the Down's sub­
jects were sub-divided into those susceptible to infection and
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those not, and nine of the polymorphic systems were compared 
both singly and in multiples between the two groups. Even 
after applying a number of statistical techniques no 
evidence of decreased fitness with respect to any of these 
polymorphic systems could be detected. In this section also, 
a number of liver function tests were carried out and compari 
sons between the antigen positive and antigen negative 
subjects were made in an attempt to assess if the higher fre­
quency of hepatitis might lead to severe enough liver damage 
to affect the levels of the serum proteins. The final im­
pression was that if such an effect was in operation the 
resulting change would be minimal.
Section 5 was confined to a comparison of the Down's group 
and 54 subjects with Tuberous Sclerosis in an attempt to 
estimate if selection by mortality played a significant part 
in either the levels of the individual proteins or in the 
frequency distributions of the polymorphic systems. In two 
polymorphic systems (haptoglobin and Gc proteins) abnormal 
distributions were detected in the Tuberous Sclerosis subject 
the suggestion made in Section 3 that the abnormal distribu­
tion of Gc protein frequencies in Down's syndrome not being 
due to the locus being on the trisomic chromosome was 
strengthened.
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In Section 6 a critical evaluation of the use of the pheno­
type shift in the gene location on the trisomic chromosome 
was made by the development of existing mathematical models 
to include three alleles at one locus and three alleJj2s one 
being of the silent variety. Applying these derived 
equations an estimate was made of the number of Down's sub­
jects required to produce a significant phenotype shift for 
several gene frequencies and the short comings of this and 
other surveys was pointed out. Using the derived equations 
it was shown that using pairs of genes had no advantage in 
reducing the numbers required, but the application of the 
Haldane log ratio test to the frequency distributions v/as 
far superior to the use of the simple chi square.
Future Developments.
The possibilities arising out of the search for new antigeni- 
cally-identifiable serum proteins and the addition to the 
range of anti-sera for the estimation of those presently 
known in serum is ‘stifficiently obvious not to require elabora­
tion, but the investigation of the polymorphic proteins (both 
genetical polymorphisms and tissue isoenzyme systems) require 
some brief observations. Most common diseases seem to have a 
polygenic background, this includes such a diversity as the
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common birth defects as well as common diseases of the adult 
as the major psychoses, diabetes, peptic ulcer, rheumatic 
arthritis, atherosclerosis, hypertension and psoriasis, 
where multiple genes appear to interact with unknown factors 
to produce the necessary phenotype. Differential population 
frequencies are known for birth defects, thus cleft lip and 
palate have a high frequency among the Japanese, an inter­
mediate frequency among Europeans and a low frequency among 
negro races (i). While no absolute proof exists that these 
differences are genetical, this hypothesis is most likely. 
What is also likely on a priori grounds is that polymorphisms 
affecting developmental proteins exist and will be associated 
with small deviations in enzyme activity. With only two 
polymorphisms interacting, a given developmental process 
could be placed beyond the required threshold and a resulting 
developmental defect arise. However a full understanding of 
all the genes and all environmental problems affecting a 
given process may fail to lead to full understanding or pre­
vention. Identical twins usually have a concordance of less 
than 50% for common birth defects while non-identical twins 
have concordence rates around 5% (2). Since identical twins 
share a common gene pool and a similar uterine environment 
this frequent lack of concordence suggests that the processes
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may have an indeterminate aetiology. In other words neither 
hereditary nor environmental factors may adequately account 
for the defect which is postulated to be caused by random 
failure of a given developmental sequence to occur.
If we agree with Motulski that the total number of human 
structural genes to be 50.000 and that some 25$ of these are 
polymorphic then the possibilities would seem endless (3) and 
taking into account the observations made above the scope 
would seem infinite. But finite or infinite as the scope may 
be, this investigation has shown, if nothing else, the need 
for the careful definition of the Down's subjects under in­
vestigation, with factors such as age, sex, maternal age 
distribution and patterns of infection rate and mortality to 
be taken into consideration before any valid conclusions can 
can be drawn from the data. The role of the various pheno­
type distributions in such studies as the susceptibility to 
disease and mortality, and possibly in the process of non­
disjunction will eventually throw more light on the patho­
genesis of the syndrome that the simple gene location on the 
additional chromosome. Finally, for purely logistical reasons 
two principal lines of investigation remained outside this 
investigation, namely the foetal proteins in the prospective 
Down's child, and extensive family phenotyping. It is
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respectfully suggested that these two fertile fields ov/ai 
the investigator with the time, energy and practically un 
limited resources.
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APPENDIX
SELECTION OF SUBJECTS
Down's Syndrome
The 256 Down's subjects which form the basis of this in­
vestigation were all resident in two large hospitals for 
the mentally subnormal, St. Lawrence's Hospital, Caterham 
(total population 1720) and Royal Earlswood Hospital,
Redhill (total population 1145). Both these institutions 
draw their patients from approximately the same geographical 
area of South London and Surrey, which is an area of mixed 
ethnology. By examination of the subjects name, appearance 
and family background an attempt was made to exclude any who 
were not of Caucasion origin.
The sample consisted of 114 females and 142 males, the age 
distribution of the sample is given in Table 1.
The original choice of subject was made on the basis of 
clinical diagnosis but each case was confirmed by chromosomal 
analysis of peripheral blood. Only those subjects shown to 
be trisomic for chromosome 21 were finally accepted, those 
cases exhibiting mosaicism (4 cases), and translocation
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(3 cases) were not included. The chromosomal investigation 
of only one tissue (in this case peripheral blood) does not 
totally exclude the possibility of mosaicism in other 
tissues, and such mosaics might occur in the sample. All 
the chromosomal investigations wore carried out by the 
Cytogenetical Laboratory at St. Lawrence*s Hospital, and I 
am indebted to the members of that department and to 
Dr. 6.W.R. Richards for making available their records.
Drawing any sample of subjects from a institutionalised 
population, as this investigation does, is bound to introduce 
some degree of bias in the sample, and this bias will vary 
considerably from one institution to another depending on 
local priorities for admission• In general, admission only 
takes place when social pressures are present in addition to 
medical reasons. In a follow-up survey of Down's subjects in 
Denmark, Osier and van den Tcmpel (l) showed the reasons for 
institutionalistic os being:-
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Table 1
Down8s Syndrn. Tuberous Scl. Controls
Aae Group No. cf./±... Cv.% No. rf Cu No. . af /» Cv.%
0 5 2 0.78 0.78 0 0 0 0 o 0
5 - 9 ; : 9 3.5 4.3 0 0 0 24 2.8 2.8
10 mm 14 '24 9.4 13.7 4 .7.4 : 7.4 40 4.7 7.5
15 - 19 35 13.7 27.4 ■ ' 8 ■ 14.8 22.2 68 7.9 15.4
20 - 24 27 14.5 41.9 9 16.7 38.9 74 8.7 24.1
25 - 29 35 13.7 55.6 ‘ ' 11 20.4 58.9 84 9.8 33.9
30 - 34 40 15.6 71.2 7 13 71.9 96 11.2 45.1
35 - 39 24 9.4'; 80.6 4 7.4 ■' 79.3 95 11.1 56.2
40 - 44 20 7.8 ;■ 88.4 5 9.3 88.6 92 10.8 67.0
45 49 10 3.9 92.3 ' 4 7.4 95.9 63 7.4 74.4
50 mm 54 ' 9 3.5 95.8 2 3.7 99.6 52 6.1 80.5
55 - 59 8 3.1 98.9 0 0 100 52 6.1 86.6
60 *» 64 3 1.2 100 0 0 100 50 5.7 92.3
65 - 69 0 0 100 0 0 100 36 4.2 96.5
70 *8*. 0 0 100 0 0 100 27 3.2 100
Table 1. Age Distribution and Cumulative % Distribution
of 256 Subjects with Down8s Syndrome, 54 Subjects 
with Tuberous Sclerosis and 853 Mentally Sub” 
Normal Control 'Subjects*
Mother exhausted. ................*80
Broken family. ...••.•..•••••••...... 47
Disturbance of sihs................. 44
Physicians advice..••••••..••••••....43
Best for subject.  .......••.••••.36
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Other reasons 
No answer. • • •
This selection of subjects among those which have proved 
an unacceptable financial or social burden on their imme­
diate family probably explains the excess of mentally sub­
normal patients arising from the lower socio-economic 
groups (2 - 9). Table 2 compares the social doss distri­
bution of the Down’s and control groups (os defined in-the 
classification of Occupations 1960 (10) ) with the census 
data for London and the proportional distribution of 
mentally subnormal subjects (11)0
Table 2
Social Class (per thousand)
Group JL + 11 111 IV * V
Present survey (Down’s) 124 495 .381
Present survey (Controls) 149 416 435
Census (London) 170 542 287
Kent* Subnormal Hales'" 76 325 599
Kent. Subnormal Females 89 269 642 .
Registrar General’s Statistical Review (11).
Table 2. Social Class Distribution per Thousand of the
Down’s and Control Subjects Compared with Censes 
Data and other Surveys on the Mentally Subnormal.
26
29
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From Table 2 it can be seen that both the Down’s and control 
subjects show a similar excess of subjects of social classes 
IV and V at the expense of classes 1 and 11, that this bias 
is less extreme than the data on England and Wales quoted 
above is probably due to the abnormal socio-economic distri­
bution to be found in S.E. England favouring classes 1 and 
II. Whether such a socio-economic bias could influence the 
data in this investigation has not been pursued as it would 
require a much greater sample than was available, but in the 
relevant sections it was noted that there were changes which 
might arise from such bias (2, 3).
Control Subjects
The control subjects were drawn from one of the two hospitals 
described above (St. L,) and were not so much selected as 
those subjects remaining after a number had been rejected for< 
several reasons. A subject was rejected from the sample if 
there was any case for non-Caucasian origin, or if chromo­
somal investigation showed any additional or loss of 
chromosomal material. No subject was included if the records 
showed any medication for the three months proceeding the 
investigation (eliminating possible changes through enzyme 
induction) or if the subject had been exposed to long term 
medication such as barbiturates which could have led to liver
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damage. It has been suggested that among the non-specific 
causes which could bring about biochemical changes (albeit 
transitory) is the emotional shock of being institutionalised 
(12) and for this reason no subject was accepted for invest­
igation who had been resident for less than one year.
After selection as outlined above, a control pool of 853 
subjects remained from which, at random the various control 
groups described in the various sections were drawn. The age 
distribution of these 853 (198 females and 655 males) is 
shown in Table I above. For purely logistic reasons, not all 
of these control pool could be investigated for etch parameter, 
but there is no reason to suppose that the smaller control 
groups differ in either age distribution or kind from the 
larger control pool. The control pool and the Down’s group 
being drawn from the same hospital populations could be 
assumed to be in receipt of similar diets and vaccination 
regimes. In neither the Down’s nor the control pool were any 
subjects in receipt of specialised diets.
Any attempt to list the diagnoses of the control pool would 
create the false impression that the clinical cause of their 
subnormality was known. In any mentally subnormal population
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the greater majority of cases can only be classified in terms 
of the severity of the reduced intelligence, or in terms of 
the approximate dating of the initial insult (prematal, 
perinatal or post-natal etc.), classifications which are 
crude even at the best. In his survey of 800 cases admitted 
in a ten year period at the Fountain Hospital, Berg (13) could 
only establish specific aetiological factors or distinct 
syndromes for only one third of the cases. Table 3 below 
divides the control pool into three degrees of severity of 
mental defect, idiot (i.e. IQ 0 - 50), Imbecile (IQ 51 - 80) 
and Feebleminded (IQ 81 — 100) by age.
- 249 -
Appendix
Age Group
Tabl<
Idiot
2 3
Imbecile
Feeble­
minded Total
5 - 9 1 19 4 24
10 - 14 2 32 6 40
15 - 19 ■ ■: 4 54 10 68
20 - 24 5 58 11 74
25 - 29 5 66 13 84
30 - 34 6 76 14 96
35 - 39 6 75 14 95
40 - 44 5 . 74 13 92
45 ~ 49 4 50 9 63
50 - 54 3 41 8 52
55 - 59 3 41 8 52
60 - 64 2 41 7 50
65 - 69 2 29 5 36
70 + 1 22 4 27
49 678 126 853
Table 3, 853 Mentally Subnormal Subjects in the Control
Pool in Three Degrees of Severity of Mental 
Defect by Age (Years).
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Tuberous Sclerosis
Section 5 reports on the comparison of 54 subjects with
trol groups in an attempt to estimate any effect on either 
circulating protein levels or phenotype distributions by 
selection by mortality. In the selection of the subjects 
with T.S.,the mortality data of Down's subjects as reported 
in the li^rature was considered and compared with the 
reported mortality figures for T.S. This data is compared 
in Fig. 1, the Down's data is based on a number of surveys 
(14 - 19)t and it will be seen that in the 0 - 5  year age 
group two curves are represented, the upper curve is based 
on the earlier data of Carter (14) and Record & Smith (19) 
and predating the general use of antibiotics show a sig­
nificantly higher mortality.
Tuberous Sclerosis (T.S.) and the Down's subjects and con-
Fig. 1. M/irt-nl.i.ty. Data, .(f.rnm, pithl is had, dntn).. on. D.emn-'-& 
by.nrl.r,pine 40 .1.9.50.,,, x. p,fl.s.i».i&Sfl.).-..rtnxl
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Mortality data on T.S. is much more scanty and less reliable 
than that on Down's syndrome. Bielchov/sky and Gallus (20) 
in a survey on 78 cases reported death in 22 cases by the 
5th year, 35 by the 10th year, 67 by the 25th year and 76 by
the 50th year. Vaas on 128 cases reported a mere Z% death
by the end of the first year, by the 10th year and 75%
by the 25th year (21). Shrieg & Bornstein (22) reported 30/^  
dead by the 5th year and 75/6 by xhe 20th year. These data 
are combined and smoothed by eye in Fig. 1.
The cumulative mortality of 30/» for T.S. subjects of 5 years
or less is probably a gross under-estimate. The majority of 
the cases are originally diagnosed by the triad of features, 
mental subnormality, epilepsy and sebaceous adenoma v/ith only 
the latter feature differentiating the syndrome from a number 
of other causes of epilepsy and mental subnormality. The 
appearance of the sebaceous adenoma, however, is often late, 
Dawson (23) reported the appearance between 5 and 13 years, 
in their report on eight cases Do La Cruz and La Veck (24) 
gave a mean of 4.5 years and Kofman 6 Hyland (25) reported 
that the appearance of the sebaceous adenoma could be as late 
as 26 years. This late appearance of the principal diagnostic 
feature would bring about a number of missed cases in the
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0 - 5  year group which would increase the mortality probably 
to the 50/S mark of the Down's subjects. In this respect it 
is of interest to note that in his survey on a number of 
families Borberg (26) found only one case of T.S. in each of 
the 0 - 5 and 5 - 10 groups both of whom were dead, and of 
four cases in the 10 - 15 year group three were dead.
Taking the above data on the mortality in the Down's and T.S. 
group it seems reasonable to suggest that both show very 
similar mortality rates in the first five years after birth 
with some half of them not reaching their fifth birthday, and 
if selection by mortality was in operation then the maximum 
pressure would be exerted during this period. Of course it 
is possible that this selection in the first five years of 
life is just a continuation of factors operating in pre­
natal periods, but unfortunately there is little reliable 
evidence of prenatal death rates in Down's syndrome and none 
at all for T.S.
The T.S. subjects investigated in Section 5 were all resident 
in a number of hospitals for the mentally subnormal, and all 
presented the triad of diagnosable features of mental sub­
normality, epilepsy and sebaceous adenoma. All the subjects 
■were selected by age, only those over 10 years were included
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and the age distribution of the 54 cases investigated are shown 
in Table 1.
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